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Abstract 
 
New general methodology for the stereoselective synthesis of unnatural -amino 
acids has been developed.  Early work focussed on investigating methods for the 
generation of chiral allylic alcohols using cross-metathesis of a simple enone with 
various terminal alkenes, followed by an asymmetric ketone reduction. 
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The allylic alcohols were then converted to protected allylic amines via Overman 
rearrangement chemistry.  Oxidative alkene cleavage and hydrolysis of these 
intermediates generated a range of -amino acid targets.  Attempts were also 
made to apply the developed methodology to the synthesis of a simple -
disubstituted -amino acid target. 
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The Overman rearrangement was also applied to the generation of a late-stage 
intermediate which could be used in the synthesis of (2S,3S)-capreomycidine, a 
component of a number of peptides which exhibit antibacterial activity. 
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1.0 Introduction 

1.1 -Amino acids 

1.1.1 Properties of -amino acids 
-Amino acids are very important natural products, which constitute the subunits of 
proteins.  Their prevalence in nature means that they have a vast range of potential 
applications across many fields including biology, medicine, and chemistry.1 
 
-Amino acids exist in either the D or L form, as shown in Figure 1 and all of the 
natural proteinogenic examples are of the L form with the exception of glycine (R = 
H), which does not bear a stereogenic centre. 
 
NH2
HO2C R
H
L-amino acid
NH2
HO2C H
R
D-amino acid  
Figure 1. -Amino acid structures 

,-Disubstituted -amino acids bear an additional group on the -carbon atom 
relative to their natural counterparts (Figure 2), and this gives these compounds a 
number of interesting properties.   
 
NH2
HO2C
R2
R1  
Figure 2.  ,-Disubstituted -amino acids 
 
The incorporation of these units into peptides gives rise to a number of unusual 
secondary structures as a result of the additional steric bulk.2,3  ,-Disubstituted 
-amino acids can therefore be used to design and synthesise peptides with 
relatively rigid, well-defined secondary structures which may give rise to improved 
substrate specificity and biological activity.  The lack of an -hydrogen atom also 
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means that these structures have the potential to act as enzyme inhibitors which 
have the ability to bind to an active site, but not to undergo a number of standard 
enzymatic reactions.  The ,-disubstituted -amino acid motif is found in a 
number of pharmaceutical compounds, such as methyldopa 1 (Figure 3), a known 
anti-hypertensive drug.4 
 
HO
HO
OH
O
NH2
1  
Figure 3.  Methyldopa 
 
While many methods for the synthesis of -amino acids have been published in the 
literature, with the addition in recent years of methodology for generating ,-
disubstituted examples, there remains the need for fast and efficient syntheses of 
both classes of compounds which are flexible for the generation of a wide range of 
these targets with varying side chains.  In particular, routes which lead to the 
formation of these compounds in a highly enantioselective manner are desirable. 
 
 
1.1.2 Previous syntheses of -amino acids 
The development of methods for the enantioselective synthesis of -amino acids is 
commonplace in the literature and often makes use of the chiral pool, or 
approaches using chiral auxiliaries5 or chiral catalysis.6,7  While a detailed review of 
these methods is outwith the scope of this thesis, selected examples of approaches 
to their synthesis are summarised below: 
 
 Asymmetric addition of cyanide to aldehydes (Strecker synthesis) 
In 1850, Strecker first published a method for the synthesis of -amino acids which 
involves the condensation of an aldehyde 2 with ammonia to give a Schiff base, to 
which cyanide can be added, yielding an -amino nitrile intermediate 3.  
Subsequent hydrolysis then yields the racemic -amino acid product 4, as 
summarised in Scheme 1.1.8 
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Scheme 1.1.  Strecker synthesis of -amino acids 
 
More recently, asymmetric variants of the Strecker synthesis have been reported in 
the literature, which make use of both organocatalysts and metal catalysts,9 and 
the first of these was reported in 1996 by Lipton and co-workers.10  This method 
makes use of a diketopiperazine organocatalyst 7 in the generation of the -amino 
nitrile intermediates 6 from pre-formed imines 5, as shown in Scheme 1.2.  
Formation of the -amino nitriles proved successful in high yield, and with high 
enantiomeric excess values observed in the products with a range of substituted 
aryl groups.  For example, when R = Ph, a 97% product yield with >99% e.e. was 
reported.  This approach was not applicable, however, to examples with 
heteroaromatic or aliphatic R groups, where e.e. values were as low as <10%. 
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N
Ph
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HN
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N NH2
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Scheme 1.2.  Diketopiperazine-catalysed Strecker synthesis 
 
 Catalytic asymmetric hydrogenation of dehydroamino acids 
A particularly efficient method for the stereoselective synthesis of -amino acids is 
the asymmetric hydrogenation of dehydroamino acids using metal catalysts, 
typically rhodium(I) or ruthenium(II), complexed with a chiral ligand which can be 
capable of achieving addition of hydrogen across a carbon-carbon double bond in a 
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highly enantioselective manner.  An early, well-known example of a chiral 
phosphane ligand used for this reaction is DiPAMP 11, a dimeric form of 
methylphenyl-o-anisylphosphane (PAMP) which was developed by Knowles and co-
workers.11  The utility of this ligand, complexed to rhodium, is highlighted in its 
application to a key step in an industrial synthesis of L-3,4-dihydroxyphenylalanine 
(L-DOPA) 10, a drug used in the treatment of Parkinson’s disease.  The 
dehydroamino acid intermediate 8 can be hydrogenated enantioselectively in the 
presence of [Rh(DiPAMP)(COD)]BF4, giving the protected L-DOPA derivative 9 in 
quantitative yield, and with an enantiomeric excess value of 95%.  Completion of 
the L-DOPA target was then achieved by removal of the protecting groups under 
acidic conditions, as shown in Scheme 1.3.12 
 
MeO
AcO
NHAc
O
OH
MeO
AcO
NHAc
O
OH
[Rh(DiPAMP)(COD)]BF4
100%
H3O
+
HO
HO
NH2
O
OH
95% e.e.
P P
OMe
MeO
11
DiPAMP
8 9
10  
Scheme 1.3.  Synthesis of L-DOPA via asymmetric hydrogenation 
 
 Asymmetric carbon-nitrogen bond formation 
It is possible to incorporate the -amino group of -amino acids using either 
nucleophilic or electrophilic nitrogen sources.  One such use of an electrophilic 
reagent was discussed in 2002 by Jørgensen and co-workers, who reported the -
amination of aldehydes 12 with azodicarboxylates 13, allowing eventual access to a 
range of -amino acid products.13  The presence of L-proline as an organocatalyst 
allowed these amination reactions to be carried out with moderate levels of 
enantioselectivity by forming an enamine intermediate with the aldehyde substrate 
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and then directing the incoming nitrogen atom of the azodicarboxylate 13 
selectively to one face.  The approach is summarised in Scheme 1.4.  
 
H
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H
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O
O
R2
+
N
H
H
CO2H
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13
R2 = Et, 
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R1
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14
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Scheme 1.4.  L-Proline-catalysed electrophilic amination of aldehydes 
 
Conversion of the -aminated products 14 to protected -amino acids was possible 
using a series of relatively straightforward transformations.  One particular example 
15 discussed in the paper is shown below in Scheme 1.5, and involved the 
conversion of the aldehyde to the corresponding methyl ester by permanganate 
oxidation followed by treatment with (trimethylsilyl)diazomethane.  Trifluoroacetic 
acid was then employed to remove the Boc groups, and reduction and finally Boc 
reprotection gave protected -amino acid 16 with no loss of enantiomeric excess 
established in the amination step (>90% e.e.). 
 
H
O
iPr
N
HN
O
O
tBu
O tBu
O
MeO
O
iPr
H
N O tBu
O
(i) KMnO4
(ii) TMSCHN2
(iii) TFA
(iv) Raney nickel
(v) Boc2O/DMAP15 16  
Scheme 1.5.  Completion of protected -amino acid 16 
 
 Asymmetric alkylation of glycine derivatives 
In 1981, Schöllkopf and co-workers published details of a method for the 
enantioselective synthesis of (R)-amino acids using L-valine 17 as a chiral auxiliary.  
L-Valine was attached to the ethyl ester of glycine, and this was followed by a 
cyclisation to generate diketopiperazine 20, and finally O-methylation to give bis-
lactim ether 21, as shown in Scheme 1.6.5 
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O
HN
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THF, 40 °C
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Et3N
CHCl3/THF
-70 °C
·HCl
Toluene
91% (2 steps)
[Me3O]BF4
CH2Cl2, r.t.
82%
17 18 19
2021
Scheme 1.6.  Synthesis of Schöllkopf bis-lactim ether 21 
 
The bis-lactim ether 21 could then be subjected to diastereoselective alkylation 
with a range of alkyl halides, with the presence of the relatively large isopropyl 
group leading to alkylation taking place preferentially from the opposite face of the 
anion of 21, generated by deprotonation with n-butyllithium (Scheme 1.7).  
Completion of the -amino acid targets was then achieved by hydrolysis of ether 22 
with dilute acid, which gives initially the methyl ester derivative of the -amino 
acids 23, which could then be converted to the -amino acids by hydrolysis with 
either acid or base. 
 
N
N
OMe
OMe
N
N
OMe
OMe
R  (i) 
nBuLi
(ii) R X
0.25 M HCl
H2N
OMe
O
R
21 22 23  
Scheme 1.7.  Diastereoselective alkylation of Schöllkopf bis-lactim ether 21 
 
Selected results for the alkylation and hydrolysis steps are highlighted below in 
Table 1, with enantiomeric excess values determined for methyl esters 23. 
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Alkylating agent Yield of 22 (%) Yield of 23 (%) e.e. of ester 23 (%) 
BrCH2C6H5 81 73 91-95 
Br(CH2)6CH3 62 75 75-80 
BrCH2-3,4-(OCH3)2C6H3 91 78 85 
BrCH2-CH=CH-C6H5 90 89 >95 
Table 1.  Results of alkylation of bis-lactim ether 21 
 
While relatively high yields and levels of enantioselectivity were encountered using 
this approach, the requirement for additional steps to both incorporate and remove 
the chiral auxiliary lead to a less efficient synthetic route than catalytic procedures. 
 
 
1.1.3 Previous syntheses of ,-disubstituted -amino acids 
In recent years, much literature has been published which discusses methods for 
the synthesis of ,-disubstituted -amino acids using a number of approaches for 
the functionalisation of -amino acid derivatives.14  These include the 
diastereoselective alkylation of oxazinones derived from asymmetric Strecker 
reaction products,15 and the asymmetric alkylation of -amino acid enolates.16 
 
Another approach which has proven to be applicable to the synthesis of both -
amino acids and ,-disubstituted -amino acids is the use of Overman 
rearrangement chemistry to generate protected allylic amines, which can be readily 
converted to -amino acid targets.  The Overman rearrangement is a well-
established reaction which has been shown to have wide scope for the generation of 
a large variety of allylic amines and importantly, the stereochemical outcome of 
these reactions can be controlled. 
 
  
1.2 The Overman rearrangement 
 
1.2.1 [3,3]-Sigmatropic rearrangements 
[3,3]-Sigmatropic rearrangements, such as the Claisen rearrangement shown in 
Scheme 1.8, are a class of pericyclic reaction in which a sigma bond moves from the 
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1 position to the relative 3 position at each of its ends.  Rearrangements of this 
type proceed in a concerted manner, via a highly ordered 6-membered transition 
state.17 
 
O R O RH1
2
3
1
2
3
1
2
3
1
2
3
24 25  
Scheme 1.8.  [3,3]-Sigmatropic rearrangement 
 
As with all pericyclic reactions, [3,3]-sigmatropic rearrangement reactions obey the 
Woodward-Hoffmann rules,18 which state that: 
 A ground-state (thermal) pericyclic reaction is symmetry-allowed when the 
total number of (4q+2)s and (4r)a components is odd 
 A pericyclic reaction in the first electronically excited state (photochemical) 
is symmetry-allowed when the total number of (4q+2)s and (4r)a components 
is even 
 
Here, ‘component’ refers to a bond or orbital which takes part in a pericyclic 
reaction.  The letters q and r here are simply integers.  The letter s stands for 
suprafacial, with a suprafacial component forming new bonds on the same face at 
both ends.  The letter a represents antarafacial, and an antarafacial component 
forms new bonds on opposite faces at both ends. 
 
In the case of [3,3]-sigmatropic rearrangements, three components are involved in 
the reaction: two nonconjugated  bonds, and one  bond which joins these.  Each 
of these components contributes two electons, and is assigned according to Figure 
4.19,20 
 
O R
2
2
2
 
Figure 4.  Assignment of components in [3,3]-sigmatropic rearrangement 
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By drawing a three-dimensional representation of the orbitals involved in the 
reaction, it can be determined if each of these components is a suprafacial or 
antarafacial component, as shown in Figure 5. 
 
2a
2a
2s
 
Figure 5.  Orbitals involved in [3,3]-sigmatropic rearrangement 
 
Therefore in the case of [3,3]-sigmatropic rearrangement reactions, there is one 
component which satisfies the (4q+2)s formula (2s), and no components which 
satisfy (4r)a.  This gives a total of 1, which is odd, and hence [3,3]-sigmatropic 
rearrangements in the ground state are symmetry-allowed according to the 
Woodward-Hoffmann rules. 
 
 
1.2.2 The Claisen rearrangement 
The Claisen rearrangement was the first example of a [3,3]-sigmatropic 
rearrangement, originally reported in the literature in 1912.21  Claisen found that 
aromatic allylic ethers 26 were able to rearrange to substituted phenol derivatives 
28 when heated to 200 °C, as shown in Scheme 1.9. 
 
O
200 °C
O
H
OH
tautomerism
85%
26 27 28  
Scheme 1.9.  Aromatic Claisen rearrangement 
 
Following this result, efforts were focussed on developing an aliphatic variant of 
the Claisen rearrangement, involving the [3,3]-sigmatropic rearrangement of allylic 
vinyl ethers 24 to ,-unsaturated carbonyl compounds 25 (Scheme 1.10).22  The 
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driving force of this reaction is the formation of a new carbon-oxygen double bond 
at the expense of a weaker carbon-carbon double bond.  
 
O R O R
heat or
metal
catalyst H
24 25  
Scheme 1.10.  Aliphatic Claisen rearrangement 
 
Further variations of the Claisen rearrangement were subsequently developed to 
allow the formation of functional groups other than aldehydes.  These include the 
Johnson-Claisen rearrangement for the generation of esters 30,23 the Eschenmoser-
Claisen rearrangement of N,O-ketene acetals 31 to amides 32,24 and the all-carbon 
version of the Claisen rearrangement, known as the Cope rearrangement25 as 
summarised in Scheme 1.11.   
 
MeO O R MeO O R
Me2N O R Me2N O R
Johnson-Claisen rearrangement
Eschenmoser-Claisen rearrangement
Cope rearrangement
R R
29 30
31 32
33 34
 
Scheme 1.11.  Variations of the Claisen rearrangement 
 
A further analogous reaction to the Claisen rearrangement was reported in the 
literature by Mumm and Möller, who first discussed the rearrangement of allylic 
imidates 35, shown in Scheme 1.12.26 
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NH
OR
HN
OR
heat
35 36  
Scheme 1.12.  Rearrangement of allylic imidates 
 
While this rearrangement provides a potentially useful method for accessing 
protected allylic amines from derivatives of more readily available allylic alcohols, 
the generation of the allylic imidate intermediates and their subsequent 
rearrangement are often slow and tend to require high temperatures to proceed.  
As a result of these elevated temperatures, decomposition of the imidates prior to 
rearrangement is a potential issue. 
 
 
1.2.3 History of the Overman rearrangement 
In 1974, Professor Larry Overman first reported a subtype of the imidate 
rearrangement which involved the [3,3]-sigmatropic rearrangement of allylic 
trichloroacetimidates 37 to allylic trichloroacetamides 38, as outlined in Scheme 
1.13.27 
 
R1 R2
O
CCl3
HN
R1 R2
O
CCl3
HN
 or
catalyst
37 38  
Scheme 1.13.  [3,3]-Sigmatropic rearrangement of allylic trichloroacetimidates 
 
Now referred to as the Overman rearrangement, these reactions were shown to 
proceed in high yield under either thermal reaction conditions, or using mercury(II) 
catalysis.  Selected results from Overman’s original paper are shown in Scheme 1.14.  
Note that the failure of the mercury(II)-catalysed rearrangement of the 2-
cyclohexen-1-yl acetimidate 43 can be attributed to the preference for nucleophilic 
attack by nitrogen at the C-2 position as opposed to the required C-3 attack. 
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3
 
Scheme 1.14.  First reported examples of Overman rearrangement 
 
Following the publication of these results, the Overman rearrangement has proved 
popular as it provides an effective method for the 1,3-transposition of alcohol and 
amine functionality which does not require particularly harsh conditions.  Hydrolysis 
of the trichloroacetamides to corresponding free amines can also be easily achieved, 
and hence the Overman rearrangement has found utility in the synthesis of many 
important classes of molecules, such as amino sugars, nucleotides, N-heterocycles 
and amino acids.28 
 
Importantly, generation of the allylic trichloroacetimidate substrates 37 for the 
Overman rearrangement is very straightforward from the corresponding allylic 
alcohols 45, which are treated with trichloroacetonitrile in the presence of a 
catalytic quantity of base29,30 such as sodium hydride or 1,8-
diazabicyclo[5.4.0]undec-7-ene, as shown in Scheme 1.15.31  Generally, the allylic 
trichloroacetimidates are used immediately after formation, with simple 
purification by filtration through a short plug of silica capable of providing the pure 
allylic trichloroacetimidates required. 
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Scheme 1.15.  Synthesis of allylic trichloroacetimidates 
 
The use of allylic trifluoroacetimidates in Overman rearrangements has also been 
reported and in some cases, an increased reaction rate has been observed for the 
rearrangement of these substrates.  However, formation of the required allylic 
trifluoroacetimidate substrates is significantly more challenging than allylic 
trichloroacetimidates, often requiring the use of the highly toxic gas, 
trifluoroacetonitrile.  Therefore, allylic trifluoroacetimidates have not found 
comparably widespread utility as rearrangement substrates.32,33 
 
 
1.2.4 Thermal Overman rearrangements 
The reaction conditions required for a thermal Overman rearrangement initially 
involved simply dissolving the trichloroacetimidate substrate in an aprotic, high-
boiling point solvent such as toluene or xylene, and heating under reflux until 
completion.   
 
Allylic trichloroacetimidates derived from primary, secondary and tertiary-
substituted allylic alcohols have all been shown to be applicable to the Overman 
rearrangement, and an increase in reaction rate is observed with increasing 
substitution.  Primary substituted systems tend to require temperatures of 140 °C 
and 4–24 hours, while the tertiary variants can rearrange at 80 °C in a few hours.34 
 
In 1998, an important modification was made to standard thermal Overman 
rearrangement conditions when Isobe and co-workers reported that the addition of 
a small quantity of potassium carbonate to the reaction mixture generally improves 
product yields.35  The higher yields can be attributed to the neutralisation of acid 
that may be generated at the high temperatures encountered during thermal 
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rearrangement conditions, which in turn can lead to decomposition of the acid-
sensitive trichloroacetimidate. 
 
One particular example which highlights this improvement involved the thermal 
Overman rearrangement of allylic trichloroacetimidate 46, shown in Scheme 1.16.  
With no potassium carbonate present, this reaction initially proceeded in 74% yield 
over 2 steps from the allylic alcohol, although this drastically lowered by around 
50% upon scale-up.  Addition of potassium carbonate (2 mg/ mL of solvent) led to 
the generation of the trichloroacetamide product 47 in a yield of 90%, which was 
reproducible on scaling the reaction up to using 10 g of the allylic alcohol starting 
material. 
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Scheme 1.16.  Isobe modification of thermal rearrangement conditions 
 
As previously mentioned, the involvement of a 6-membered transition state 
dictates the stereochemical outcome of Overman rearrangement reactions.  
Selectivity exists for the formation of allylic trichloroacetamides with E geometry 
across the allylic double bond, as a result of the large trichloromethyl group 
occupying an axial position in the chair-like transition state.  1,3-Diaxial 
interactions are minimised when the hydrogen atom is placed in an axial position, 
with the larger R group equatorial, as shown in Figure 6.34  Thus, allylic 
trichloroacetimidates derived from both E- and Z-allylic alcohols show a high level 
of preference for the formation of E-products in the vast majority of cases, with 
the main exception being tertiary substituted alcohols with two similarly-sized 
substitutents on the -carbon.  It is worth noting that the substrates derived from 
allylic alcohols with Z-geometry require longer reaction times and / or higher 
reaction temperatures in comparison to the E allylic alcohols. 
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Figure 6.  Preferred Overman rearrangement transition state leading to E-product 
 
One of the most attractive features of using a [3,3]-sigmatropic rearrangement to 
access protected allylic amines is that complete transfer of chirality between 
stereocentres is observed as a direct result of the well-ordered transition state.  
Therefore, in the case of an enantiomerically enriched sample of a secondary or 
tertiary allylic alcohol, the level of enantiomeric excess will be carried through to 
the trichloroacetamide product.  This was first discussed in the literature by 
Yamamoto et al., who converted allylic alcohol 50 to the corresponding allylic 
trichloroacetimidate 51 which was subjected to a thermal Overman rearrangement, 
as shown in Scheme 1.17.  Comparison of optical rotation values of rearrangement 
product derivatives and 1H NMR spectroscopic analysis using chiral shift reagents 
allowed the group to confirm that the allylic alcohol starting material 50 had an 
optical purity of 45±2%, while the rearrangement product 52 was 45.6% optically 
pure.  This result served to show that a complete transfer of chirality is achieved in 
rearrangements of this type, and additionally provided evidence for progress of the 
rearrangement via a chair-like transition state.36 
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Scheme 1.17.  Chirality transfer in secondary allylic trichloroacetimidates 
 
The complete transfer of chirality is not limited to only E-allylic 
trichloroacetimidates, but is also observed in the thermal rearrangement of the 
equivalent compounds with Z-geometry such as 54 as discussed by Bloch and co-
workers in 1999, highlighted in Scheme 1.18.37  
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Scheme 1.18.  Chirality transfer in rearrangement of Z-allylic trichloroacetimidates 
 
In examples where an additional stereogenic centre is present in the rearrangement 
substrate, diastereoselectivity in formation of the new C-N bond is possible, 
although this greatly depends on the substituents present.  However, the use of 
metal catalysis in Overman rearrangements can allow much greater control of the 
stereochemical outcome of such reactions. 
 
 
1.2.5 Metal-catalysed Overman rearrangements 
As previously discussed, Overman published details of the first metal-catalysed 
[3,3]-sigmatropic rearrangements of allylic trichloroacetimidates in 1974.27  Here, 
he showed that the presence of catalytic mercuric trifluoroacetate (Hg(O2CCF3)2) 
allowed these reactions to successfully proceed at room temperature or below, 
often within minutes owing to a proposed enhancement in rate calculated to be 
over 1 × 1012 in comparison to the corresponding thermal reactions.34 
 
Following this observation, the use of alternative metal catalysts was studied, and 
it was subsequently discovered that palladium(II) catalysis was also applicable.38  
The most commonly used palladium(II) catalysts in Overman rearrangement 
chemistry now are PdCl2(CH3CN)2 and PdCl2(PhCN)2, which are typically present in 
loadings of approximately 4 to 8 mol%.  These catalysts are soluble in aprotic 
solvents such as tetrahydrofuran and toluene, which are often used during these 
rearrangements. 
 
In the presence of a metal catalyst, the Overman rearrangement is thought to 
proceed via a cyclisation-induced mechanism, as shown in Figure 7.  Here, the 
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metal centre coordinates to the alkene and promotes cyclisation via nucleophilic 
attack by nitrogen.  Collapse of the 6-membered ring then generates the carbonyl, 
and movement of the allylic system gives the desired allylic trichloroacetamide 
product.39  
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Figure 7.  Mechanism of metal-catalysed Overman rearrangement 
 
As with the thermal Overman rearrangement, the progression of the metal-
catalysed variant through a 6-membered intermediate means that the 
stereochemical outcome of the reaction is once again controlled. 
 
In 1992, Metz and co-workers discussed the palladium(II)-catalysed Overman 
rearrangement of a range of secondary allylic trichloroacetimidates, and found that 
as in the case of thermal rearrangements of these compounds, the products were 
formed with complete selectivity for E geometry across the double bond, and with 
complete transfer of chirality between the stereogenic centres (Scheme 1.19).40  It 
is worth noting that the rearrangement of 56 was also attempted under thermal 
conditions, and the desired product was isolated in a yield of 61%, although a 
reaction time of 8 hours in toluene heating under reflux was required. 
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Scheme 1.19.  Palladium(II)-catalysed rearrangement of secondary allylic trichloroacetimidates 
 
As in the case of thermal rearrangements, metal-catalysed Overman rearrangments 
can proceed with some degree of diastereoselectivity depending on the 
substitutents present as a result of steric control.  However, one of the most 
attractive features associated with the use of metal catalysts in Overman 
rearrangements is their potential to coordinate to not only the alkene, but also 
certain groups present in the vicinal position, such as protected amines.  This can 
have a marked effect on the diastereoselectivity observed in these reactions.  For 
example, Gonda et al. reported the results of both the thermal and palladium(II)-
catalysed rearrangement of allylic trichloroacetimidate 60, as shown in Scheme 
1.20.41 
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Scheme 1.20.  Diastereoselective Overman rearrangement 
 
These results showed that the presence of a metal catalyst greatly enhanced the 
diastereoselectivity of this rearrangement reaction, and it was believed that 
  
28 
coordination of the palladium centre was occurring to both the alkene and the 
protected nitrogen, thus directing the rearrangement via the transition state shown 
in Figure 8, resulting in the observed preference for formation of the 
diastereoisomer anti-61. 
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Figure 8.  Source of diastereoselectivity in palladium(II)-catalysed rearrangement 
 
 
1.2.6 Enantioselective metal-catalysed Overman rearrangements 
One of the greatest advancements in metal-catalysed Overman rearrangements has 
been the development of chiral palladium(II) catalysts capable of conducting the 
Overman rearrangement of allylic trichloroacetimidates derived from primary allylic 
alcohols in an enantioselective manner.  This is possible because direct 
coordination of the palladium centre to the rearrangement substrate occurs during 
the reaction. 
 
In 1997, Overman and co-workers discussed the first application of palladium(II) 
diamine catalysts such as A to the enantioselective rearrangement of allylic 
imidates, shown in Scheme 1.21.42  While the rearrangement of N-arylbenzimidate 
62 proceeded in moderate yield and with an encouraging level of enantioselectivity, 
catalyst A failed to promote rearrangement of the corresponding allylic 
trichloroacetimidate in the same manner.  It was believed that this was due to a 
strong coordination between the trichloroacetimidate’s nitrogen atom and the 
cationic palladium complex which led to a competing elimination of 
trichloroacetamide. 
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Scheme 1.21.  First enantioselective Overman rearrangement catalyst 
 
Following this result, Donde and Overman studied the rearrangement of similar 
allylic N-arylbenzimidates using a selection of ferrocenyloxazoline palladacyclic 
(FOP) catalysts.43  These rearrangements proved successful, proceeding with much 
improved enantiomeric excess values of up to 96% in the products.  One drawback 
to this work is that the N-arylbenzamide products are not particularly useful 
synthetic intermediates, as their conversion to the corresponding desired allylic 
amines is not easily achieved. 
 
A key paper published by Overman and co-workers in 2003 discussed the results of a 
screen of chiral palladium(II) catalysts B–I (Figure 9), including the FOP catalysts B 
and C for the enantioselective rearrangement of allylic N-
aryltrifluoroacetimidates.44 
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Figure 9.  Asymmetric rearrangement catalysts 
 
These catalysts were applied to rearrangement reactions involving a selection of 
substrates with both E and Z geometry in the double bond.  The catalysts were used 
in a loading of 5 mol%, and the trifluoroacetate-bridged examples C, E and G were 
generated by treatment of the corresponding halides (B,D and F) with 4 equivalents 
(relative to the halide-bridged precursors) of AgOCOCF3.  Catalysts H and I were 
activated by TlOTf (4 equivalents) prior to use.  The formation and rearrangement 
of the N-aryltrifluoroacetimidates 65 is outlined in Scheme 1.22.  
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Scheme 1.22.  Formation and rearrangement of allylic N-aryltrifluoroacetimidates 
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Preliminary results in this study showed that the coboltocenyl oxazolidine 
palladacycle (COP) complex E successfully catalysed the rearrangement of 
substrates with either E- or Z-geometry in high yield and with the best levels of 
enantioselectivity in this catalyst screen.  The FOP catalyst C also achieved 
promising results with the substrate (when R = npropyl), as summarised in Table 2. 
 
Catalyst Substrate Geometry Yield (%) e.e. (%) / configuration 
C E 88 76/S 
C Z 21 87/R 
E E 84 84/S 
E Z 71 94/R 
G E 43 86/S 
G Z 19 88/R 
H E 49 82/S 
H Z 15 67/R 
I E 66 48/S 
I Z 13 42/R 
Table 2.  Results of catalyst screen 
 
A further study also showed that the chloride-bridged COP catalyst (COP-Cl) D was 
capable of achieving comparable product yields and high enantioselectivity even 
when not activated with AgOCOCF3, as had been used previously with catalysts B, D, 
and F.  This was a particularly positive result, as it improves the efficiency of these 
rearrangement reactions, allowing the direct use of a stable catalyst. 
 
A final investigation in this paper compared the use of the unactivated COP-Cl 
catalyst D and its activated trifluoroacetate derivative E with a number of 
rearrangement substrates.  It was found that while product yields and enantiomeric 
excess values were high in each instance with both catalysts, there was a slight 
advantage in applying COP E to the rearrangement of substrates with Z-geometry 
across the double bond and COP-Cl D to examples with E-geometry. 
 
Following these encouraging results, Anderson and Overman showed that the COP-
Cl catalyst D could also be successfully applied to the enantioselective Overman 
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rearrangement of allylic trichloroacetimidates 67 to the synthetically useful allylic 
trichloroacetamides 68, as shown in Scheme 1.23.45 
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Scheme 1.23.  COP-Cl catalysed rearrangement of allylic trichloroacetimidates 
 
A range of allylic trichloroacetimidate substrates 67 with varying R groups present 
were subjected to Overman rearrangement in the presence of 5 mol% of COP-Cl D.  
Excellent product yields and enantioselectivity levels were achieved in the 
rearrangement of allylic trichloroacetimidates with E-geometry, while the 
rearrangement of Z-allylic trichloroacetimidates was not favoured.  It was also 
found that the optimum reaction temperature for the use of this catalyst was 38 °C, 
which resulted in the highest product yields.  These results are summarised in Table 
3. 
 
R Geometry Temperature Yield (%) e.e. (%) / configuration 
npropyl E r.t. 80 94/S 
npropyl E 38 °C 99 95/S 
npropyl Z 38 °C 17 71/R 
cyclohexyl E 38 °C 82 96/S 
CH2CH2Ph E 38 °C 93 93/S 
tbutyl E 38 °C 7 unknown 
(CH2)2COMe E 38 °C 98 95/S 
(CH2)2COMe E r.t. 80 94/S 
(CH2)3NBn(Boc) E 38 °C 96 95/S 
(CH2)3NBn(Boc) E r.t. 87 95/S 
Table 3.  COP-Cl catalysed Overman rearrangement results 
 
These results exemplify the excellent utility of the COP-Cl catalyst D in the 
enantioselective generation of allylic trichloroacetamides, which are extremely 
useful synthetic intermediates as they are readily deprotected to form the 
corresponding allylic amines. 
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Following on from the publication of the results discussed above, the COP-Cl 
catalysts D and J, commonly referred to as (S)-(+)-COP-Cl and (R)-(-)COP-Cl 
respectively (Figure 10) have become popular, and hence are now available 
commercially, in addition to some similar derivatives capable of promoting 
Overman rearrangement reactions enantioselectively. 
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Figure 10.  Commercially available asymmetric Overman rearrangement catalysts 
 
 
1.2.7 The Overman rearrangement applied to -amino acid synthesis 
As the Overman rearrangement has proved to be a reliable method of introducing 
amine functionality in a stereoselective manner, it has found utility in the synthesis 
of a range of natural products including -amino acids in literature examples. 
 
Vyas and co-workers reported in 1984 the introduction of the key amine group of 
(±)-acivicin 75 by way of a thermal Overman rearrangement, carried out on the 
trichloroacetimidate derivative of the diol 69.  The presence of the second hydroxyl 
group allows eventual completion of the -amino acid functionality by oxidation to 
a carboxylic acid (Scheme 1.24).46 
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Scheme 1.24.  Vyas synthesis of (±)-acivicin 
 
In 2002, Walsh and co-workers applied the thermal Overman rearrangement 
reaction to the formation of a range of allylic amines, which were then converted 
to protected -amino acid targets by means of an oxidative cleavage of the alkene, 
followed by trichloroacetamide hydrolysis (Scheme 1.25).47  The allylic alcohol 
substrates for the rearrangement were synthesised via the asymmetric vinylation of 
aldehydes.  The vinylzinc reagents 77 were formed from a range of commercially 
available terminal alkynes 76 and their subsequent addition to benzaldehyde was 
conducted in the presence of an enantiomerically pure isoborneol-based amino 
alcohol ligand known as (-)-MIB, which generated the allylic alcohols 78 with 
enantiomeric excess values ranging from 93% to 97%.  These allylic alcohols were 
then subjected to a standard thermal Overman rearrangement, generating the 
corresponding protected allylic amides 79, which proceeded with conservation of 
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the high enantiomeric excess values in all cases except when R = cyclopropyl, which 
saw a decrease from 95% in the alcohol to 89% in the trichloroacetamide.  Finally, 
oxidative cleavage of the double bond led to the completion of protected -amino 
acids 80 or the corresponding methyl esters 81, as shown in Scheme 1.25. 
 
 
 
Scheme 1.25.  Walsh approach to -amino acids 
 
The rearrangement step applied in this route allowed the generation of a range of 
relatively sterically hindered allylic trichloroacetamides in good to excellent yield, 
generally requiring heating under reflux for just 1–2 hours.  Selected yields are 
summarised in Table 4. 
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Trichloroacetamide Yield (%) e.e. (%) 
Ph
NH
CCl3
O
 
64 95 (99a) 
Ph
NH
CCl3
O
 
93 89 
Ph
NH
CCl3
O
 
96 95 (99a) 
Ph
NH
CCl3
O
 
90 96 (99a) 
Ph
NH
CCl3
O
 
83 97 (99a) 
Ph
NH
CCl3
O
Cl
 
66 93a 
                             a e.e. value after recrystallisation 
Table 4.  Overman rearrangement results 
 
Within the Sutherland research group, previous projects have investigated the 
application of metal-catalysed Overman rearrangements to the synthesis of -
hydroxy--amino acids.48  The methodology, outlined in Scheme 1.26, involved the 
generation of allylic alcohols by a chiral pool approach, with a Horner-Wadsworth-
Emmons reaction utilised to introduce the required double bond.  The presence of 
the methoxymethyl (MOM)-protected hydroxyl not only provides the required 
hydroxyl group in the -position of the final amino acid products, but is also 
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capable of directing the Overman rearrangement step to proceed in a highly 
diastereoselective manner. 
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Scheme 1.26.  Synthesis of -hydroxy -amino acids 
 
During the Overman rearrangement stage, it was essential to achieve a high level of 
selectivity for the required diastereoisomer anti-89.  The presence of the MOM 
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protected hydroxyl group on allylic trichloroacetimidate 88 allowed a substrate-
directed rearrangement to take place, where palladium co-ordinates to the alkene 
and also two oxygen atoms, which directs co-ordination to one face, as shown in 
the transition state in Figure 11, leading to selective formation of the anti-product 
diastereoisomer. 
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Figure 11.  Directing effect of MOM group in Overman rearrangement 
 
In the cases where R = CH3, the rearrangement proceeded in 64% yield and with an 
anti : syn ratio of 10 : 1.  However, in examples where steric bulk was greater in 
this position, the slower rate of rearrangement allowed a competing reaction to 
proceed, where palladium(0) catalysed an undesired allylic substitution reaction.  
Helpfully, the addition of p-benzoquinone, a mild oxidant which converts 
palladium(0) to palladium(II) prevented formation of this by-product.  The results of 
the rearrangement step, which then proceeded in good yield and with high 
diastereoselectivity, are summarised in Table 5. 
 
R Additive Yield (%) anti : syn 
CH3 none 64 10 : 1 
iBu p-benzoquinone 73 14 : 1 
PhCH2 p-benzoquinone 70 12 : 1 
PhCH2CH2 p-benzoquinone 69 9 : 1 
Table 5.  Overman rearrangement results 
 
Following the successful rearrangement chemistry, completion of the desired amino 
acid targets was achieved in high yield by oxidation of the alkene and removal of 
the protecting groups (Scheme 1.26). 
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In 1996, Larchevêque and co-workers reported the application of the Overman 
rearrangement to the generation of ,-disubstituted -amino acids and -amino 
aldehydes, synthesised via trisubstituted monoprotected allylic diols 93.49  Here, 
the required allylic diols are synthesised by treatment of an -hydroxy aldehyde 92 
with a vinylic organometallic reagent.  In order to generate the required amino acid 
enantiomers, control of the stereochemistry of the hydroxyl group of the allylic 
alcohol was essential.  Helpfully, the addition of the organometallic reagents 
proceeded not only in good yield, but also with high syn : anti ratios greater than 
92:8 in all but one instance.  Conversion of these intermediates to the 
corresponding allylic trichloroacetimidates 94 and subsequent Overman 
rearrangement installed the required quaternary substituted carbon centre of the 
allylic amines.  Ozonolysis of the alkene, oxidation of the aldehyde intermediate to 
the required carboxylic acid and then trichloroacetamide hydrolysis completed 
formation of the amino acid targets 98, as shown in Scheme 1.27. 
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Scheme 1.27.  Larchevêque approach to ,-disubstituted -amino acids 
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In the development of this methodology, the thermal Overman rearrangement step 
was conducted with a variety of R groups present.  The yields achieved for a 
selection of the allylic trichloroacetamides 95 are summarised in Table 6 below.  In 
each case, only a single product diastereoisomer was detected by 1H NMR 
spectroscopic analysis. 
 
R1 R2 R3 Yield (%) 
Ph nBu Me 98 
iPr Me nBu 62 
iPr Me Et 60 
iPr Ph Me 70 
Table 6.  Results of thermal Overman rearrangement step 
 
It is worth noting that attempts were made to conduct the rearrangement step in 
the presence of mercury(II) and palladium(II) catalysts, although the desired 
products were not isolated and instead, elimination of the trichloroacetamides was 
occurring to generate dienes. 
 
This route represents a highly stereoselective method for accessing ,-
disubstituted -amino acids which relies on the Overman rearrangement proceeding 
with complete chirality transfer to give enantiomerically pure -amino acid 
products. 
 
The Overman rearrangement represents an excellent reaction which provides access 
to a large array of protected allylic amines which have widespread utility in organic 
synthesis.  Importantly, the stereochemical outcome of these reactions is highly 
controlled and predictable.  Additionally, the substrates required are easily 
generated from allylic alcohols, which are common synthetic intermediates.  The 
conversion of protected allylic amines to -amino acids has proven successful in a 
number of literature examples, as outlined above and hence the investigation of 
methodology for the enantioselective synthesis of allylic alcohols could provide an 
efficient method for the generation of a variety of -amino acid targets. 
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1.3 Proposed Research 
 
The aim of this research project was to develop new methodology for the 
stereoselective synthesis of a range of -amino acids.  The route studied should be 
flexible enough to allow the eventual generation of both -amino acid and ,-
disubstituted -amino acid targets with a variety of side chains which can be 
accessed in a fast, efficient manner. 
 
The strategy under investigation here can be considered in three distinct stages, 
summarised in Scheme 1.28.  Firstly, a range of di- and tri-substituted chiral allylic 
alcohols 99 would be generated enantioselectively.  These would then be subjected 
to Overman rearrangement chemistry to convert them to allylic trichloroacetamides 
100.  Finally, oxidative cleavage of the allylic double bond and amide hydrolysis 
would complete the formation of the desired -amino acid targets 98. 
 
R1
R2
R3
OH
R1
NH
CCl3
O
R3
R2
NH2
R3
R2
HO
O
(i) Cl3CCN
(ii) [3,3]-
sigmatropic 
rearrangement
(i) NaIO4
RuCl3·xH2O
(ii) acid
or base
99 98100  
Scheme 1.28.  Proposed synthetic strategy 
 
The proposed method for the generation of chiral allylic alcohols is outlined in 
Scheme 1.29, and relies on chemistry published by Evans and Leffray whereby a 
vinyl sulfone derivative such as 103 is subjected to an asymmetric dihydroxylation.  
This installs the desired configuration at the alcohol’s stereogenic centre and the 
presence of the -hydroxyl group promotes a spontaneous 1,2-elimination to 
generate the corresponding aldehyde 104 in situ.  This could then be trapped with 
a range of phosphonium salts or phosphonate esters under Wittig or Horner-
Wadsworth-Emmons (HWE) olefination conditions respectively to complete the 
formation of di- or tri-substituted allylic alcohols.50 
 
  
42 
Ph
S
Ph
OO
Grubbs 2nd
generation
catalyst K
Ph
S
Ph
OO
Ph
OH
H
O
Ph3P R
Ph R
OH
O
P R1
R2
EtO
EtO
Ph
R1
R2
OH
N N
Ru
Ph
PCy3
Cl
Cl
K
Grubbs 2nd
generation
catalyst
Mes Mes
X-
AD-mix-
+
101 102 103
104105
106  
Scheme 1.29.  Proposed synthesis of substituted chiral allylic alcohols 
 
In order to transform these allylic alcohols to the corresponding protected allylic 
amines, Overman rearrangement chemistry would be employed.  The alcohols 106 
could be easily converted to allylic trichloroacetimidates 107, which are the 
necessary substrates for the [3,3]-sigmatropic rearrangement, as shown in Scheme 
1.30. 
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Scheme 1.30.  Conversion of allylic alcohols to allylic trichloroacetamides 
 
From these allylic trichloroacetamides 108, the desired -amino acid targets can 
be generated by carrying out a ruthenium-catalysed oxidation of the allylic double 
bond to introduce the required carboxylic acid functionality, followed by hydrolysis 
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of the trichloroacetamide group under acidic or basic conditions as highlighted in 
Scheme 1.28. 
 
In order to develop the methodology proposed, initial studies would focus on the 
generation of -amino acids before being applied to the more challenging ,-
disubstituted examples. 
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2.0 Results and Discussion 
 
2.1 Synthesis of -amino acids via organophosphorus olefinations 
 
2.1.1 Synthesis of chiral allylic alcohols via dihydroxylation and olefination 
The first step in the proposed synthesis of substituted chiral allylic alcohols 
involved generation of the vinyl sulfone derivative 103 via a cross-metathesis 
reaction between the terminal alkene 4-phenyl-1-butene 101 and phenyl vinyl 
sulfone 102 in the presence of Grubbs 2nd generation catalyst K as outlined in 
Scheme 2.1. 
 
This reaction was carried out according to a literature procedure published by Grela 
and Bieniek, using a 2:1 ratio of phenyl vinyl sulfone 102 : 4-phenyl-1-butene 101 
in the presence of 5 mol% of catalyst K.51  Under these conditions, the reaction 
reached completion in 6 hours.  However, repeated purification of the crude 
reaction product by silica column chromatography failed to adequately separate the 
desired product 103 from excess phenyl vinyl sulfone 102.  In an attempt to 
prevent the requirement for separation of these two components, the reaction was 
repeated with 4-phenyl-1-butene in excess (1.5 equivalents).  However, this did not 
reach completion and unreacted phenyl vinyl sulfone remained after 46 h.  Finally, 
the cross-metathesis reaction was run using a 1:1 ratio of the terminal alkene 
partners and a total catalyst loading of 6 mol%, which on a small scale (0.1 g of 
phenyl vinyl sulfone) led to the successful formation and isolation of the clean 
product 103 in 77% yield.  However, when the same conditions were applied on a 
larger scale (1.4 g of phenyl vinyl sulfone), the reaction required repeated additions 
of both 4-phenyl-1-butene and Grubbs 2nd generation catalyst K, despite which 
traces of phenyl vinyl sulfone still remained after an extended reaction time which 
again could not be removed by column chromatography. 
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Scheme 2.1.  Cross-metathesis of 4-phenyl-1-butene and phenyl vinyl sulfone 
 
Due to the significant problems associated with the isolation of vinyl sulfone 
derivative 103, it was decided to substitute 4-phenyl-1-pentene with an alternative 
alkene bearing an inert side chain which would give a product with polarity that 
differs enough from that of phenyl vinyl sulfone, thus allowing separation of the 
two by chromatography.  As the side chain introduced here will be cleaved later in 
the route, a variety of groups could be present in this position with no effect on the 
eventual targets.  Therefore, 4,4-dimethyl-1-pentene 109 was subjected to cross-
metathesis with phenyl vinyl sulfone using the original Grela and Bieniek conditions 
(Scheme 2.2).  As expected, the reaction successfully reached completion and this 
time the polarity of cross-metathesis product 110 differed enough from that of 
phenyl vinyl sulfone 112 to allow successful separation of the two components by 
silica column chromatography, leading to isolation of the desired product 110 in 
67% yield.  As the tert-butyl substituted vinyl sulfone 110 was easily synthesised, 
this was used for a study of the next stage of the proposed route. 
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Scheme 2.2.  Cross-metathesis of 4,4-dimethyl-1-pentene and phenyl vinyl sulfone 
 
Introduction of the required hydroxyl group and allylic double bond was attempted 
using a combined Sharpless asymmetric dihydroxylation and Horner-Wadsworth-
Emmons olefination approach previously described by Evans and Leffray.50 
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The Sharpless asymmetric dihydroxylation was first reported in 1988, and fully 
developed reaction conditions were outlined by Sharpless and co-workers in 
1992.52,53  The reaction achieves the cis-vicinal dihydroxylation of alkenes, capable 
of proceeding with enantiomeric excess values greater than 90% in the product diols.  
Two pre-mixed, commercially available reagent powders known as AD-mix- and 
AD-mix- are most commonly used.  They both contain a chiral ligand and give 
opposing stereochemical outcomes, which are based on the size of the alkene 
substitutents as summarised in Figure 12. 
 
RM
HRL
RS
RS = small group
RM = medium group
RL = large group
OHHO
RL H
RMRS
OHHO
RL H
RMRS
AD-mix-
AD-mix-
 
Figure 12.  Stereochemical outcome of Sharpless asymmetric dihydroxylation 
 
The AD-mixes contain the following components: 
 catalytic potassium osmate (K[OsO2(OH)4]), a non-volatile source of osmium 
tetroxide, the required oxidant 
 stoichiometric potassium ferricyanide (K3Fe(CN)6), used to oxidise the H2OsO4 
by-product back to reactive osmium tetroxide, making the reaction catalytic 
with respect to the expensive, toxic osmium reagent 
 potassium carbonate (K2CO3) which maintains the reaction pH 
 (DHQ)2PHAL (in AD-mix-) or (DHQD)2-PHAL (in AD-mix-), enantiomerically-
pure cinchona alkaloid ligands which provide the chiral environment 
necessary for an enantioselective reduction (Figure 13) 
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Figure 13.  Sharpless asymmetric dihydroxylation ligands 
 
In addition to the required AD-mix, the reactions are generally carried out in the 
presence of methanesulfonamide, which increases the rate of hydrolysis of the 
osmate ester intermediates. 
 
The large cinchona alkaloid ligands such as (DHQ)2-PHAL and (DHQD)2-PHAL provide 
a chiral environment in which the dihydroxylation takes place in U-shaped binding 
pocket.54  From the results of applying the Sharpless asymmetric dihydroxylation to 
a wide range of substrates, a mnemonic has been developed which provides a 
model of the catalyst active site and can be used to predict the stereochemical 
outcome of a Sharpless dihydroxylation (Figure 14).53 
 
AD-mix-
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steric 
barrier
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steric 
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H
 
Figure 14.  Mnemonic for prediction of enantioselectivity 
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The vinyl sulfone 110, with RL = sulfone, was treated with AD-mix- to achieve the 
desired enantioselectivity and dihydroxylation of the alkene should lead to a 
spontaneous 1,2-elimination, generating the -hydroxy aldehyde 110 in situ.  
Addition of a solution of deprotonated triethyl phosphonoacetate under Horner-
Wadsworth-Emmons conditions should then give the desired allylic alcohol 112 in a 
single step, as shown in Scheme 2.3.  Unfortunately when this reaction was 
attempted under the Evans and Leffray conditions, none of the desired allylic 
alcohol product 112 was detected after the olefination step.  In fact, only the vinyl 
sulfone starting material 110 was found to be present in the crude reaction product, 
indicating that the reaction had failed at the dihydroxylation stage.  
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Scheme 2.3.  Dihydroxylation/ Horner-Wadsworth-Emmons olefination 
 
It was thought that the failure of this reaction could be attributed to the presence 
of the bulky tert-butyl group preventing access of the substrate to the catalyst 
active site.  To assess this hypothesis, the same reaction was carried out on phenyl-
substituted vinyl sulfone 103, as shown in Scheme 2.4.  Using the phenyl-
substituted substrate 103, the reaction proved successful and the desired allylic 
alcohol product 113 was isolated in 24% yield. 
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Scheme 2.4.  Dihydroxylation/ Horner-Wadsworth-Emmons olefination 
 
Due to the problems associated with the purification of the vinyl sulfone 
intermediate 103 and the low yield of the subsequent dihydroxylation/olefination 
reaction, it was decided that an alternative synthesis of allylic alcohols should be 
investigated. 
 
 
2.1.2 Synthesis of chiral allylic alcohols via chiral pool approach 
The alternative approach to allylic alcohols adopted is shown in Scheme 2.5, and 
relies on a combined Swern oxidation and Horner-Wadsworth-Emmons olefination to 
install the allylic double bond.  This time, the required hydroxyl group is in place in 
the starting material (S)-ethyl lactate 114, which is cheap and readily available. 
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Scheme 2.5.  Proposed alternative synthesis of allylic alcohols 
 
The first step in this route involved a simple hydroxyl protection using tert-
butyldiphenylchlorosilane in the presence of imidazole according to a literature 
procedure, as shown in Scheme 2.6.55  This reaction proceeded successfully, giving 
ether 115 in 81% yield.  This was followed by reduction of the ethyl ester to the 
corresponding primary alcohol 116.  Initially, this was attempted using 2.2 
equivalents of diisobutylaluminium hydride solution however the product yield was 
a relatively low 33% and it appeared that loss of the silyl group was occurring during 
the reaction.  A literature procedure published by Duffield and Pettit which 
describes the reduction of ester 115 to alcohol 116 was then trialled using borane-
tetrahydrofuran complex solution, and this successfully generated the desired 
product in 84% yield.56 
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Scheme 2.6.  Synthesis of monoprotected diol 116 
  
51 
In order to introduce the allylic double bond and a potentially wide variety of side 
chains, the primary alcohol 116 was subjected to a Swern oxidation to the 
corresponding aldehyde,57 which could then be trapped with a range of 
phosphonate esters, forming a new carbon-carbon double bond.  This type of 
strategy has been successfully utilised within the research group many times 
previously, and the conditions are well-established.58,59  The Swern oxidation 
product simply requires concentration in vacuo before being treated with a solution 
of the deprotonated phosphonate ester, providing the protected allylic alcohol in a 
fast, efficient manner. 
 
The first phosphonate ester used for the investigation of the olefination step was 
triethyl phosphonoacetate.  In order to promote the selective formation of the E-
alkene product, the Masamune Roush variation of the Horner-Wadsworth-Emmons 
olefination was employed.60  The proposed mechanism for the Horner-Wadsworth-
Emmons olefination is shown in Scheme 2.7.  The lithium cation present in the 
reaction mixture coordinates between the two oxygen atoms of the phosphonate 
ester, and acts as a Lewis acid to facilitate its deprotonation.  The deprotonated 
ester is stabilised both by this coordination, and by resonance and so the acidic 
proton can be removed by 1,8-diazabicyclo[5.4.0]undec-7-ene.  These conditions 
are particularly mild and can be applied to the olefination of a wide range of 
substrates, including those where sensitivity to strong bases such as butyllithium is 
an issue. 
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Scheme 2.7.  Mechanism of Horner-Wadsworth-Emmons olefination 
 
The stereochemical outcome of this olefination is determined by the 
stereochemistry achieved in the 4-membered oxaphosphetane ring intermediate.  
Here, there are two options possible, where the ester group and the R group can be 
in either a syn or anti relationship with one another.  As the formation of the 
oxaphosphetane ring is a reversible process, the thermodynamic product is favoured 
which here is the anti stereoisomer with minimal steric clash between the 
relatively bulky ester and R groups.  Subsequent decomposition of the anti 
oxaphosphetane ring leads to the E alkene product, as shown in Scheme 2.8.61 
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Scheme 2.8.  Origin of stereoselectivity in Horner-Wadsworth-Emmons reaction 
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This approach proved successful and gave the desired product 119 in a yield of 79% 
over the two steps from alcohol 116 (Scheme 2.9).  Only the desired E-alkene was 
observed by 1H NMR spectroscopic analysis of the product, indicated by a coupling 
constant of 15.5 Hz in the signals arising from the alkene protons. 
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Scheme 2.9.  Swern oxidation and Horner-Wadsworth-Emmons olefination 
 
As previously reported in the literature, compounds bearing electron-withdrawing 
sidechains such as esters in conjugation with the alkene tend to be unsuccessful 
substrates for Overman rearrangement chemistry, although the allylic 
trichloroacetimidate formation step is known to proceed as normal.62  It has been 
shown that the presence of an electron-withdrawing group in conjugation with the 
alkene such as in 120 leads to the possibility of a conjugate addition taking place 
from the trichloroacetimidate nitrogen atom to form the corresponding oxazoline 
122, as shown in Scheme 2.10.  This process competes with the desired [3,3]-
sigmatropic rearrangement, and in general, very little of the rearrangement 
product 121 is observed.63 
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Scheme 2.10.  Competing reaction pathways with conjugated ester 
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In order to overcome this potential problem, manipulation of the ester side chain 
was required.  Conversion of the ester to a protected hydroxyl group would lead to 
generation of a substrate suitable for investigation of the Overman rearrangement 
chemistry.  First, ester 119 was reduced to the corresponding alcohol 123 using 2.2 
equivalents of diisobutylaluminium hydride, a reaction which proceeded in 97% 
without the need for purification (Scheme 2.11). 
 
OEt
O
OTBDPS
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OTBDPSDIBAL-H
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-78 °C to r.t.
97%119 123  
Scheme 2.11.  Diisobutylaluminium hydride reduction 
 
Protection of the free hydroxyl group was then required, and the methoxymethyl  
(MOM) protecting group was selected as orthogonal deprotection conditions are 
required for this and the already–installed silyl group which required removal in the 
next synthetic step, as shown in Scheme 2.12.  Alcohol 123 was treated with 
bromomethyl methyl ether in the presence of Hünig’s base to give ether 124 in 82% 
yield, while the removal of the silyl protecting group was achieved in 73% yield 
using tetra-n-butylammonium fluoride. 
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Scheme 2.12.  Generation of allylic alcohol 125 
 
 
2.1.3 Conversion of allylic alcohol to allylic trichloroacetamide 
With the first allylic alcohol 125 in hand, it was then possible to conduct an 
investigation of the formation of allylic trichloroacetimidate 126 and its subsequent 
Overman rearrangement to allylic trichloroacetamide 127, as shown in Scheme 2.13.  
Synthesis of the allylic trichloroacetimidate was carried out successfully using 
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trichloroacetonitrile in the presence of base.  As these compounds are relatively 
unstable, the reaction product was immediately subjected to rearrangement.   
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Scheme 2.13.  Synthesis and rearrangement of allylic trichloroacetimidate 126 
 
In order to determine the optimum method for carrying out the Overman 
rearrangement, four sets of reaction conditions including both thermal and metal-
catalysed variants were tested.  In addition to the standard palladium(II) 
rearrangement catalyst bis(acetonitrile)palladium(II) chloride, platinum(II) chloride 
and gold(III) chloride were also screened, as both literature precedent and studies 
within our group have indicated that these could be successfully applied to 
Overman rearrangement reactions.64,65  The results are summarised below in Table 
7.  Note that the product yields quoted are over two steps from the allylic alcohol 
125. 
 
Reaction conditions Product Yield (%) 
K2CO3, p-xylene, 140 °C, 15 h 66 
PdCl2(CH3CN)2 (10 mol%), toluene, r.t., 15 h 51 
PtCl2 (15 mol%), THF, r.t., 135 h 34 
AuCl3 (15 mol%), THF, r.t. No reaction 
Table 7.  Results of Overman rearrangement study 
 
The results of this study showed that the reaction was successfully achieved under 
both thermal reaction conditions and palladium(II) catalysis, with both approaches 
generating the allylic trichloroacetamide in good yield.  When platinum(II) catalysis 
was trialled, a relatively high loading and longer reaction time were required, to 
attain only a moderate product yield.  The gold(III) catalyst failed to promote the 
rearrangement, and no product was detected after 192 h.  The use of thermal 
rearrangement conditions led to a significantly cleaner reaction profile than 
utilising palladium(II) catalysis, explaining the lower product yield observed. 
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2.1.4 Completion of -amino acid target 
With the protected amine functionality in place, it was then possible to introduce 
the required carboxylic acid group by use of an oxidative cleavage of the allylic 
double bond.  This was to be achieved under conditions originally published by 
Sharpless and co-workers where sodium periodate is used in the presence of a 
ruthenium(III) catalyst to install a carboxylic acid group on each carbon originating 
from the alkene.66  The catalytic cycle involved in this reaction is outlined below in 
Figure 15.67  Here, periodate oxidises ruthenium(III) chloride to ruthenium tetroxide, 
which enters the catalytic cycle and dihydroxylates the alkene.  This diol is then 
cleaved by periodate to form two aldehyde intermediates, which are then 
converted to carboxylic acids by ruthenium tetroxide, which itself is reformed by 
oxidation. 
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Figure 15.  Proposed catalytic cycle of Sharpless oxidative cleavage 
 
When these conditions were applied to the oxidation of trichloroacetamide 127, 
the desired carboxylic acid product 128 was successfully generated with a crude 
yield of 77% (Scheme 2.14).  In this instance, the carboxylic acid by-product formed 
is acetic acid, which was removed upon work-up. 
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Scheme 2.14.  Oxidative cleavage of alkene 
 
Following this, removal of both the trichloroacetamide and methoxymethyl 
protecting groups was required in order to complete the synthesis of the first -
amino acid target.  Helpfully, it was possible to achieve this simultaneously by 
heating the carboxylic acid 128 in 6 M hydrochloric acid under reflux, as shown in 
Scheme 2.15.  Using this approach, the amino acid target, D-serine 129 was formed 
in quantitative yield, and isolated as the hydrochloride salt. 
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Scheme 2.15.  Completion of -amino acid target 
 
 
2.1.5 Attempted synthesis of further allylic alcohol intermediates 
As the chemistry required to synthesise the first amino acid target had been 
developed, attempts were made to apply the methodology to the synthesis of a 
number of other -amino acids with a variety of side chains.  These groups would 
be introduced during the Horner-Wadsworth-Emmons step by treating the aldehyde 
with different phosphonate esters.  If inert alkyl side chains were added at this 
stage, no further manipulation would be required before the Overman 
rearrangement step and hence the final -amino acid targets could be generated 
rapidly. 
 
The next phosphonate ester to be applied to the olefination step was diethyl 
phenylethyl phosphonate, shown in Scheme 2.16.  Alcohol 116 was again oxidised 
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to the corresponding aldehyde as previously discussed and this was to be treated 
with a solution of the deprotonated phosphonate ester. 
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Scheme 2.16.  Swern oxidation and Horner-Wadsworth-Emmons olefination 
 
As there is no electron-withdrawing group in the phosphonate ester side chain, co-
ordination to a metal cation would be possible only to the P=O bond, and would not 
be expected to significantly aid deprotonation in this instance, and so it was likely 
that a stronger base than DBU would be required.  Therefore, a search of the 
literature was conducted to find conditions which would be suitable for the 
deprotonation of alkyl-substituted phosphonate esters.  The success of this search 
was limited, and the closest matching procedures were those which involved the 
use of phosphonate esters bearing unsaturated alkyl groups. 
 
The olefination was initially attempted using lithium bis(trimethylsilyl)amide 
according to a procedure described by Trost and Gunzner,68 although none of the 
desired alkene 130 was isolated upon purification.  Next, the reaction was 
repeated using lithium diisopropylamide as the base, which was generated in situ 
from diisoproylamine and butyllithium.69  Again, the reaction failed and so an 
attempt was made to carry out the olefination under the Masamune Roush 
conditions previously discussed although as expected, none of the desired product 
was observed.60  It was then considered that perhaps using the aldehyde as a crude 
product of the Swern oxidation step was impeding the progress of the reaction, and 
so an attempt was made to remove the residual triethylamine by carrying out 
washes with water and 2 M hydrochloric acid before addition of the phosphonate 
ester, the deprotonation of which had again been attempted using lithium 
diisopropylamide.  Unfortunately, this reaction failed to yield the desired product.  
These results are summarised in Table 8. 
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Conditions Outcome 
LiHMDS, THF, -78 °C to r.t. No product isolated 
nBuLi, iPr2NH, THF, -78 °C to r.t. No product isolated 
LiCl, DBU, CH3CN, r.t. No product isolated 
nBuLi, iPr2NH, THF, -78 °C; aldehyde worked up  No product isolated 
Table 8.  Attempted Horner-Wadsworth-Emmons olefination 
 
The failure of these attempted olefinations was considered to be a result of the 
lack of an electron-witdrawing sidechain on the phosphonate ester, and indeed in 
1966, Corey and Kwiatkowski showed that while the deprotonation of these 
phosphonates and their subsequent attack of aldehydes is possible, it is the 
elimination of phosphate via the oxaphosphetane ring which fails (see mechanism in 
Scheme 2.7).  It is thought that an electon-withdrawing group is required to 
dissipate a negative charge which builds up on the carbon - to phosphorus in the 4-
membered transition state, therefore allowing rapid elimination to proceed.70 
 
These results showed that the methodology developed within this project would not 
prove flexible enough for the synthesis of the wide range of -mono- and ,-di-
substituted -amino acids required bearing alkyl functionality and therefore, an 
alternative approach was investigated in which the reactivity of the components 
involved in the olefination step was reversed.   
 
The new method involved an attempt to convert the alcohol intermediate 116 to 
the corresponding tributylphosphonium salt 132 via the iodide 131, as shown in 
Scheme 2.17.  The phosphonium salt 132 could then be used in E-selective Wittig 
olefination reactions with a range of aldehydes, which are readily available 
commercially.  This would introduce the allylic double bond and desired side chain.  
The iodination was carried out according to a literature procedure described by 
Garegg and Samuelsson, and the desired product 131 was isolated in 96% yield.71   
However, when this was treated with tributylphosphine, none of the desired 
phosphonium salt was detected by 1H NMR spectroscopic analysis of the reaction 
mixture after 4 days.  It was believed that the approach of tributylphosphine to the 
substrate may have been sterically hindered by the presence of the large silyl 
protecting group.  1H NMR spectroscopic analysis also indicated that oxidation of 
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tributylphosphine to tributylphosphine oxide was occurring during the course of the 
reaction, and degassing the reaction mixture did not help the reaction to proceed 
successfully. 
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Scheme 2.17.  Attempted synthesis of phosphonium salt 132 
 
A final attempt was then made to introduce the required alkene and various side 
chains to the alcohol intermediate 116.  If the alcohol could be converted to a 
terminal alkene, this could be subjected to cross-metathesis chemistry with some 
simple terminal alkene partners to generate the desired protected allylic alcohol 
substrates. 
 
Scheme 2.18 shows the method attempted for the generation of the desired 
terminal alkene 133 via Swern oxidation and Wittig methylenation, which was 
carried out according to a literature procedure described by Schmidt and 
Sattelkau.72  Unfortunately, this methylenation proved unsuccessful and none of the 
desired product 133 was isolated.  It was believed that the presence of the strong 
butyllithium base was perhaps causing decomposition of the aldehyde intermediate 
by loss of the silyl protecting group.  
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Scheme 2.18.  Attempted generation of terminal alkene 133 
 
As several approaches based on organophosphorus olefinations had failed to 
incorporate the required alkene and side chains to the alcohol intermediate 116, 
the decision was made to focus efforts on an alternative strategy for the synthesis 
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of the desired range of allylic alcohols which would prove flexible enough to 
introduce many side chains without the need for harsh reaction conditions. 
 
 
2.2 Synthesis of -amino acids via cross-metathesis 
 
2.2.1 Proposed route to allylic alcohols 
The new approach proposed for the synthesis of allylic alcohols, outlined in Scheme 
2.19, focuses on the use of cross-metathesis chemistry with a common enone 
intermediate to incorporate the required side chain substitution on the eventual 
allylic double bond.  Due to the large number of both mono- and di-substituted 
terminal alkenes available commercially, this strategy would potentially allow the 
eventual generation of a wide variety of di- and tri-substituted allylic alcohol 
intermediates. 
 
In order to install the hydroxyl group, a 1,2-reduction of the carbonyl could be 
carried out and crucially, the stereochemistry at this centre can be controlled if the 
reaction is carried out in an appropriate chiral environment. 
 
As before, the proposed methodology would be developed initially for the synthesis 
of -amino acids before later application to the generation of targets bearing ,-
disubstitution. 
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Scheme 2.19.  Proposed synthesis of allylic alcohols 
 
 
2.2.2 Synthesis of enone intermediates via cross-metathesis 
The first aim of this route was to synthesise a simple enone to be used as a 
substrate for cross-metathesis with the various terminal alkene partners.  As the 
oxidative cleavage reaction later in the synthesis removes the alkyl portion of this 
enone, the use of almost any inert group should be appropriate.  Here, a 
phenylethyl group was selected as it should not be capable of reacting under any of 
the conditions it will be subjected to, and provides a simple 1H NMR pattern, 
making analysis of subsequent intermediates straightforward.  The starting material 
required, hydrocinnamic acid, is also relatively cheap and readily available. 
 
Crucial to the generation of the required enone intermediate 136 is the 
introduction of a vinyl group to hydrocinnamic acid.  A problem commonly 
encountered in the alkylation of carboxylic acid derivatives with organometallic 
reagents to form ketones is the propensity of the reaction products to undergo a 
second alkylation, generating the corresponding tertiary alcohol, as shown in 
Scheme 2.20.  Often, complex mixtures of starting material, ketone, and tertiary 
alcohol are detected after reaction. 
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Scheme 2.20.  Nucleophilic alkylation of carboxylic acid derivatives 
 
In 1981, Weinreb showed that formation of the undesired tertiary alcohol can be 
minimised if the alkylation is carried out on an N-methoxy-N-methyl amide, which 
are easily generated from the corresponding carboxylic acid derivative and amine.  
The methoxy oxygen atom here coordinates to the organometallic reagent (Figure 
16), stabilising the tetrahedral intermediate formed upon the first addition.  This 
intermediate does not collapse to the ketone product until quenched by acid during 
the work-up, thus preventing attack by a second equivalent of the organometallic 
reagent.73 
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Figure 16.  Weinreb amide coordination 
 
While the use of Weinreb amides has proven successful in circumventing the issue 
of tertiary alcohol formation, the cost of starting materials required for amide 
formation is relatively high.  In 1997, Martín et al. reported the use of morpholine 
amides as substrates for alkylation by organometallic reagents to generate 
ketones.74  Morpholine itself is a very cheap amine and can be used to easily form 
amides.  The oxygen atom present in the morpholine ring is able to stabilise the 
tetrahedral intermediate formed during alkylation in a similar way to the Weinreb 
amides, and studies have shown that the alkylation reactions proceed in relatively 
high yield with minimal tertiary alcohol formation.  Indeed, Martín’s paper reported 
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the synthesis of the enone 136 required for this project, and hence this approach 
was adopted here. 
 
As shown in Scheme 2.21, the desired morpholine amide 135 was generated easily 
via the corresponding acid chloride 139 which was formed by simply stirring 
hydrocinnamic acid 134 in neat thionyl chloride.  As the acid chloride is likely to be 
very reactive and sensitive to hydrolysis, no purification was carried out at this 
stage, and the crude product was immediately treated with morpholine to give the 
amide 135 in an excellent yield of 99% over the two steps. 
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Scheme 2.21.  Synthesis of morpholine amide 135 
 
Conversion of the morpholine amide 135 to the key enone intermediate 136 was 
carried out according to the conditions outlined in the Martín paper, using 
vinylmagnesium bromide, as shown in Scheme 2.22.  Helpfully, this Grignard 
reagent is commercially available as a solution in tetrahydrofuran.  The alkylation 
was carried out with a highest yield of 74%, although on a number of repeats of this 
experiment, this high yield proved somewhat inconsistent.  It was found that low 
product yields obtainedin some instances could be attributed to the formation of 
the double-alkylated tertiary alcohol.  In order to limit the formation of this 
undesired by-product and achieve consistently high yields of enone 136, the 
reaction time was kept to 1 hour or less to limit the possibility of the second 
alkylation taking place. 
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O
O THF, 0 °C
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MgBr
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O
135 136  
Scheme 2.22.  Formation of key enone intermediate 136 
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With the key enone intermediate 136 successfully synthesised, introduction of the 
eventual -amino acid side chains was achieved via cross-metathesis chemistry, 
which is very well established in the literature.75,76  Cross-metathesis has proved 
very popular in recent years, as it represents a simple method for the generation of 
new carbon-carbon double bonds which does not require harsh conditions, and is 
relatively atom-economical as only small loadings of the catalyst are required.  The 
cross-metathesis of two monosubstituted alkene partners also proceeds with 
selectivity for the E-alkene product, which is desired in this project. 
 
A number of catalysts have been developed which can promote alkene metathesis 
reactions including ring-closing metathesis, cross-metathesis and ring-opening 
metathesis.  The most commonly-encountered catalyst applied to cross-metathesis 
is Grubbs second generation catalyst K (Figure 17), first discussed in the literature 
in 1999.77 
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Figure 17.  Grubbs 2nd generation catalyst for cross-metathesis 
 
This catalyst acts as a source of a metal-carbene complex, and this undergoes a 
[2+2]-cycloaddition with the first alkene partner to form a 4-membered 
metallocyclobutane.  Collapse of this generates an alkene by-product (ethane in the 
methathesis of two terminal alkenes) and a new metal-carbene which is able to 
react with the second alkene partner, forming another metallocyclobutane from 
which the desired metathesis product is generated.  Note that in the first cycle, the 
phenyl group will be present on the metal-carbene complex, and this will be lost in 
the first alkene by-product in place of ethene.  This widely-accepted mechanism for 
the cross-metathesis of two alkenes was first proposed in 1970 by Hérisson and 
Chauvin and is shown in Figure 18.78 
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Figure 18.  Mechanism of alkene cross-metathesis 
 
A paper published by Grubbs and co-workers in 2003 categorised the various types 
of olefins which can undergo cross-metathesis according to their ability to 
homodimerise in the presence of a particular metathesis catalyst.79  Four ‘types’ of 
olefins were discussed, ranging from type I, which undergo homodimerisation 
rapidly, type II which homodimerise slowly, to type III which do not homodimerise, 
and finally type IV which fail to undergo cross-metathesis themselves but do not 
interfere with the metathesis catalyst’s activity.  The categories essentially relate 
to the order of reactivity of the olefin partners, with type I being the most reactive 
to cross-metathesis. 
 
According to this classification, the enone intermediate 136 is a type II olefin in 
reactions catalysed by Grubbs 2nd generation catalyst K, while simple terminal 
alkenes such as the metathesis partners used in this project are of type I.  Grubbs’ 
paper states that cross-metathesis reactions between an olefin of type I and one of 
type II should successfully lead to a selective heterodimerisation of the two alkene 
partners.  This is due to the fact that although homodimerisation of the type I 
alkene is possible, the homodimer itself can undergo a second metathesis reaction 
with the type II olefin to generate the desired product (Figure 19). 
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Figure 19.  Selectivity in cross-metathesis between type I and type II olefins 
 
The first terminal alkene partner selected for metathesis with enone 136 was 1-
hexene, which provided a simple alkyl chain for initial development of the 
methodology.  The first of these cross-metathesis reactions was carried out 
according to standard conditions.80  In the presence of Grubbs 2nd generation 
catalyst K (4 mol%), the substituted enone 140 was successfully generated in 75% 
yield, as shown in Scheme 2.23.   
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Scheme 2.23.  Cross-metathesis of enone 136 with 1-hexene 
 
Importantly, this reaction proceeded with complete selectivity for the desired E-
alkene product, and none of the alkene with Z-geometry was detected by 1H NMR 
spectroscopic analysis of the crude reaction product, as indicated by an observed 
coupling constant value of J = 15.8 Hz in the two signals derived from the alkene 
protons, which are shown in Figure 20. 
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Figure 20. 1H NMR spectroscopy signals derived from alkene protons of 140 
 
As this cross-metathesis reaction proceeded in a straightforward manner with a high 
product yield, the same key enone intermediate was subjected to these reaction 
conditions with three other terminal alkene partners, as shown in Scheme 2.24.  
These reactions achieved product yields ranging from a moderate 47% to 58%, 
observed for the tert-butyl substituted example 142.  The reaction involving the 
synthesis of nitrile-substituted trichloroacetamide 143 proved sluggish, and 
required repeated additions of catalyst (total catalyst loading = 9 mol%) to achieve 
complete consumption of the enone starting material 136. 
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Scheme 2.24.  Cross-metathesis reaction with additional alkene partners 
 
An additional -amino acid target, which bears a stereogenic centre in the -
position was also selected for synthesis and in order to introduce the required side 
chain, a cross metathesis reaction between enone 136 and a protected derivative 
of (S)-(+)-4-penten-2-ol 144 was necessary.  Protection of the hydroxyl group was 
first needed and the methoxymethyl group was selected as a suitable choice.  (S)-
(+)-4-penten-2-ol 144 was therefore subjected to standard MOM protection 
conditions using bromomethyl methyl ether in the presence of base, as shown in 
Scheme 2.25.  1H NMR spectroscopic analysis of the crude product showed that the 
required alkene 145 had been successfully generated in 89% crude yield, with only 
minor impurities present.  However when purification by silica column 
chromatography was attempted, decomposition of the product occurred, and none 
of the required product was isolated in a pure form. 
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Scheme 2.25.  Attempted MOM protection of (S)-(+)-4-penten-2-ol 
 
An alternative protection strategy was then selected for (S)-(+)-4-penten-2-ol 144, 
and silyl protection was deemed appropriate, as it would be capable of resisting the 
reaction conditions involved with the route under development.  Therefore, the 
alcohol was treated with tert-butyldimethylsilyl chloride in the presence of 
imidazole according to a literature procedure by Overman and Rishton, as shown in 
Scheme 2.26.81  However, neither the desired protected product 146 or starting 
material alcohol were identified upon work-up.  The protection was then attempted 
using triethylamine and 4-di(methylamino)pyridine, as described in the literature by 
Kalivretenos et al., and this time the desired protected alcohol was generated in 
52% yield.82 
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Scheme 2.26.  Silyl protection of (S)-(+)-4-penten-2-ol 
 
The silyloxy-substituted terminal alkene 146 was then subjected to cross-
metathesis with enone 136 using the standard reaction conditions, as shown in 
Scheme 2.27.  Although a slightly increased loading of Grubbs catalyst K (5 mol%) 
was required, the reaction proceeded successfully with an excellent yield of 89%. 
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Scheme 2.27.  Cross metathesis of enone 136 with silyloxy-substituted terminal alkene 146 
 
 
2.2.3 Enantioselective ketone reductions to generate allylic alcohols 
In order to complete the generation of the desired allylic alcohol intermediates, 
reduction of the enone carbonyl groups was required.  This could be achieved 
enantioselectively by employing CBS protocol.  The CBS reduction, named after its 
developers Corey, Bakshi and Shibata, was developed in the late 1980s and involves 
a 1,2-reduction of ketones to alcohols in the presence of an enantiomerically pure 
oxazaborolidine catalyst of the type shown in Figure 21 and a borane reducing 
agent.83,84  These oxazaborolidine catalysts are capable of achieving the reduction 
of simple ketones in excellent yield attaining enantiomeric excess values greater 
than 90% in the alcohol products. 
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Figure 21.  Typical CBS oxazaborolidine catalyst 
 
Both enantiomers of these oxazaborolidine catalysts are available commercially and 
as expected, opposite enantiomers of oxazaborolidine lead to generation of 
opposite allylic alcohol product enantiomers.  The product enantiomer formed 
preferentially can be predicted (Figure 22).  It can be seen that a highly 
enantioselective reduction is possible when there is a significant difference in size 
between the groups on either side of the carbonyl.  With the enone substrates 140–
143 and 147 used in this project, there is not a particularly significant difference in 
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the size between these groups although it has been shown that in general, a vinylic 
double bond will generally behave as the large group in these reductions.85 
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Figure 22.  Prediction of enantiomeric outcome of CBS reduction 
 
The source of enantioselectivity observed in the CBS reduction can be understood 
by consideration of the reaction mechanism, a simplified version of which is shown 
in Figure 23.86  The active reducing agent here is formed when borane coordinates 
to the oxazaborolidine nitrogen.  The ketone substrate then coordinates to the 
boron atom within the oxazaborolidine bicycle, the Lewis acidity of which is 
increased by the initial coordination of borane to nitrogen.  The ketone binds in a 
manner which minimises steric interaction between the large substituent and the 
oxazaborolidine, with the large substituent placed in a pseudoequatorial position in 
the 6-membered transition state.  This coordination then allows the hydride from 
borane to be delivered preferentially to one face of the ketone. 
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Figure 23.  Source of enantioselectivity with (S)-(-)-2-methyl-CBS-oxazaborolidine 
 
In order to find the optimal conditions for this CBS reduction, a study was carried 
out to determine the effect of altering the loading of the CBS catalyst on both the 
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yield and enantiomeric excess of the product.  The butyl-substituted enone 140 was 
selected as a standard substrate for the reduction reactions with (S)-(-)-2-methyl-
CBS-oxazaborolidine, selected as the catalyst to favour formation of the desired 
(R)-enantiomer of the allylic alcohol 148, as shown in Scheme 2.28. 
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Scheme 2.28.  CBS reduction of enone 140 
 
This reduction reaction was attempted under standard conditions discussed by 
Evans and Morken in the literature, and initially carried out in the presence of 0.2 
equivalents of the CBS oxazaborolidine catalyst.87  This was subsequently increased 
to 0.5 equivalents in a repeat of the reduction, and finally to a stoichiometric 
quantity of the oxazaborolidine.  The product yields were high in each instance, 
although the enantiomeric excess values were shown to improve significantly with 
increasing equivalents of oxazaborolidine, as shown in Table 9.  Comparison of []D 
values to literature data confirmed the formation of the required (R)-enantiomer of 
the allylic alcohol. 
 
Equivalents of oxazaborolidine Yield (%) e.e (%) 
0.2 57 31 
0.5 100 71 
1.0 99 84 
Table 9.  Results of CBS reduction study 
 
The enantiomeric excess values quoted here were determined by chiral HPLC 
analysis, using a Chiralcel IB column.  In order to determine HPLC conditions for the 
separation of enantiomers of the enol products, a racemic sample of each of these 
was required.  These enol racemates were generated by carrying out a 
straightforward reduction using diisobutylaluminium hydride, as shown in Scheme 
2.29. 
 
  
74 
Ph
O
R
DIBAL-H (1.0 M)
toluene, 0 °C Ph
OH
R
R = nBu (51%)
       (CH2)2Ph (60%)
       CH2
tBu (100%)
       (CH2)3CN (54%)
       (S)-CH2CH(OTBDMS)CH3 (53%)  
Scheme 2.29.  Racemic reduction of enone intermediates 
 
The results of the catalyst screen showed that the highest enantiomeric excess 
values in the product are observed when a stoichiometric quantity of the CBS 
oxazaborolidine is used.  As the enantioselectivity established in the CBS reduction 
is carried through to the eventual amino acid target, it is crucial that high 
enantiomeric excess values are attained at this stage.  Therefore, it was decided 
that a stoichiometric quantity of CBS oxazaborolidine should be utilised in the 
reduction of the remaining enone intermediates, as shown in Scheme 2.30.  High 
yields were achieved for each of these reduction reactions, with moderate to high 
levels of enantioselectivity observed.  1H and 13C NMR spectroscopic analysis of 
alcohol 152, with comparison to the diisobutylaluminium hydride-reduced sample, 
indicated that only a single diastereoisomer of the product was detectable. 
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Scheme 2.30.  CBS reduction of remaining enone intermediates 
 
While the CBS reduction was successfully achieved to synthesise all of the desired 
allylic alcohols, this strategy is slightly lacking in efficiency, as it requires the CBS 
enantioselective reduction and also racemic diisobutylaluminium hydride reduction 
of each individual enone synthesised in addition to subsequent chiral HPLC analysis 
of all these reaction products.  An alternative approach was therefore considered, 
where the 1,2-reduction of the enone functionality was carried out on key enone 
intermediate 136 prior to cross-metathesis with the various terminal alkene 
partners.  This would mean that chiral HPLC analysis would only be required once, 
as the stereogenic centre would not be affected by the cross-metathesis chemistry.  
Using the reduction conditions employed previously, both the racemic and 
enantioselective reductions were carried out on enone 136, proceeding in yields 
comparable to previous examples as shown in Scheme 2.31.  It is worth mentioning 
that an initial attempt to carry out the reduction of enone 136 to racemic alcohol 
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rac-153 using sodium borohydride had resulted in a 1:1 ratio of the desired product 
and the product with a fully reduced alcohol with further reduction of the carbon-
carbon double bond, the result of a 1,4-addition of hydride to enone 136. 
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Scheme 2.31.  Reduction of enone 136 
 
With the reduction of enone 136 successfully achieved, the racemic sample was 
utilised in a test cross-metathesis reaction with 1-hexene, as shown in Scheme 2.32.  
According to literature precedent, the cross-metathesis of enol partners should be 
possible to achieve, with enols falling into the Type II category according to Grubbs’ 
classification.79  However, when this reaction was attempted, none of the desired 
product rac-153 was detected by 1H NMR spectroscopic analysis upon purification. 
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Scheme 2.32.  Cross metathesis of alcohol rac-153 with 1-hexene 
 
As this cross-metathesis failed, it was decided to continue with the original strategy 
of carrying out the cross-metathesis prior to the reduction step. 
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2.2.4 Conversion of allylic alcohols to allylic trichloroacetimidates 
With the desired allylic alcohols successfully synthesised, a study of the Overman 
rearrangement chemistry was then carried out.  As discussed previously, the [3,3]-
sigmatropic rearrangement of allylic trichloroacetimidates derived from secondary 
alcohols is possible under both thermal conditions and metal catalysis, although 
thermal rearrangements tend to give a cleaner reaction profile and hence higher 
yields. 
 
The butyl-substituted enol 148 was initially used as the substrate for 
trichloroacetimidate formation and subsequent Overman rearrangement, as shown 
in Scheme 2.33.   
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Scheme 2.33.  Conversion of enol 148 to trichloroacetimidate and Overman rearrangement 
 
Initially, the trichloroacetimidate formation was carried out using the reaction 
conditions discussed in chapter 2.1.  On the first attempt of this reaction, the 
acetimidate formation was stirred at room temperature for 9 h, and this was 
followed by a PdCl2(CH3CN)2-catalysed rearrangement.  The yield of 
trichloroacetamide 155 was a relatively disappointing 37% in this instance, and the 
presence of some remaining unreacted allylic alcohol starting material cited as the 
reason for this.  Therefore, the trichloroacetimidate formation step for alcohol 148 
and the remaining examples was allowed to stir at room temperature for 24 h 
before subjecting to the rearrangement conditions.  When this rearrangement 
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chemistry was repeated in combination with the longer acetimidate formation 
reaction, a slightly increased product yield of 41% was attained, although repeated 
purification by silica column chromatography failed to separate the desired product 
from minor impurities present. 
 
The rearrangement reaction was then carried out under thermal reaction conditions.  
Again, the acetimidate formation was allowed to stir at room temperature for 24 h.  
Using this approach, a much cleaner reaction product was observed, and upon 
purification, a 67% product yield was achieved (Scheme 2.34). 
 
The conditions employed for the synthesis of allylic trichloroacetamide 155 were 
then applied to conversion of the remaining allylic alcohols, as shown below in 
Scheme 2.34.  All of these reactions were carried out in high yield.  Note that the 
product yields quoted below are over two steps from the corresponding allylic 
alcohols. 
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Scheme 2.34.  Synthesis of allylic trichloroacetamides 155–159 
 
 
2.2.5 Completion of -amino acid targets 
With the desired protected amine functionality in place, it was then possible to 
introduce the carboxylic acid group required in the final amino acid targets.  In 
order to achieve this, Sharpless oxidation conditions were employed to cleave the 
alkene using ruthenium(III) catalysis.66  The reaction was initially carried out on 
allylic trichloroacetamide 155, as shown in Scheme 2.35, generating the desired 
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product 160 and hydrocinnamic acid 134 as a by-product.  Attempts to separate 
these two reaction components by silica column chromatography proved difficult 
due to their ability to form hydrogen bonds with the stationary phase, and resulted 
in a relatively low product yield of 29%. 
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Scheme 2.35.  Oxidative cleavage of allylic trichloroacetamide 155 
 
As separation of the two acid products was problematic, it was decided to subject 
the crude reaction product to a simple esterification to generate the corresponding 
methyl esters, which would be significantly easier to purify by column 
chromatography.  This method was successfully applied to the generation of esters 
155-158, as shown in Scheme 2.36.  Again, the product yields quoted are over 2 
steps from the allylic trichloroacetamides. 
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Scheme 2.36.  Oxidative cleavage and esterification 
 
During one instance of carrying out this oxidation and esterification on the nitrile-
substituted trichloroacetamide 158, additional ruthenium trichloride hydrate (2.5 
mol%) and sodium periodate (1 equivalent) were added after a reaction time of 18 h, 
as TLC analysis at this stage appeared to show the presence of residual starting 
material.  Upon purification after the esterification step, a significant by-product 
was isolated.  Analysis indicated that the nitrile group had undergone hydrolysis to 
the corresponding carboxylic acid during the oxidative cleavage reaction, and 
subsequent esterification led to the formation of the diester 165, which was 
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isolated in 35% yield (Figure 24).  The presence of this diester resulted in a 
significantly lower yield of 17% of the desired ester 164. 
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165  
Figure 24.  Diester by-product 
 
Problems were encountered in the oxidative cleavage of silyloxy-substituted 
trichloroacetamide 159.  When subjected to the Sharpless oxidation and 
esterification, none of the desired ester 166 was formed, and a complex product 
mixture was observed by 1H NMR spectroscopic analysis.  At this stage, it was 
believed that this was perhaps due to loss of the silyl protecting group occurring 
during the esterification step where relatively harsh reaction conditions are 
encountered and HCl is generated.  Therefore, the oxidation was repeated 
according to the Sharpless protocol, although this was followed by a milder 
esterfication procedure utilising (trimethylsilyl)diazomethane as shown in Scheme 
2.37.  The desired ester product 166 was isolated upon purification, although in a 
disappointing yield of just 16% over the 2 steps.  This result suggested that the 
oxidative cleavage step was problematic with the silyloxy-substituted substrate.  
This was confirmed when attempts to purify the cleaved carboxylic acid directly 
from the Sharpless oxidation step without esterification failed. 
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Scheme 2.37.  Attempted generation of ester 166 
 
Alternative methods for the oxidative cleavage of the alkene 159 were then 
investigated, the first of which was ozonolysis in the presence of a methanolic 
solution of sodium hydroxide in an attempt to carry out the oxidation and 
esterification in a single reaction.  The conditions applied were described in the 
literature by Marshall and Garofalo (Scheme 2.38), and resulted in the successful 
isolation of the desired ester 166 in a modest 25% yield upon purification.88 
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Scheme 2.38.  Ozonolysis of trichloroacetamide 159 
 
A literature procedure published by Ranu et al.89 which uses tert-
butylhydroperoxide in the presence of a Lewis acid catalyst was then trialled as this 
uses relatively mild conditions, and was followed by the mild TMS-diazomethane 
esterification as shown in Scheme 2.39.  However, none of the desired ester 166 
was isolated and a proportion of the unreacted starting material 159 remained in 
the crude product.  Finally, conditions published by Figueiredo et al. were 
employed, and the oxidation was carried out using potassium permanganate and 
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sodium periodate.90  When followed by the same TMS-diazomethane esterification, 
ester 166 was isolated in a satisfactory yield of 30% over the two steps. 
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Scheme 2.39.  Alternative oxidations of trichloroacetamide 159 
 
In order to complete the synthesis of the -amino acid targets, removal of both the 
trichloroacetamide group and the methyl ester was required for each example.  
This was achieved by heating the ester intermediates under reflux in 6 M 
hydrochloric acid, as shown in Scheme 2.40.  In the case of the silyloxy substituted 
compound 166, it was found that the silyl protecting group was also removed as 
desired under these reaction conditions.  Upon workup however, it was found that 
lactonisation had occurred also and so in order to reopen the lactone ring, 
purification was carried out using an ion exchange column.  This gave the -amino 
acid target 170 in a yield of 71%. 
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Scheme 2.40.  Completion of -amino acid targets 
 
As the nitrile functionality on ester 164 is sensitive to hydrolysis in the presence of 
6 M hydrochloric acid, an alternative strategy was utilised for its deprotection.  An 
attempt was made to hydrolyse the methyl ester and trichloroacetamide groups 
simultaneously in the presence of base, which would hopefully leave the nitrile 
group intact.  Lithium hydroxide was employed, as shown in Scheme 2.41, although 
it was found that while ester hydrolysis was successful, the trichloroacetamide 
groups remained unreacted.  Therefore the acid intermediate 171 was reacted with 
6 M HCl under reflux and as expected, hydrolysis of the trichloroacetamide group 
occurred.  The harsh reaction conditions led to conversion of the nitrile group to 
the corresponding amide 172, which was formed in quantitative yield over the two 
steps. 
 
  
86 
MeO
O
CN
NH
CCl3
O
HO
O
CN
NH
CCl3
OLiOH·H2O
tBuOH, H2O
0 °C to r.t.
HO
O
NH2
NH2
O
6 M HCl
120 °C
100% (2 steps)
164 171
172
·HCl
 
Scheme 2.41.  Deprotection of trichloroacetamide 164 
 
It was also possible to complete the synthesis of an additional -amino acid target 
173 from the diester 165, isolated as a by-product during the oxidative 
cleavage/esterification step as previously described.  This was achieved as above by 
treating the diester with acid under reflux, as shown in Scheme 2.42, and the 
target L-aminoadipic acid 173 was generated in quantitative yield. 
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Scheme 2.42.  Completion of diacid 173 
 
At this stage, the new methodology for the generation of -amino acids had been 
successfully developed.  Importantly, the introduction of a variety of side chains 
was possible during the mild cross-metathesis conditions, and the use of an 
asymmetric ketone reduction to form the required chiral allylic alcohols meant that 
access to either product enantiomer would be possible by application of both 
enantiomers of the commercially-available CBS oxazaborolidine reagent.  A study of 
conditions required for the Overman rearrangement conditions and subsequent 
conversion to -amino acids led to the completed synthesis of the target 
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compounds 167–170 and 172 in an efficient, stereoselective manner from simple 
starting materials. 
 
 
2.2.6 Synthesis of trisubstituted enone via cross-metathesis 
With -amino acid targets 167–170 and 172 successfully completed, the developed 
methodology was applied to the attempted synthesis of ,-disubstituted examples.  
This could be achieved by using disubstituted terminal alkenes in the cross-
metathesis reaction with the enone intermediate 136.  For this approach to be 
successful, this cross-metathesis has to proceed in good yield and with a high 
degree of E/Z-selectivity.  In 1999, Chatterjee and Grubbs published details of the 
synthesis of trisubstituted alkenes via cross-metathesis and showed that Grubbs 2nd 
generation catalyst K succeeded in promoting these reactions with a number of 
examples where one of the substituents on the disubstituted alkene partner is a 
methyl group.80  The reactions discussed proceeded in good yield and with 
moderate levels of E:Z selectivity, the highest being a 4:1 product ratio. 
 
Under Grubbs’ classification of olefin cross-metathesis partners, simple 2,2-
disubstituted olefins belong to the type III category when Grubbs 2nd generation 
catalyst K is used.79  Type III olefins are less reactive than type II partners, and are 
not susceptible to homodimerisation.  This reduced reactivity, attributed to steric 
hindrance, means that often a relatively high excess of the terminal alkene partner 
is required to attain a high yield of the desired heterocoupled product.  This excess 
can help to prevent the formation of the type II homodimer, which would be unable 
to undergo a second metathesis with the type III olefin. 
 
Enone intermediate 136 was subjected to cross-metathesis with 2,2-dimethyl 
pentene, as shown in Scheme 2.43 and both the product yield and E/Z selectivity 
were noted using a range of conditions. 
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Scheme 2.43.  Cross-metathesis to form trisubstituted alkenes 
 
Initially, the standard reaction conditions applied to the synthesis of enone 140 
were employed, using 5 mol% of Grubbs 2nd generation catalyst.  However, the 
reaction was slow and required additional 2-methyl-1-pentene and Grubbs 2nd 
generation catalyst K, although a very poor yield product yield of 6% was achieved 
(Table 10, entry 1).  Repeats of this reaction using higher catalyst loadings and 
increased reaction temperatures were also attempted, with limited improvement in 
product yield.  Use of a copper(I) chloride co-catalyst was also trialled, as literature 
precedent indicated that this can improve reaction turnover.  However, this failed 
to yield any of the desired alkene product (entry 4).91  The most significant 
improvement came in changing the cross-metathesis catalyst to Hoveyda-Grubbs 2nd 
generation catalyst L (Figure 25), with reaction time significantly decreased and 
improvement in both yield and E/Z-selectivity observed (entry 5).  Further 
investigation showed that this catalyst provides the highest yield of trisubstituted 
alkene 174 when the reaction is carried out at 45 °C, allowing lower catalyst 
loadings to be used. 
 
Entry Catalyst (initial/ 
total loading, mol%) 
Solvent Temperature 
(°C) 
Time 
(h) 
Yield 
(%) 
E : Z 
1 K (5/15) CH2Cl2 45 190  6 1.7 : 1 
2 K (20/25) CH2Cl2 45 72 25 3 : 2 
3 K (20/25) toluene 80 88 31 1.2 : 1 
4 K (5/10) + CuI (10) CH2Cl2 45 71 0 _ 
5 L (20) toluene 80 24 41 2 : 1 
6 L (5/10) toluene 80 354 18 1.2 : 1 
7 L (10/22.5) toluene 80 162 23 2.2 : 1 
8 L (5/6) CH2Cl2 45 72 53 1.7 : 1 
Table 10.  Results of cross-metathesis study 
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Figure 25.  Hoveyda-Grubbs 2nd generation catalyst L for cross-metathesis 
 
Confirmation of the geometry of the alkene products was achieved using 1H NMR 
spectroscopic analysis by the nuclear Overhauser effect.  Selective irradiation of 
the 1H NMR signal arising from the alkene proton at 5.97 ppm provided the ability to 
distinguish between the E and Z product isomers.  In the E-isomer, the alkene 
proton should interact through space with the CH2 group of carbon-3, while the Z-
isomer’s alkene proton should interact with the methyl group substituent of the 
double bond, as indicated in Figure 26. 
 
Ph
O O
Ph
1
2
357
8
1
23
57
8
 
Figure 26.  Anticipated through-space interaction with alkene protons 
 
These experiments confirmed that the major isomer formed in each attempt of the 
reaction was, as expected, the E-isomer, and the spectra from this study are shown 
below in Figure 27 (E-isomer) and Figure 28 (Z-isomer). 
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Figure 27.  nOe spectrum for E-174 
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Figure 28.  nOe spectrum for Z-174 
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2.2.7 Installation of quaternary centre via Overman rearrangement 
With the limited quantities of trisubstituted alkene E-174 synthesised, its reduction 
to allylic alcohol 175 was carried out.  As before, this was attempted using the CBS 
asymmetric reduction protocol and proceeded in quantitative yield, as shown in 
Scheme 2.44.  Again, chiral HPLC analysis was carried out with comparison to a 
racemic sample of the allylic alcohol (synthesised in 54% via DIBAL-H reduction), 
and this indicated an enantiomeric excess value of 46% in the CBS reduction product. 
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Scheme 2.44.  Asymmetric reduction of trisubstituted enone E-174 
 
Conversion of allylic alcohol 175 to the corresponding allylic trichloroacetimidate 
176 was then attempted using the standard conditions previously discussed.  
However, the additional methyl group introduced additional steric bulk across the 
alkene relative to the disubstituted examples and significantly lowered the reaction 
rates.  Therefore, acetimidate formation required additional reaction time and 
eventually heating under reflux to promote consumption of the starting material 
175. 
 
The rearrangement step was also initially attempted under thermal conditions 
although again, the presence of the additional methyl group meant that longer 
reaction times were applied.  However, none of the desired product was isolated in 
the first attempts at this reaction.  The use of palladium catalysis also failed to 
promote the rearrangement.  Finally, the reaction was attempted by heating the 
allylic trichloroacetimidate 175 at 130 °C in toluene in a sealed reaction tube.  In 
this instance, it appeared that a small quantity of the desired rearrangement 
product 177 had formed, although only in a disappointing yield of 11% over the 2 
steps (Scheme 2.45). 
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Scheme 2.45.  Overman rearrangement to form quaternary centre 
 
Although the attempted synthesis of an ,-disubstituted -amino acid target was 
met with limited success, it was hoped that the methodology developed could be 
applied to the synthesis of more complex -amino acid targets. 
 
 
2.2.8 Attempted synthesis of orthogonally-protected meso-diaminopimelic acid 
An investigation was undertaken to use the chemistry developed for the generation 
of an orthogonally protected derivative 178 of diaminopimelic acid 179, a non-
proteinogenic diamino diacid (Figure 29). 
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Figure 29.  Protected meso-diaminopimelic acid derivative and meso-diaminopimelic acid 
 
meso-Diaminopimelic acid (meso-DAP) 179 is found as a component of bacterial cell 
walls, and is a precursor in the biosynthesis of L-lysine.92  Therefore, compounds 
similar in structure to meso-DAP have the potential for exhibiting antibiotic activity 
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by inhibiting this biosynthetic pathway and preventing bacterial cell wall formation.  
Rapid generation of meso-DAP analogues could be aided with the generation of a 
synthetically useful orthogonally-protected derivative such as 178, as this would 
allow the individual manipulation of the functional groups. 
 
The planned synthesis of 178 involved the generation of a chiral allylic alcohol 185 
via cross-metathesis and CBS reduction, which could again be subjected to Overman 
rearrangement to introduce one of the required protected amine groups.  Sharpless 
oxidation followed by esterification would complete the synthesis of 178 by 
installing the second ester group.  The steps proposed to complete the synthesis of 
the target compound are outlined below in Scheme 2.46.  The starting material is 
Cbz-protected lysine, which is commercially available as a single enantiomer and 
provides one of the required protected amines and an ester found in the eventual 
target compound. 
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Scheme 2.46.  Cross-metathesis approach to target 178 
 
The first reaction required for this route was a conversion of Cbz-L-lysine to the 
corresponding primary alcohol, and this was carried out according to a literature 
procedure by Bence and Crooks using sodium nitroferricyanide, as shown in Scheme 
2.47.93  The crude product of this reaction was then subjected to esterification 
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under standard conditions, and the desired methyl ester 182 was isolated in a yield 
of 53% over the 2 steps. 
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Scheme 2.47.  Synthesis of primary alcohol 182 
 
Primary alcohol 182 was treated under standard Swern oxidation conditions, and 
the crude aldehyde 187 was reacted with a solution of deprotonated 
methyltriphenylphosphonium bromide (1.5 equivalents), which had been treated 
with potassium bis(trimethylsilyl)amide (1.3 equivalents).94  Unfortunately after the 
olefination reaction mixture had been stirred overnight, none of the desired 
terminal alkene 183 was isolated (Scheme 2.48). 
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Scheme 2.48.  Swern oxidation and methylenation 
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In order to establish whether this reaction had failed at the Swern oxidation step, 
or during methylenation, the oxidation was carried out a second time, although this 
attempt was followed by olefination with triethyl phosphonoacetate under 
Masamune Roush conditions which had previously been shown to successfully react 
with crude aldehydes synthesised in the same manner.58  The test reaction carried 
out is shown in Scheme 2.49, and successfully generated -unsaturated ester 188 
in a yield of 47% over the 2 steps. 
 
O
H
OMe
O
NHCbz
P
O
EtO
EtO OEt
O
LiCl, DBU
CH3CN, r.t.
47% (2 steps)
OMe
O
NHCbz
EtO
O
187 188  
Scheme 2.49.  Test Horner-Wadsworth-Emmons olefination 
 
The successful outcome of this HWE olefination confirms that it is possible to 
generate aldehyde 187 using a Swern oxidation, and it was the methylenation of 
this intermediate that was proving problematic.  The Swern oxidation and 
methylenation procedure was therefore repeated, increasing the equivalents of 
phosphonium salt from 1.5 to 5.0 and equivalents of the KHMDS base from 1.3 to 
5.0.  A fresh bottle of KHMDS was also purchased, although the highest yield of 
terminal alkene 183 isolated using this was just 26% (Scheme 2.50).  Changing the 
base used to potassium tert-butoxide failed to lead to the formation of any of the 
product. 
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Scheme 2.50.  Improved methylenation of aldehyde 187 
 
An alternative method was then investigated for the desired methylenation reaction.  
Nysted reagent95, a zinc-based reagent used for the methylenation of carbonyl 
compounds, was used to treat aldehyde 187, which was again generated via the 
Swern oxidation of alcohol 182.  The methylenation was carried out using Nysted 
reagent in the presence of boron trifluoride diethyl etherate according to a 
literature procedure by Matsubara et al., as shown in Scheme 2.51.96  Unfortunately, 
despite attempting this reaction several times, none of the desired alkene 183 was 
isolated. 
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Scheme 2.51.  Attempted Nysted methylenation of aldehyde 187 
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As none of the attempts described above were successful in generating alkene 183 
in the high yield required for the eventual synthesis of orthogonally-protected 
meso-diaminopimelic acid 178, work in this area was discontinued. 
 
 
2.3 Towards the stereoselective synthesis of capreomycidine 
 
2.3.1 Properties of capreomycidine-containing compounds 
(2S,3R)-Capreomycidine 189 is a non-proteinogenic -amino acid with a cyclic 
structure incorporating a guanidine group (Figure 30). 
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Figure 30.  (2S,3R)-Capreomycidine 189 
 
(2S,3R)-Capreomycidine 189 is a component of the families of capreomycins and 
the related tuberactinomycins, both of which are cyclic pentapeptides (Figure 31).  
Capreomycins have been shown to exhibit biological activity against strains of 
Mycobacterium tuberculosis which have proved resistant to other antibiotics.97  It 
has been shown that the capreomycidine unit within these structures is necessary 
for the biological activity exhibited.98 
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Figure 31.  Structures of capreomycins and tuberactinomycins 
 
In addition to the significant biological activity of (2S,3R)-capreomycidine-
containing compounds, its diastereoisomer (2S,3S)-capreomycidine 190 (also 
referred to as epi-capreomycidine) is also found incorporated into complex 
structures such as muraymycin A1 (Figure 32) which inhibits a key enzyme involved 
in peptidoglycan biosynthesis in bacteria.99 
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Figure 32.  Muraymycin A1, inhibitor of peptidoglycan biosynthesis 
 
Previous approaches to the synthesis of (2S,3R)-capreomycidine 189 and (2S,3S)-
capreomycidine 190 include the use of kinetic resolution100 and chiral auxiliaries.97  
The development of a stereoselective, efficient route suitable for the generation of 
large quantities of these amino acids could aid the generation of a range of 
compounds with attractive biological activity.   
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2.3.2 Proposed synthetic route to (2S,3R)-capreomycidine 
Initial efforts would focus on the synthesis of (2S,3R)-capreomycidine 189, using 
the steps outlined in Scheme 2.52.  A key step involved in this route is the 
stereoselective introduction of a hydroxyl group to an enolate derived from 
protected L-aspartic acid 192, which is achieved using Davis’ oxaziridine 193.  
Protection of this group is followed by reduction of the methyl ester to primary 
alcohol 196, which is then subjected to a Swern oxidation/olefination reaction to 
introduce the required nitro group, which could be converted to amine 198 by 
hydrogenation.  Introduction of a protected guanidine unit, followed by a key ring 
closure step and deprotection would then generate the desired target compound. 
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Scheme 2.52.  Proposed synthesis of (2S,3R)-capreomycidine 189 
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2.3.3 Generation of alcohol via stereoselective hydroxylation 
The first steps of this proposed route involved the protection of L-aspartic acid 191.  
As shown in Scheme 2.53, a single reaction can be used to protect both carboxylic 
acid groups as methyl esters and the amine with a Boc group.  This was carried out 
according to a procedure previously used within the Sutherland research group and 
gave the protected product 192 in 82% yield.101 
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(i) TMSCl
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Et3N, r.t
82%.
NHBoc
191 192  
Scheme 2.53.  Protection of L-aspartic acid 
 
The next step in the route involved the stereoselective introduction of a hydroxyl 
group onto the methylene group of diester 192.  This was to be achieved using 
Davis’ oxaziridine 193, an electrophilic source of oxygen which was first applied to 
the synthesis of -hydroxy carbonyl compounds in 1984.102  The oxaziridine reagent 
itself was synthesised in 2 steps from commercially available starting materials, as 
outlined in Scheme 2.54.103 
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Scheme 2.54.  Synthesis of Davis’ oxaziridine 193 
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Attempts were then made to carry out the hydroxylation reaction using oxaziridine 
193, as shown in Scheme 2.55.  The procedure was carried out according to a 
literature procedure published by O’Brien and co-workers whereby the enolate 
derivative of diester 192 was formed by treatment with base before addition of the 
oxaziridine reagent.  The presence of the large Boc group on nitrogen should 
prevent access of the oxaziridine from the top face, and hence the hydroxyl group 
should be added in an anti relationship with this protected amine.104  Unfortunately, 
the first attempts at this reaction failed to yield any of the desired alcohol product 
anti-194.  Increasing the reaction time from 1 hour to 2 hours led to the isolation 
of the alcohol product in a low yield of just 9%.  However, analysis of the reaction 
product indicated that the hydroxyl group had the undesired syn relationship with 
the protected amine.  The reaction time was then increased further to 6 hours at -
78 °C, followed by stirring overnight at room temperature.  While this led to the 
generation of the anti product anti-194, which was isolated in 20% yield, there was 
still significant formation of the syn product, this time formed in 19% yield.  Further 
repeats of this reaction failed to lead to the generation of significant quantities of 
the desired product, and the ratio of syn:anti products was inconsistent, varying 
from 1:1 to approximately 3:1.  Therefore, this approach did not allow the 
generation of significant quantities of the anti alcohol product to continue with the 
investigation of this route. 
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Scheme 2.55.  Stereoselective hydroxylation of 192 
 
The failure of this hydroxylation reaction on a number of attempts led to the 
proposal of an alternative approach to the synthesis of (2S,3R)-capreomycidine 189. 
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2.3.4 Alternative proposed synthesis of (2S,3R)-capreomycidine 
The alternative route, shown in Scheme 2.56 makes use of the Overman 
rearrangement of an allylic trichloroacetimidate as a key step.  This time, the 
allylic trichloroacetimidate is derived from a primary allylic alcohol and therefore 
control of the stereochemical outcome of the rearrangement reaction is necessary.  
This can be achieved using a chiral Pd catalyst, which will allow the reaction to 
proceed in an enantioselective manner.  A particularly attractive feature of this 
approach is the use of either (S)-(+)-COP-Cl D or (R)-(-)-COP-Cl J as the 
rearrangement catalyst, which should allow the installation of opposing 
stereochemistry at C-3 centre, thus meaning that this route has the potential to 
lead to the eventual synthesis of (2S,3R)-capreomycidine 189 or (2S,3S)-
capreomycidine 190.  Introduction of the protected guanidine unit, followed by 
hydroboration and oxidation of the terminal alkene would give a primary alcohol 
which could undergo mesylation to give the substrate required for a ring closure 
reaction to form the cyclic amino acid core.  Finally, removal of the protecting 
groups would give the desired capreomycidine target.  The starting material 
required for this route is D-serine 129, which is again cheap and readily-available 
and has the required stereochemistry for one of the stereocentres already 
established. 
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Scheme 2.56.  Proposed alternative synthesis of (2S,3R)-capreomycidine 189 
 
 
2.3.5 Protection of D-serine 
The initial steps of this route are concerned with the complete protection of D-
serine 129.  The amine is protected with a Boc group, while the carboxylic acid can 
be protected as the methyl ester.  Finally, the free hydroxyl can be protected as a 
silyl ether.  These protection reactions were carried out in a straightforward 
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manner using conditions published by Nicolaou and co-workers, as shown below in 
Scheme 2.57.105  The required ester 212 was synthesised in a total yield of 75% over 
the 3 steps.  Helpfully, purification was not required until after the silyl protection 
step, and so this chemistry was able to provide the desired protected derivative of 
D-serine in a fast, efficient manner. 
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Scheme 2.57.  Protection of D-serine 
 
 
2.3.6 Generation of allylic alcohol intermediate 
In order to generate the desired allylic alcohol 206, an olefination reaction with 
triethyl phosphonoacetate would be used to install the necessary C=C double bond.  
To achieve this, conversion of the methyl ester 212 to the corresponding aldehyde 
was required, and attempts were made to achieve this using diisobutylaluminium 
hydride.  In theory, the use of one equivalent of diisubutylaluminium hydride should 
cause a single reduction of the methyl ester 212 to the aldehyde 213. 
 
The reduction was attempted using one equivalent of diisobutylaluminium hydride, 
and the crude product of the reaction was immediately treated with a solution of 
deprotonated triethyl phosphonoacetate in an attempt to generate the ,-
unsaturated ester 205, as shown in Scheme 2.58.  However upon work-up, none of 
the desired product was found to have formed, and mostly the methyl ester starting 
material 212 from the reduction step remained.  Several further attempts using this 
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approach, with the reaction time increased from 1.5 hours to 18 hours, failed to 
complete the conversion of ester 212 to aldehyde 213 cleanly. 
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Scheme 2.58.  Attempted DIBAL-H reduction and Horner-Wadsworth-Emmons olefination 
 
As the reduction step was failing to generate the desired aldehyde intermediate, it 
was decided to alter this approach to one which involved chemistry which was well-
established within the group for the formation of similar compounds.  As shown in 
Scheme 2.59 below, this required first of all the generation of the primary alcohol 
204, which could then be subjected to a combined Swern oxidation and Horner-
Wadsworth-Emmons olefination reaction, as discussed previously within this thesis.  
Again, the reduction could be achieved using diisobutylaluminium hydride, although 
this time 2.2 equivalents of this reducing agent was employed to fully reduce the 
methyl ester 212 to primary alcohol 204.  As expected, this reaction successfully 
generated the required alcohol 204 in 46% yield. 
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Scheme 2.59.  Reduction of methyl ester to primary alcohol 
 
  
107 
The primary alcohol 204 was then subjected to a Swern oxidation reaction, and the 
crude product of this was immediately treated with a solution of deprotonated 
triethyl phosphonoacetate to complete the olefination.  This took place under 
Masamune-Roush conditions, as outlined in Scheme 2.60.60  The reaction outlined 
here proved successful, and the desired ,-unsaturated ester product 205 was 
formed in 76% yield, with a high E/Z ratio of 13:1.  Helpfully, separation of the two 
geometric isomers was straightforward via silica column chromatography. 
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Scheme 2.60.  Swern oxidation and HWE olefination 
 
In order to complete the formation of the desired allylic alcohol substrate, a 
reduction of the ethyl ester 205 was carried out.  As diisobutylaluminum hydride 
had proven to successfully achieve the reduction of esters to primary alcohols 
within this and previous projects, this was initially selected as the reducing agent, 
as shown in Scheme 2.61.  Unfortunately, none of the desired allylic alcohol 
product was isolated.  It was thought that a 1,4-reduction of the allylic double bond 
may have been occurring under these conditions. 
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Scheme 2.61.  Attempted reduction to allylic alcohol 
 
This particular issue encountered with the 1,2-reduction of -amino-,-
unsaturated esters of this type has previously been discussed in the literature, and 
is thought to be attributed to the coordination of diisobutylaluminium to the Boc 
protecting group and the alkene, increases the susceptibility of the ester to 1,4-
reduction.  Moriwake et al. showed that this undesired reduction can be prevented 
if the unsaturated ester is treated with a Lewis acid such as boron trifluoride 
diethyl etherate before addition of diisobutylaluminium hydride.  The Boc group’s 
oxygen atom coordinates to the Lewis acid, while diisobutylaluminium hydride can 
coordinate only to the ester carbonyl group, promoting the desired 1,2-reduction. 
 
These alternative reaction conditions were therefore applied to the formation of 
allylic alcohol 206, as shown below in Scheme 2.62, and this time successfully 
generated the desired product in 78% yield.106 
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Scheme 2.62.  Improved reduction to allylic alcohol 
 
 
2.3.7 Investigation of Overman rearrangement conditions 
With the allylic alcohol in hand, it was then possible to investigate the 
stereoselective Overman rearrangement step.  As shown in Scheme 2.63, the allylic 
trichloroacetimidate formation step was carried out as previously described, 
although as a primary alcohol was involved this time, the reaction time required 
was just 5 hours. 
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Scheme 2.63.  Synthesis and Overman rearrangement of allylic trichloroacetimidate 214 
 
From the allylic trichloroacetimidate 214, a range of reaction conditions were used 
to promote the Overman rearrangement and both product yield and ratio of 
syn:anti-product diastereoisomers were noted (Table 11). 
 
Initially, (S)-(+)-COP-Cl was used as, according to literature precedent, this was 
expected to furnish the desired product diastereoisomer syn-207.  For a thorough 
investigation of this reaction, the same rearrangement was carried out this time in 
the presence of (R)-(-)-COP-Cl in an attempt to install the opposite stereochemistry, 
henceforth generating the anti-product diastereomer anti-207.  However, upon 
comparison of the 1H NMR spectra of the major products of both of these reactions, 
it was discovered that the same product diastereomer had preferentially formed in 
the presence of both of these catalysts, which was an unexpected observation. 
 
The rearrangement was also carried out using the achiral Pd(II) catalyst, 
PdCl2(CH3CN)2 and again, the same product diastereoisomer was formed in 
preference.  The rearrangement was also carried out under thermal conditions, 
heating at 140 °C in p-xylene with a small amount of potassium carbonate present.  
Little to no stereoselectivity for the rearrangement reaction under these conditions 
should be observed, and indeed a 1:1 ratio of both diastereomers was detected by 
1H NMR spectroscopic analysis.  Separation of these diastereoisomers was possible 
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by silica column chromatography, and gave individual samples of both products.  
Further analysis and comparison to literature data confirmed that the 
diastereoisomer formed preferentially in each of the metal-catalysed reactions was 
in fact the anti-diastereoisomer.41 
 
Conditions Catalyst loading Time (h) Yield (%) anti : syn 
(S)-(+)-COP-Cl, CH2Cl2, 38 °C 8 mol% 161 76 4.7 : 1 
(R)-(-)-COP-Cl, CH2Cl2, 38 °C 9 mol% 162 58 6 : 1 
K2CO3, p-xylene, 140 °C N/A 140 67 1 : 1 
PdCl2(CH3CN)2, CH2Cl2, 38 °C 10 mol% 24 53 11 : 1 
Table 11.  Results of Overman rearrangement study 
 
These unexpected results suggest that some factor is interfering with the expected 
progression of these rearrangement reactions, as it had been predicted that the (S)-
(+)-COP-Cl catalyst D and (R)-(-)-COP-Cl catalyst J should be selective for the 
formation of opposite product diastereoisomers, which is not the observed outcome.  
The levels of diastereoselectivity are not as high as may have been anticipated, and 
also very long reaction times were required in the presence of these catalysts.  It 
was thought that the presence of the two bulky protecting groups on the 
rearrangement substrate 214 may have hindered the approach of these large 
catalysts in the expected manner, thus leading to the observed stereochemical 
outcome in the rearrangement step. 
 
At this stage, it was decided to take forward the anti-207 and continue with the 
proposed route in an attempt to develop the methodology for the synthesis of 
(2S,3S)-capreomycidine 190, which itself is found in as a component of many 
compounds which exhibit antibacterial activity.  From the results of this reaction 
study shown in Table 10, it can be seen that while the (S)-(+)-COP-Cl D catalysed 
reaction gives the overall highest product yield, the highest diastereomeric ratio 
product is achieved when the simple PdCl2(CH3CN)2 catalyst is utilised.  The 
reaction time is also significantly lower here compared to when the larger chiral 
catalysts are used, and so when this rearrangement reaction was carried out on a 
larger scale, this catalyst was selected to achieve the desired product efficiently. 
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Formation of compounds such as 207 via Overman rearrangement chemistry has 
previously been discussed in the literature by Gonda et al.41  Selectivity for the 
formation of the anti product diastereoisomer in the presence of PdCl2(CH3CN)2 can 
be explained by co-ordination of palladium(II) to the amine nitrogen atom which 
promotes the progress of the rearrangement via the transition state shown in Figure 
8 in chapter 1.2. 
 
 
2.3.8 Removal of trichloroacetyl group 
In order to introduce the required protected guanidine unit, hydrolysis of the 
trichloroacetyl while leaving the two other protecting groups intact was necessary.  
This was initially attempted using sodium hydroxide, as shown in Scheme 2.64.  
Unfortunately, the hydrolysis of the trichloroacetamide failed to proceed at room 
temperature after 4 days, and the unreacted starting material was recovered.  The 
reaction was repeated, this time with heating to 65 °C although again no reaction 
occurred. 
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Scheme 2.64.  Attempted hydrolysis of trichloroacetyl group 
 
An alternative approach was then adopted for the removal of the 
trichloroacetamide group, this time by reduction.  Sodium borohydride was 
employed, as shown in Scheme 2.65.  These conditions were expected to readily 
generate amine 215, although the reduction proved to be slow, and required 
stirring for 5 days.  Despite the long reaction time, the product yield was relatively 
low at 23%. 
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Scheme 2.65.  Removal of trichloroacetyl group by reduction 
 
As small quantities of the amine 215 were generated via this method, only a 
preliminary investigation into the introduction of the protected guanidine unit was 
conducted, implementing reaction conditions used within the group previously as 
outlined in Scheme 2.66.107,108,109  Unfortunately, none of the desired product was 
detected. 
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Scheme 2.66.  Attempted introduction of guanidine unit 
 
At this stage, time restrictions unfortunately dictated that further development of 
this synthetic route is not currently possible.  However, successful generation of the 
late-stage amine intermediate 215 was achieved and therefore, further 
investigation of this route would be desirable.  The use of a stronger reducing agent 
could improve the formation of the required amine 215 and as the chemistry 
required for introduction of the Boc-protected guanidine unit is known within the 
literature, so would be expected to successfully generate the intermediate required 
for the ring-closing step.  Following this, relatively straightforward chemistry can 
be applied to complete the formation of the desired (2S,3S)-capreomycidine target 
190 as described in Scheme 2.56. 
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2.4 Conclusions 
 
During the course of this research project, new methodology has been developed 
for the synthesis of chiral allylic alcohols which could be utilised in the generation 
of -amino acid targets.  Initial studies investigated the use of organophosphorus 
olefination reagents for allylic alcohol generation and while the scope of this 
methodology was limited, an investigation of Overman rearrangement conditions 
was conducted to determine the optimum method for the conversion of secondary 
allylic alcohol 125 to allylic trichloroacetamide 127.  -Amino acid target D-serine 
129 was then formed by oxidative cleavage of the double bond, followed by 
hydrolysis of the trichloroacetamide under acidic conditions (Scheme 2.67). 
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Scheme 2.67.  Synthesis of D-serine via organophosphorus olefination chemistry 
 
An alternative approach was then investigated for the synthesis of chiral allylic 
alcohols which has improved flexibility for the generation of a range of alcohols 
with various side chains in place.  This involved the cross-metathesis of enone 136 
with terminal alkene partners, followed by asymmetric CBS-catalysed ketone 
reduction (Scheme 2.68). 
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Scheme 2.68.  Alternative methodology developed for chiral allylic alcohol generation 
 
Again, the Overman rearrangement was employed to generate allylic 
trichloroacetamides which was followed by oxidative cleavage and hydrolysis as 
shown in Scheme 2.67 to furnished -amino acid targets 167–170 and 172 in a 
highly efficient manner, with good product yields encountered during the key steps 
of the route.  Importantly, the use of Overman rearrangement chemistry allows the 
levels of enantiomeric excess established during CBS reduction to be transferred 
directly to the allylic trichloroacetamides, and hence to the eventual -amino acid 
targets. 
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Attempts were then made to apply the successfully developed methodology to the 
generation of some more complex -amino acid targets, including a target bearing 
quaternary-substitution on the -carbon atom, formed via a trisubstituted allylic 
alcohol 175 which was again generated from a cross-metathesis reaction with 
enone 136, followed by CBS reduction.  Initial results indicated that installation of 
the required quaternary centre is possible using a thermal Overman rearrangement 
reaction (Scheme 2.69). 
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Scheme 2.69.  Introduction of quaternary centre via Overman rearrangment 
 
Finally, a late-stage intermediate anti-207 which can be applied to the eventual 
synthesis of (2S,3S)-capreomycidine 190 was generated using Horner-Wadsworth-
Emmons olefination chemistry to form the double bond, and a metal-catalysed 
Overman rearrangement to introduce the trichloroacetamide functionality in a 
diastereoselective manner.  The intermediate was successfully formed in 9 steps 
from D-serine, again encountering high yields in many of the reactions required 
(Scheme 2.10).  Future work conducted in this area should allow the generation of 
the desired (2S,3S)-capreomycidine target 190 following the steps outlined in 
Scheme 2.56. 
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Scheme 2.70.  Generation of intermediate anti-207 
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3.0 Experimental 
 
General Experimental Information 
Reactions were carried out in oven- or flame-dried glassware under an argon 
atmosphere unless otherwise stated.  Starting materials and reagents were obtained 
from commercial sources and used as received.  Lithium chloride was oven-dried for 
at least 12 hours prior to use.  Dry solvents were purified using a PureSolv 500 MD 
solvent purification system.  Flash column chromatography was carried out using 
Fisher matrix silica 60.  Macherey-Nagel aluminium-backed plates pre-coated with 
silica gel 60 (UV254) were used for thin layer chromatography, and were visualised 
by staining with potassium permanganate.  1H NMR and 13C NMR spectra were 
recorded on a Bruker DPX 400 spectrometer with chemical shift values in parts per 
million relative to tetramethylsilane (H 0.00 and C 0.0) or residual chloroform (H 
7.28 and C 77.2) as standard.  Proton and carbon assignments are based on two-
dimensional COSY and DEPT experiments respectively.  Mass spectra were obtained 
using a JEOL JMS-700 spectrometer.  Infrared spectra were obtained neat using a 
Shimadzu IRPrestige-21 spectrometer or using sodium chloride plates on a JASCO 
FTIR 410 spectrometer.  Optical rotations were determined as solutions irradiating 
with the sodium D line ( = 589 nm) using an AA series Automatic polarimeter.  []D 
values are given in units 10-1 degcm2g-1.  Chiral HPLC was performed on a Hewlett 
Packard Agilent 1100 Series instrument and was calibrated with the appropriate 
racemic sample mixture. 
 
General Procedure 1:  Cross-metathesis of 5-phenylpent-1-en-3-one 114 with 
terminal alkene partners 
O
R
Grubbs 2nd
generation catalyst K
CH2Cl2, 45 °C
O
R
 
The terminal alkene partner was added to a stirred solution of 5-phenylpent-1-en-3-
one 114 in dichloromethane, followed by a solution of Grubbs 2nd generation 
catalyst (4 mol%) in dichloromethane.  The resulting reaction mixture was heated to 
45 °C and allowed to stir under reflux until complete consumption of 5-phenylpent-
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1-en-3-one 114 was detected by TLC analysis.  The reaction mixture was then 
allowed to cool to room temperature and concentrated in vacuo.  Purification was 
carried out by silica column chromatography to give the desired enone product. 
 
 
General Procedure 2:  Enantioselective CBS oxazaborolidine-catalysed reduction 
of enones to allylic alcohols 
R
O
R
OH
(S)-(-)-2-Methyl-CBS-
oxazaborolidine (1.0 M)
BH3·THF (1.0 M)
THF, -20 °C
 
A stirred solution of the enone intermediate in tetrahydrofuran was cooled to -
20 °C before (S)-(-)-2-methyl-CBS-oxazaborolidine solution (1.0 M in toluene) was 
added, followed by borane tetrahydrofuran complex solution (1.0 M in 
tetrahydrofuran).  The resulting reaction mixture was then stirred at -20 °C for 2.5 
h before being quenched by the slow addition of methanol (15 mL).  Once gas 
evolution ceased, the mixture was concentrated in vacuo and then purified by silica 
column chromatography to give the desired allylic alcohol product. 
 
 
General Procedure 3:  Reduction of enones to allylic alcohols using 
diisobutylaluminium hydride 
O
R
DIBAL-H (1.0 M)
toluene, 0 °C
OH
R
 
A stirred solution of the enone (1.0 eq) in toluene was cooled to 0 °C before 
diisobutylaluminium hydride solution (1.0 M in hexanes, 1.5 eq) was added dropwise.  
The resulting reaction mixture was allowed to stir at 0 °C for 3 h before being 
quenched by the addition of methanol (20 mL) and filtered through a pad of Celite®, 
which was washed with warm methanol (50 mL).  The combined filtrates were 
concentrated in vacuo, and purification was carried out by silica column 
chromatography to give the desired allylic alcohol product. 
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General Procedure 4:  Conversion of allylic alcohol to allylic 
trichloroacetimidate 
OH
R
O
R
CCl3
NHCl3CCN
DBU
CH2Cl2
0 °C, then r.t.
 
A stirred solution of the allylic alcohol (1.0 eq) in dichloromethane was cooled to 
0 °C before 1,8-diazabicyclo[5.4.0]undec-7-ene (0.5 eq) was added, followed by 
trichloroacetonitrile (1.5 eq).  The reaction mixture was allowed to stir at 0 °C for 
0.2 h, and then at room temperature for 24 h before being filtered through a short 
plug of silica, which was washed with diethyl ether (50 mL).  The combined filtrates 
were concentrated in vacuo to give the desired crude allylic trichloroacetimidate, 
which was used without further purification. 
 
 
General Procedure 5:  Overman rearrangement of allylic trichloroacetimidate to 
allylic trichloroacetamide (thermal conditions) 
R
O
CCl3
NH
R
NH
CCl3
O
K2CO3
p-xylene
140 °C
 
The crude allylic trichloroacetimidate (1.0 eq) was dissolved in p-xylene, and 
potassium carbonate (0.003 g per mL of solvent) was added.  The reaction mixture 
was heated to 140 °C and stirred under reflux overnight before being allowed to 
cool to room temperature and then concentrated in vacuo.  Purification was carried 
out by silica column chromatography to give the desired allylic trichloroacetamide 
product. 
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General Procedure 6:  Oxidative cleavage of allylic double bond and 
esterification 
NH
R
CCl3
O
R
MeO
O
NH
CCl3
O
(i) NaIO4
RuCl3·xH2O
CH3CN/CCl4/H2O
r.t.
(ii) SOCl2
MeOH, 65 °C  
The allylic trichloroacetamide (1.0 eq) was dissolved in acetonitrile and carbon 
tetrachloride and to this stirred solution, sodium periodate (4.1 eq, dissolved in 
water) was added.  Ruthenium(III) chloride hydrate (0.1 eq) was then added, and 
the reaction mixture was stirred at room temperature for 22 h before being 
partitioned between water (100 mL) and dichloromethane (100 mL).  The organic 
phase was dried (MgSO4), filtered, and concentrated in vacuo.  The residue was 
then dissolved in methanol, and the solution cooled to 0 °C before thionyl chloride 
(5.0 eq) was added dropwise.  The resulting reaction mixture was stirred at 0 °C for 
0.1 h and then heated to 65 °C and stirred under reflux for 22 h before being 
allowed to cool to room temperature and concentrated in vacuo.  The residue was 
partitioned between a saturated aqueous solution of sodium hydrogen carbonate 
(30 mL) and ethyl acetate (30 mL) and the organic phase was dried (MgSO4), filtered, 
and concentrated in vacuo.  Purification was carried out by silica column 
chromatography to give the desired methyl ester. 
 
 
General Procedure 7:  Deprotection to generate -amino acid targets 
MeO
R
O
NH
CCl3
O
HO
O
R
NH26 M HCl
reflux
·HCl
 
The methyl ester (1.0 eq) was dissolved in 6 M hydrochloric acid, and the resulting 
reaction mixture was heated under reflux overnight before being allowed to cool to 
room temperature.  Water (20 mL) and diethyl ether (30 mL) were added, the 
layers were separated, and the aqueous phase was concentrated in vacuo to give 
the desired -amino acid product as the hydrochloride salt. 
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(E)-4-Phenyl-1-(phenylsulfonyl)-1-butene110 
S
O O
1
2
3
4
103  
Grubbs 2nd generation catalyst K (0.025 g, 0.03 mmol, dissolved in 5 mL of 
dichloromethane) was added to a stirred solution of 4-phenyl-1-butene 101 (0.089 
mL, 0.59 mmol) and phenyl vinyl sulfone 102 (0.100 g, 0.59 mmol) in 
dichloromethane (15 mL).  The reaction mixture was heated to 45 °C and stirred 
under reflux for 20 h before further 4-phenyl-1-butene (0.018 mL, 0.12 mmol) and 
Grubbs 2nd generation catalyst K (0.005 g, 0.006 mmol, dissolved in 2 mL of 
dichloromethane) were added. The reaction mixture was stirred under reflux for a 
further 2.5 h before being allowed to cool to room temperature and concentrated 
in vacuo.  Purification was carried out by silica column chromatography, and elution 
with 7:43 diethyl ether/petroleum ether gave (E)-4-phenyl-1-(phenylsulfonyl)-1-
butene 103 as a pale yellow oil (0.124 g, 77%).  max/cm
-1 (NaCl) 3060 (CH), 3027 
(CH), 2926 (CH), 1626 (C=C), 1496, 1446, 1317, 1146, 1087, 822, 750; H (400 MHz, 
CDCl3) 2.52–2.60 (2H, m, 3-H2), 2.77 (2H, t, J 7.6 Hz, 4-H2), 6.29 (1H, dt, J 15.0, 1.5 
Hz, 1-H), 7.01 (1H, dt, J 15.0, 6.9 Hz, 2-H), 7.09–7.14 (2H, m, 2 × ArH), 7.15–7.21 
(1H, m, ArH), 7.22–7.28 (2H, m, 2 × ArH), 7.49–7.56 (2H, m, 2 × ArH), 7.58–7.64 (1H, 
m, ArH), 7.79–7.84 (2H, m, 2 × ArH); C (100 MHz, CDCl3) 33.3 (CH2), 34.0 (CH2), 
126.5 (CH), 127.7 (2 × CH), 128.5 (2 × CH), 128.7 (2 × CH), 129.3 (2 × CH), 131.2 
(CH), 133.4 (CH), 140.1 (C), 140.7 (C), 146.1 (CH); m/z (CI) 273.0952 (MH+. 
C16H17O2S requires 273.0949), 259 (11%), 245 (5), 183 (10), 130 (13), 91 (10), 69 (9). 
 
 
(E)-4,4-Dimethyl-1-(phenylsulfonyl)-1-pentene 
S
OO
1
2
3
4
5
110  
Grubbs 2nd generation catalyst K (0.200 g, 0.24 mmol, dissolved in 20 mL of 
dichloromethane) was added to a stirred solution of 4,4-dimethyl-1-pentene 109 
(1.17 mL, 8.15 mmol) and phenyl vinyl sulfone 102 (2.74 g, 16.3 mmol) in 
  
121 
dichloromethane (100 mL).  The reaction mixture was heated to 45 °C and allowed 
to stir under reflux for 23 h.  Further Grubbs 2nd generation catalyst K (0.143 g, 
0.17 mmol, dissolved in 10 mL of dichloromethane) was then added and the 
reaction was again stirred under reflux for 27 h before being concentrated in vacuo.  
Purification was carried out by silica column chromatography, and elution with 1:7 
diethyl ether/petroleum ether gave (E)-4,4-dimethyl-1-(phenylsulfonyl)-1-pentene 
110 as a colourless oil (1.31 g, 67%).  max/cm
-1 (NaCl) 3062 (CH), 2958 (CH), 1631 
(C=C), 1475, 1446, 1367, 1317, 1146, 1087, 976, 822, 753 cm-1; H (400 MHz, CDCl3) 
0.92 (9H, s, C(CH3)3), 2.11 (2H, dd, J 7.9, 1.2 Hz, 3-H2), 6.30 (1H, dt, J 15.0, 1.2 Hz, 
1-H), 7.01 (1H, dt, J 15.0, 7.9 Hz, 2-H), 7.50–7.57 (2H, m, 2 × ArH), 7.58–7.64 (1H, 
m, ArH), 7.85–7.91 (2H, m, 2 × ArH); C (100 MHz, CDCl3) 29.3 (3 × CH3), 31.6 (C), 
45.7 (CH2), 127.5 (2 × CH), 129.2 (2 × CH), 132.0 (CH), 133.2 (CH), 140.7 (C), 144.9 
(CH); m/z (CI) 239.1104 (MH+. C13H19O2S requires 239.1106), 69 (6%). 
 
 
Ethyl (2E,4S)-4-hydroxy-6-phenylhex-2-enoate 
OEt
O
OH
2
3
4
5
6
113  
(E)-4-Phenyl-1-(phenylsulfonyl)-1-butene 103 (0.100 g, 0.37 mmol) was dissolved in 
tert-butanol (2 mL) and water (2 mL) and to the stirred solution, AD-mix- (1.47 g) 
was added, followed by methanesulfonamide (0.044 g, 0.46 mmol).  The reaction 
mixture was stirred at room temperature, in air, for 50 h and then water (25 mL) 
and dichloromethane (25 mL) were added to the flask.  The resulting biphasic 
mixture was stirred at room temperature for 0.5 h and then the layers were 
separated.  The organic layers were further extracted using dichloromethane (4 × 
10 mL) and the combined organic phases were dried (MgSO4), filtered, and 
concentrated in vacuo to give the desired aldehyde intermediate.  Meanwhile, in a 
separate flask, sodium hydride (60% dispersion in mineral oil, 0.015 g, 0.37 mmol) 
was added to a stirred solution of triethyl phosphonoacetate (0.080 mL, 0.40 mmol) 
in tetrahydrofuran (5 mL).  The mixture was stirred at room temperature for 0.5 h 
and then the crude aldehyde (dissolved in 2 mL of tetrahydrofuran) was added.  The 
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resulting reaction mixture was then allowed to stir at room temperature for 67 h 
before being partitioned between water (20 mL) and diethyl ether (20 mL).  The 
layers were separated and the organic layers were further extracted using diethyl 
ether (3 × 10 mL).  The combined organic phases were then dried (MgSO4), filtered, 
and concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 3:17 ethyl acetate/petroleum ether gave ethyl 
(2E,4S)-4-hydroxy-6-phenylhex-2-enoate 113 as a colourless oil (0.021 g, 24%).  
max/cm
-1 (NaCl) 3448 (OH), 2928 (CH), 1717 (CO), 1656 (C=C), 1454, 1369, 1306, 
1179, 1034, 981, 750; []D
21 + 23.8 (c 1.5, CHCl3); H (400 MHz, CDCl3) 1.29 (3H, t, J 
7.1 Hz, OCH2CH3), 1.72–1.81 (1H, br s, OH), 1.83–1.99 (2H, m, 5-H2), 2.68–2.83 (2H, 
m, 6-H2), 4.20 (2H, q, J 7.1 Hz, OCH2CH3), 4.28–4.37 (1H, m, 4-H), 6.05 (1H, dd, J 
15.7, 1.6 Hz, 2-H), 6.96 (1H, dd, J 15.7, 4.9 Hz, 3-H), 7.17–7.33 (5H, m, 5 × ArH); C 
(100 MHz, CDCl3) 14.2 (CH3), 31.4 (CH2), 38.0 (CH2), 60.5 (CH2), 70.3 (CH), 120.4 
(CH), 126.1 (CH), 128.4 (2 × CH), 128.5 (2 × CH), 141.2 (C), 149.8 (CH), 166.5 (C); 
m/z (CI) 235.1337 (MH+. C14H19O3 requires 235.1334), 235 (MH
+, 100%), 217 (55), 189 
(64), 171 (8), 143 (25), 131 (15), 105 (15), 91 (39), 73 (5). 
 
 
Ethyl (2S)-2-(tert-butyldiphenylsilyloxy)propanoate111 
OEt
O
O
Si
2
3
115
 
To a stirred solution of ethyl L-lactate 114 (4.83 mL, 42.3 mmol) in tetrahydrofuran 
(50 mL), imidazole (4.32 g, 63.5 mmol) was added, followed by tert-
butyldiphenylchlorosilane (13.0 mL, 50.7 mmol), upon which a white precipitate 
formed.  The reaction mixture was allowed to stir at room temperature for 22 h 
before being filtered, and the solid washed with ethyl acetate (20 mL).  The 
combined filtrates were concentrated in vacuo and the resulting residue was 
partitioned between water (200 mL) and ethyl acetate (200 mL).  The layers were 
separated and the organic phase was washed further with water (2 × 150 mL) 
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before being dried (MgSO4), filtered, and concentrated in vacuo.  Purification was 
carried out by silica column chromatography, and elution with 1:19 ethyl 
acetate/petroleum ether gave ethyl (2S)-2-(tert-butyldiphenylsilyloxy)propanoate 
115 as a colourless oil (12.28 g, 81%).  max/cm
-1 (NaCl) 2933 (CH), 2858 (CH), 1753 
(CO), 1428, 1137, 703; []D
25 -42.6 (c 1.0, CHCl3) (lit.
111 []D -41.1 (c 2.0, CHCl3)); H 
(400 MHz, CDCl3) 1.09 (9H, s, SiC(CH3)3), 1.15 (3H, t, J 7.1 Hz, OCH2CH3), 1.37 (3H, 
d, J 6.7 Hz, 3-H3), 4.02 (2H, qd, J 7.1, 1.0 Hz, OCH2CH3), 4.26 (1H, q, J 6.7 Hz, 2-H), 
7.32–7.47 (6H, m, 6 × ArH), 7.62–7.71 (4H, m, 4 × ArH); C (100 MHz, CDCl3) 14.0 
(CH3), 19.2 (C), 21.3 (CH3), 26.8 (3 × CH3), 60.6 (CH2), 68.9 (CH), 127.5 (2 × CH), 
127.6 (2 × CH), 129.7 (2 × CH), 133.2 (C), 133.6 (C), 135.7 (2 × CH), 135.9 (2 × CH), 
173.8 (C); m/z (CI) 299 (MH+-C(CH3)3, 24%), 279 (100), 251 (15), 69 (7). 
 
 
(2S)-2-(tert-butyldiphenylsilyloxy)propan-1-ol56 
OH
O
Si
1
2
3
116
 
Borane tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 24.0 mL, 24.0 
mmol) was slowly added to a stirred solution of ethyl (2S)-2-(tert-
butyldiphenylsilyloxy)propanoate 115 (3.80 g, 10.7 mmol) in tetrahydrofuran (15 
mL).  The reaction mixture was heated to 65 °C and stirred under reflux for 22 h 
before being allowed to cool to room temperature.  Further borane tetrahydrofuran 
complex solution (1.0 M in tetrahydrofuran, 3.20 mL, 3.20 mmol) was added, and 
the reaction was heated to 65 °C and stirred under reflux for 5 h before being 
allowed to cool to room temperature and quenched by the addition of water (30 
mL).  The tetrahydrofuran was removed in vacuo, and the organic layers were 
extracted using dichloromethane (3 × 50 mL).  The combined organic phases were 
then dried (MgSO4), filtered, and concentrated in vacuo to give (2S)-2-(tert-
butyldiphenylsilyloxy)propan-1-ol 116 as a pale yellow oil (2.82 g, 84%).  max/cm
-1 
(NaCl) 3386 (OH), 2931 (CH), 2858 (CH), 1427, 1111, 1047, 702; []D
25 +26.7 (c 1.0, 
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CHCl3); H (400 MHz, CDCl3) 1.05 (3H, d, J 6.3 Hz, 3-H3), 1.07 (9H, s, SiC(CH3)3), 
1.92 (1H, t, J 6.4 Hz, OH), 3.39–3.46 (1H, m, 1-HH), 3.48–3.55 (1H, m, 1-HH), 3.91–
4.00 (1H, m, 2-H), 7.35–7.47 (6H, m, 6 × ArH), 7.65–7.71 (4H, m, 4 × ArH); C (100 
MHz, CDCl3) 19.2 (C), 19.6 (CH3), 27.0 (3 × CH3), 68.2 (CH2), 70.2 (CH), 127.6 (2 × 
CH), 127.8 (2 × CH), 129.7 (CH), 129.8 (CH), 133.8 (C), 134.0 (C), 135.7 (2 × CH), 
135.8 (2 × CH); m/z (CI) 257 (MH+-C(CH3)3, 18%), 237 (100), 71 (7). 
 
 
Ethyl (2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-enoate112 
O
O
O
Si
2
3
4
5
119
 
A stirred solution of oxalyl chloride (0.65 mL, 7.63 mmol) in dichloromethane (55 
mL) was cooled to -78 °C before dimethylsulfoxide (1.10 mL, 15.5 mmol) was added 
dropwise.  The mixture was stirred at -78 °C for 0.25 h and then (2S)-2-(tert-
butyldiphenylsilyloxy)propan-1-ol 116 (2.00 g, 6.36 mmol, dissolved in 5 mL of 
dichloromethane) was added.  The reaction was stirred again at -78 °C for 0.25 h 
before triethylamine (4.50 mL, 32.3 mmol) was added.  The resulting reaction 
mixture was stirred at -78 °C for 1.25 h, and then at room temperature for 4 h 
before being concentrated in vacuo to give the desired crude aldehyde, which was 
used without further purification.  Meanwhile, in a separate flask, lithium chloride 
(0.674 g, 15.9 mmol) was suspended in acetonitrile (60 mL) and 1,8-
diazabicyclo[5.4.0]undec-7-ene (2.40 mL, 16.0 mmol) was added, followed by 
triethyl phosphonoacetate (3.20 mL, 16.1 mmol).  The mixture was stirred at room 
temperature for 1 h before being added to the crude aldehyde, and the resulting 
reaction mixture was allowed to stir at room temperature for 22 h before being 
quenched by the addition of a saturated aqueous solution of ammonium chloride 
(100 mL).  The organic solvent was removed in vacuo, and the residue was 
partitioned between ethyl acetate (150 mL) and water (50 mL).  The layers were 
separated, and the organic layers were further extracted using ethyl acetate (3 × 
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150 mL).  The combined organic phases were then dried (MgSO4), filtered, and 
concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 2:23 ethyl acetate/petroleum ether gave ethyl 
(2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-enoate 119 as a colourless oil (1.91 g, 
79%).  max/cm
-1 (NaCl) 3071 (CH), 2932 (CH), 2858 (CH), 1720 (CO), 1660 (C=C), 
1428, 1273, 1157, 1112, 979, 703; []D
25 -42.2 (c 1.0, CHCl3) (lit.
112 []D
20 -40.0 (c 
2.0, CHCl3)); H (400 MHz, CDCl3) 1.08 (9H, s, SiC(CH3)3), 1.12 (3H, d, J 6.5 Hz, 5-H3), 
1.30 (3H, t, J 7.1 Hz, OCH2CH3), 4.13–4.26 (2H, m, OCH2CH3), 4.41–4.50 (1H, m, 4-
H), 6.01 (1H, dd, J 15.5, 1.6 Hz, 2-H), 6.90 (1H, dd, J 15.5, 4.4 Hz, 3-H), 7.33–7.47 
(6H, m, 6 × ArH), 7.60–7.71 (4H, m, 4 × ArH); C (100 MHz, CDCl3) 14.3 (CH3), 19.3 
(C), 23.3 (CH3), 27.0 (3 × CH3), 60.3 (CH2), 68.6 (CH), 119.1 (CH), 127.6 (4 × CH), 
129.8 (2 × CH), 133.4 (C), 134.0 (C), 135.7 (2 × CH), 135.8 (2 × CH), 151.5 (CH), 
166.9 (C); m/z (EI) 382.1963 (M+. C23H30O3Si requires 382.1964), 325 (100%), 227 
(47), 199 (77), 175 (33), 135 (13), 123 (10), 77 (14). 
 
 
(2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol113 
OH
O
Si
1
2
3
4
5
123  
A stirred solution of ethyl (2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-enoate 119 
(1.80 g, 4.71 mmol) in diethyl ether (20 mL) was cooled to -78 °C before 
diisobutylaluminium hydride solution (1.0 M in hexanes, 10.5 mL, 10.5 mmol) was 
added dropwise.  The reaction mixture was allowed to stir at room temperature for 
5 h before being cooled to 0 °C and quenched by the addition of a saturated 
aqueous solution of ammonium chloride (40 mL).  Further diethyl ether (40 mL) was 
added, and the biphasic mixture was warmed to room temperature and stirred for 
1.5 h before being filtered through a pad of Celite®.  The collected solids were 
washed with diethyl ether (400 mL) and the combined filtrates were dried (MgSO4), 
filtered, and concentrated in vacuo to give (2E,4S)-4-(tert-
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butyldiphenylsilyloxy)pent-2-en-1-ol 123 as a colourless oil (1.56 g, 97%).  max/cm
-1 
(NaCl) 3340 (OH), 2929 (CH), 2857 (CH), 1427, 1111, 1075, 997, 701; []D
21 -20.8 (c 
0.5, CHCl3) (lit.
113 []D
21 -21.2 (c 2.1, CH2Cl2)); H (400 MHz, CDCl3) 0.99 (1H, t, J 5.7 
Hz, OH), 1.06 (9H, s, SiC(CH3)3), 1.17 (3H, d, J 6.3 Hz, 5-H3), 3.99 (2H, t, J 5.7 Hz, 
1-H2), 4.29–4.38 (1H, m, 4-H), 5.55 (1H, dt, J 15.5, 5.7 Hz, 2-H), 5.65 (1H, dd, J 
15.5, 5.6 Hz, 3-H), 7.32–7.46 (6H, m, 6 × ArH), 7.63–7.71 (4H, m, 4 × ArH); C (100 
MHz, CDCl3) 19.2 (C), 24.2 (CH3), 27.0 (3 × CH3), 63.2 (CH2), 70.0 (CH), 127.4 (2 × 
CH), 127.5 (2 × CH), 127.7 (CH), 129.5 (CH), 129.6 (CH), 134.3 (C), 134.4 (C), 135.9 
(2 × CH), 136.0 (2 × CH), 136.1 (CH); m/z (CI) 323 (100%), 283 (33), 257 (19), 239 
(18), 199 (40), 179 (15), 69 (10). 
 
 
(2E,4S)-4-(tert-butyldiphenylsilyloxy)-1-(methoxymethoxy)pent-2-ene 
O O
O
Si
1
2
3
4
5
124
 
A stirred solution of (2E,4S)-4-(tert-butyldiphenylsilyloxy)pent-2-en-1-ol 123 (1.24 g, 
3.64 mmol) in dichloromethane (40 mL) was cooled to 0 °C before 
diisopropylethylamine (1.00 mL, 5.74 mmol) was added, followed by bromomethyl 
methyl ether (0.357 mL, 4.37 mmol).  The reaction mixture was allowed to stir at 
0 °C for 0.75 h and then heated to 45 °C and stirred under reflux for 26 h before 
being cooled to room temperature and quenched by the addition of 2 M 
hydrochloric acid (100 mL).  Dichloromethane (100 mL) was added, and the layers 
were separated.  The organic layers were extracted further with dichloromethane 
(50 mL), and the combined organic phases were dried (MgSO4), filtered, and 
concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 1:19 ethyl acetate/petroleum ether gave (2E,4S)-
4-(tert-butyldiphenylsilyloxy)-1-(methoxymethoxy)pent-2-ene 124 as a colourless 
oil (1.16 g, 82%).  max/cm
-1 (NaCl) 2931 (CH), 2858 (CH), 1472, 1428, 1368, 1149, 
1110, 1048, 703; []D
21 -31.8 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.06 (9H, s, 
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SiC(CH3)3), 1.14 (3H, d, J 6.0 Hz, 5-H3), 3.35 (3H, s, OCH2OCH3), 3.98 (2H, d, J 5.6 
Hz, 1-H2), 4.32 (1H, quin, J 6.0 Hz, 4-H), 4.59 (2H, s, OCH2OCH3), 5.58 (1H, dt, J 
15.4, 5.6, 2-H), 5.73 (1H, dd, J 15.4, 6.0 Hz, 3-H), 7.33–7.44 (6H, m, 6 × ArH), 7.65–
7.69 (4H, m, 4 × ArH); C (100 MHz, CDCl3) 19.2 (C), 24.2 (CH3), 27.0 (3 × CH3), 55.2 
(CH3), 67.2 (CH2), 69.5 (CH), 95.4 (CH2), 124.6 (CH), 127.4 (2 × CH), 127.5 (2 × CH), 
129.5 (CH), 129.6 (CH), 134.1 (C), 134.5 (C), 135.8 (2 × CH), 135.9 (2 × CH), 137.5 
(CH); m/z (CI) 365 (8%), 323 (91), 297 (100), 277 (22), 253 (19), 213 (77), 199 (20), 
183 (10), 153 (8), 129 (29), 91 (20), 69 (17). 
 
 
(2E,4S)-1-Methoxymethoxypent-2-en-4-ol 
O O
OH
1
2
3
4
5
125
 
A stirred solution of (2E,4S)-4-(tert-butyldiphenylsilyloxy)-1-
(methoxymethoxy)pent-2-ene 124 (2.60 g, 6.76 mmol) in tetrahydrofuran (60 mL) 
was cooled to 0 °C before tetra-n-butylammonium fluoride solution (1.0 M in 
tetrahydrofuran, 8.10 mL, 8.10 mmol) was added dropwise.  The reaction mixture 
was stirred at 0 °C for 0.2 h and then at room temperature for 18 h before being 
cooled again to 0 °C and further tetra-n-butylammonium fluoride solution (1.0 M in 
tetrahydrofuran, 1.50 mL, 1.50 mmol) was added.  The reaction mixture was 
allowed to stir at 0 °C for 0.1 h and then at room temperature for a further 5 h 
before being concentrated in vacuo.  The residue was partitioned between water 
(100 mL) and ethyl acetate (100 mL) and the organic phase was dried (MgSO4), 
filtered, and concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 2:3 ethyl acetate/petroleum ether gave (2E,4S)-
1-methoxymethoxypent-2-en-4-ol 125 as a colourless oil (0.718 g, 73%).  max/cm
-1 
(NaCl) 3421 (OH), 2931 (CH), 1655 (C=C), 1451, 1371, 1041; []D
26 +6.9 (c 1.0, 
CHCl3); H (400 MHz, CDCl3) 1.29 (3H, d, J 6.2 Hz, 5-H3), 1.60 (1H, br s, OH), 3.38 
(3H, s, OCH2OCH3), 4.06 (2H, d, J 5.2 Hz, 1-H2), 4.35 (1H, quin, J 6.2 Hz, 4-H), 4.65 
(2H, s, OCH2OCH3), 5.72–5.87 (2H, m, 2-H and 3-H); C (100 MHz, CDCl3) 23.2 (CH3), 
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55.3 (CH3), 67.2 (CH2), 68.2 (CH), 95.7 (CH2), 125.8 (CH), 137.3 (CH); m/z (EI) 127 
(38%), 97 (33), 83 (100), 57 (70), 45 (87). 
 
 
(2S,3E)-1-(Methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-ene (via 
thermal rearrangement) 
O O
NH
CCl3
O
1
2
3
4
5
127
 
A stirred solution of (2E,4S)-1-methoxymethoxypent-2-en-4-ol 125 (0.200 g, 1.37 
mmol) in dichloromethane (10 mL) was cooled to 0 °C before 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.051 mL, 0.34 mmol) was added, followed by 
trichloroacetonitrile (0.210 mL, 2.09 mmol).  The reaction mixture was allowed to 
stir at room temperature for 6.5 h before being filtered through a short plug of 
silica, which was washed with diethyl ether (200 mL).  The combined filtrates were 
concentrated in vacuo to give the desired allylic trichloroacetimidate 126 as a 
yellow oil (0.335 g), which was used without further purification.  H (400 MHz, 
CDCl3) 1.45 (3H, d, J 6.3 Hz, 5-H3), 3.37 (3H, s, OCH2OCH3), 4.09 (2H, d, J 4.9 Hz, 
1-H2), 4.64 (2H, s, OCH2OCH3), 5.52 (1H, quin, J 6.3 Hz, 4-H), 5.76–5.95 (2H, m, 2-H 
and 3-H), 8.30 (1H, s, NH).  A portion of this allylic trichloroacetimidate 
intermediate 126 (0.142 g, 0.49 mmol) was dissolved in p-xylene (10 mL) and 
potassium carbonate (0.030 g, 0.22 mmol) was added.  The reaction mixture was 
heated to 140 °C and stirred under reflux for 15 h before being allowed to cool to 
room temperature and concentrated in vacuo.  Purification was carried out by silica 
column chromatography, and elution with 1:9 ethyl acetate/petroleum ether gave 
(2S,3E)-1-(methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-ene 127 as a 
colourless oil (0.112 g, 66% over 2 steps).  max/cm
-1 (NaCl) 3331 (NH), 2933 (CH), 
1703 (CO), 1517, 1114, 1039, 821; []D
25 -2.0 (c 1.0, CHCl3); H (400 MHz, CDCl3) 
1.74 (3H, d, J 6.5 Hz, 5-H3), 3.38 (3H, s, OCH2OCH3), 3.66–3.76 (2H, m, 1-H2), 4.50–
4.58 (1H, m, 2-H), 4.63–4.69 (2H, m, OCH2OCH3), 5.52 (1H, dd, J 15.4, 6.2 Hz, 3-H), 
5.78 (1H, dqd, J 15.4, 6.5, 1.3 Hz, 4-H); C (100 MHz, CDCl3) 17.9 (CH3), 52.8 (CH), 
55.6 (CH3), 70.0 (CH2), 92.8 (C), 97.0 (CH2), 126.6 (CH), 129.2 (CH), 161.2 (C); m/z 
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(CI) 290.0116 (MH+. C9H15
35Cl3NO3 requires 290.0118), 260 (100%), 258 (100), 214 
(22), 176 (19), 174 (17), 129 (13), 97 (85), 85 (14). 
 
 
(2S,3E)-1-(Methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-ene (via 
metal-catalysed rearrangement) 
O O
NH
CCl3
O
1
2
3
4
5
127  
The allylic trichloroacetimidate starting material 126 (0.193 g, 0.66 mmol) was 
dissolved in toluene (10 mL) and bis(acetonitrile)palladium(II) chloride (0.017 g, 
0.07 mmol) was added.  The reaction mixture was allowed to stir at room 
temperature for 15 h before being concentrated in vacuo.  Purification was carried 
out by silica column chromatography, and elution with 1:9 ethyl acetate/petroleum 
ether gave (2S,3E)-1-(methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-
ene 127 as a colourless oil (0.118 g, 51% over 2 steps).  For analytical data, see 
above. 
 
 
(2R)-2-(Trichloromethylcarbonylamino)-3-(methoxymethoxy)propanoic acid 
HO
O
O O
NH
CCl3
O
2
3
128  
(2S,3E)-1-(Methoxymethoxy)-2-(trichloromethylcarbonylamino)pent-3-ene 127 
(0.116 g, 0.40 mmol) was dissolved in acetonitrile (6 mL) and carbon tetrachloride 
(6 mL) and to the stirred solution, sodium periodate (0.350 g, 1.64 mmol, dissolved 
in 9 mL of water) was added, followed by ruthenium(III) chloride hydrate (0.004 g, 
0.02 mmol).  The reaction mixture was stirred at room temperature for 5.5 h, and 
then the organic layers were extracted using dichloromethane (3 × 30 mL).  The 
combined organic phases were dried (MgSO4), filtered, and concentrated in vacuo 
to give (2R)-2-(trichloromethylcarbonylamino)-3-(methoxymethoxy)propanoic acid 
  
130 
128 as a blue/black oil (0.091 g), which was used without further purification.  
H(400 MHz, CDCl3) 3.38 (3H, s, OCH2OCH3), 3.86 (1H, dd, J 10.8, 2.6 Hz, 3-HH), 
4.24 (1H, dd, J 10.8, 2.6 Hz, 3-HH), 4.66 (2H, s, OCH2OCH3), 4.73 (1H, d, J 7.8 Hz, 
2-H), 7.81 (1H, d, J 7.8 Hz, NH). 
 
 
D-Serine hydrochloride114 
HO OH
O
NH2
2
3
129
·HCl
 
(2R)-2-(Trichloromethylcarbonylamino)-3-(methoxymethoxy)propanoic acid 128 
(0.086 g) was dissolved in 6 M hydrochloric acid (6 mL) and the reaction mixture 
was heated under reflux for 20 h before being allowed to cool to room temperature.  
The mixture was washed with diethyl ether (2 × 20 mL) and the aqueous phase was 
concentrated in vacuo to give D-serine hydrochloride 129 as a yellow residue (0.035 
g, 100% over 2 steps).  max/cm
-1 (neat) 3129 (NH2/OH), 1613 (CO), 1397, 1215, 1076, 
914, 779; []D
21 -13.4 (c 1.0, 1 M HCl) (lit.114 []D
23 -14.0 (c 0.74, 1 M HCl)); H (400 
MHz, D2O) 3.83–3.95 (3H, m, 2-H and 3-H2);m/z (CI) 113 (12%), 85 (100), 69 (54). 
 
 
(2S)-2-(tert-Butyldiphenylsilyloxy)-1-iodopropane115 
I
O
Si
1
2
3
131
 
To a stirred solution of (2S)-2-(tert-butyldiphenylsilyloxy)propan-1-ol 116 (1.00 g, 
3.2 mmol) in toluene (15 mL), triphenylphosphine (0.95 g, 3.6 mmol) was added, 
followed by imidazole (0.49 g, 7.3 mmol) and iodine (0.91 g, 3.6 mmol).  The 
reaction mixture was stirred at room temperature, in the absence of light, for 15 h 
and the solvent was then poured off.  The remaining beige-coloured residue was 
washed with diethyl ether (3 × 20 mL), and the washings were combined with the 
  
131 
reaction solvent and concentrated in vacuo.  Purification was carried out by silica 
column chromatography, and elution with 1:19 ethyl acetate/petroleum ether gave 
(2S)-(tert-butyldiphenylsilyloxy)-1-iodopropane 131 as a colourless oil (1.29 g, 96%).  
max/cm
-1 (NaCl) 3019 (CH), 2932 (CH), 2859 (CH), 1473, 1428, 1112, 1062; []D
25 -
22.5 (c 1.0, CHCl3) (lit.
115 []D
25 -26.7 (c 1.05, CHCl3)); H (400 MHz, CDCl3) 1.08 (9H, 
s, SiC(CH3)3), 1.20 (3H, d, J 6.0 Hz, 3-H2), 3.13 (2H, d, J 4.4 Hz, 1-H2), 3.65–3.73 
(1H, m, 2-H), 7.36–7.47 (6H, m, 6 × ArH), 7.66–7.71 (4H, m, 4 × ArH); C (100 MHz, 
CDCl3) 15.9 (CH2), 19.3 (C), 23.5 (CH3), 26.9 (3 × CH3), 68.2 (CH), 127.6 (2 × CH), 
127.7 (2 × CH), 129.7 (CH), 129.8 (CH), 133.7 (C), 133.9 (C), 135.7 (2 × CH), 135.8 
(2 × CH); m/z (CI) 425.0799 (MH+. C19H26IOSi requires 425.0798), 384 (100%), 75 (54). 
 
 
3-Phenylpropionyl chloride116 
Cl
O
2
3
139  
Thionyl chloride (12.2 mL, 167 mmol) was slowly added to hydrocinnamic acid 134 
(5.00 g, 33.3 mmol) with cooling to 0 °C.  The reaction mixture was stirred at 0 °C 
for 0.2 h, and then at room temperature for 4 h before being concentrated in vacuo.  
Residual thionyl chloride was removed using a toluene azeotrope, giving 3-
phenylpropionyl chloride 139 as a yellow oil (5.99 g), which was used without 
further purification.  H (400 MHz, CDCl3) 3.02 (2H, t, J 7.4 Hz, 3-H2), 3.21 (2H, t, J 
7.4 Hz, 2-H2), 7.17–7.34 (5H, m, 5 × ArH). 
 
 
1-Morpholin-4-yl-3-phenylpropan-1-one117 
N
O
O
2
3
135  
Morpholine (15.5 mL, 177 mmol) was added slowly to a stirred solution of 3-
phenylpropionyl chloride 139 (5.99 g) in dichloromethane at 0 °C, upon which a 
white precipitate formed.  The resulting suspension was heated to 45 °C and stirred 
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under reflux for 18 h.  The mixture was then allowed to cool to room temperature 
and further dichloromethane (50 mL) was added.  The organic phase was washed 
with water (2 × 100 mL) before being dried (MgSO4), filtered, and concentrated in 
vacuo.  Purification was carried out by silica column chromatography and elution 
with 7:3 ethyl acetate/petroleum ether gave 1-morpholin-4-yl-3-phenylpropan-1-
one 135 as a colourless oil (7.24 g, 99% over 2 steps).  Rf (1:1 ethyl 
acetate/petroleum ether) 0.17; H (400 MHz, CDCl3) 2.62 (2H, t, J 7.6 Hz, 3-H2), 
2.98 (2H, t, J 7.6 Hz, 2-H2), 3.36 (2H, t, J 4.4 Hz, CH2), 3.51 (2H, t, J 4.4 Hz, CH2), 
3.60–3.65 (4H, m, 2 x CH2), 7.21–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 31.5 
(CH2), 34.9 (CH2), 42.0 (CH2), 46.0 (CH2), 66.5 (CH2), 66.9 (CH2), 126.3 (CH), 128.5 
(2 × CH), 128.6 (2 × CH), 141.1 (C), 171.0 (C); m/z (CI) 220.1343 (MH+. C13H18NO2 
requires 220.1338), 219 (7%), 172 (2), 81 (3). 
 
 
5-Phenylpent-1-en-3-one118 
O
1
24
5
136  
A stirred solution of 1-morpholin-4-yl-3-phenylpropan-1-one 135 (0.550 g, 2.51 
mmol) in tetrahydrofuran (20 mL) was cooled to 0 °C before vinylmagnesium 
bromide solution (1.0 M in tetrahydrofuran, 10.0 mL, 10.0 mmol) was added 
dropwise.  The resulting reaction mixture was stirred at 0 °C for 1.75 h before 
being poured into glacial acetic acid (10 mL) and then concentrated in vacuo.  The 
residue was partitioned between dichloromethane (50 mL) and a saturated aqueous 
solution of ammonium chloride (50 mL) and the organic phase was dried (MgSO4), 
filtered and concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 1:9 ethyl acetate/petroleum ether gave 5-
phenylpent-1-en-3-one 136 as a colourless oil (0.299 g, 74%).  Rf (1:4 ethyl 
acetate/petroleum ether) 0.69; H (400 MHz, CDCl3) 2.89–2.98 (4H, m, 4-H2 and 5-
H2), 5.83 (1H, d, J 10.8 Hz, 1-HH), 6.22 (1H, d, J 17.6 Hz, 1-HH), 6.36 (1H, dd, J 
17.6, 10.8 Hz, 2-H), 7.20–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 29.8 (CH2), 
41.2 (CH2), 126.1 (CH), 128.3 (CH2), 128.4 (2 × CH), 128.5 (2 × CH), 136.5 (CH), 
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141.1 (C), 199.8 (C); m/z (CI) 161.0965 (MH+. C11H13O requires 161.0966), 160 (5%), 
91 (3). 
 
 
(4E)-1-Phenylnon-4-en-3-one119 
O
9
8
7
6
5
42
1
140  
The reaction was carried out according to general procedure 1 using 5-phenylpent-
1-en-3-one 136 (0.675 g, 4.21 mmol), 1-hexene (1.05 mL, 8.46 mmol) and Grubbs 
2nd generation catalyst K (0.143 g, 0.17 mmol) in dichloromethane (15 mL).  The 
reaction mixture was stirred under reflux for 20 h.  Purification by silica column 
chromatography, eluting with 1:19 ethyl acetate/petroleum ether, gave (4E)-1-
phenylnon-4-en-3-one 140 as a colourless oil (0.687 g, 75%).  Rf (1:4 ethyl 
acetate/petroleum ether) 0.68; max/cm
-1 (NaCl) 2931 (CH), 1711 (CO), 1454, 1180, 
699; H (400 MHz, CDCl3) 0.91 (3H, t, J 7.2 Hz, 1-H3), 1.30–1.49 (4H, m, 2-H2 and 3-
H2), 2.17–2.23 (2H, m, 4-H2), 2.84–2.96 (4H, m, 8-H2 and 9-H2), 6.09 (1H, d, J 15.8, 
6-H), 6.82 (1H, dt, J 15.8, 6.8 Hz, 5-H), 7.17–7.30 (5H, m, 5 × ArH); C (100 MHz, 
CDCl3) 13.9 (CH3), 22.3 (CH2), 30.1 (CH2), 30.2 (CH2), 32.2 (CH2), 41.6 (CH2), 126.1 
(CH), 128.4 (2 × CH), 128.5 (2 × CH), 130.3 (CH), 141.3 (C), 147.9 (CH), 199.7 (C); 
m/z (CI) 217.1596 (MH+. C15H21O requires 217.1592), 203 (15%), 159 (9), 97 (5), 85 
(32), 69 (29). 
 
 
(4E)-1,7-Diphenylhept-4-en-3-one120 
O
75
42
1
6
141  
The reaction was carried out according to general procedure 1 using 5-phenylpent-
1-en-3-one 136 (0.502 g, 3.13 mmol), 4-phenyl-1-butene (0.94 mL, 6.27 mmol) and 
Grubbs 2nd generation catalyst K (0.106 g, 0.12 mmol) in dichloromethane (15 mL).  
The reaction mixture was stirred under reflux for 18 h before additional Grubbs 2nd 
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generation catalyst (0.026 g, 0.03 mmol) was added and the reaction was stirred 
under reflux for a further 6 h.  Purification by silica column chromatography, 
eluting with 3:17 diethyl ether/petroleum ether gave (4E)-1,7-diphenylhept-4-en-3-
one 141 as a colourless oil (0.386 g, 47%).  Rf (1:4 ethyl acetate/petroleum ether) 
0.53; H (400 MHz, CDCl3) 2.47–2.53 (2H, m, 2-H2), 2.77 (2H, t, J 7.2 Hz, 1-H2), 2.81–
2.95 (4H, m, 6-H2 and 7-H2), 6.11 (1H, d, J 15.8 Hz, 4-H), 6.84 (1H, dt, J 15.8, 7.2 
Hz, 3-H), 7.14–7.32 (10H, m, 10 × ArH); C (100 MHz, CDCl3) 30.1 (CH2), 34.1 (CH2), 
34.4 (CH2), 41.7 (CH2), 126.1 (CH), 126.2 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 128.5 
(4 × CH), 130.7 (CH), 140.7 (C), 141.2 (C), 146.3 (CH), 199.5 (C); m/z (EI) 264.1516 
(M+. C19H20O requires 264.1514), 159 (54%), 131 (8), 105 (15), 91 (100), 65 (12), 44 
(49). 
 
 
(4E)-7,7-Dimethyl-1-phenyloct-4-en-3-one 
O
6
5
42
1
142
8
 
The reaction was carried out according to general procedure 1 using 5-phenylpent-
1-en-3-one 136 (0.769 g, 4.80 mmol), 4,4-dimethyl-1-pentene (1.40 mL, 9.74 mmol) 
and Grubbs 2nd generation catalyst (0.163 g, 0.19 mmol) in dichloromethane (20 
mL).  The reaction mixture was stirred under reflux for 24 h and purification by 
silica column chromatography, eluting with 1:9 ethyl acetate/petroleum ether, 
gave (4E)-7,7-dimethyl-1-phenyloct-4-en-3-one 142 as a pale yellow oil (0.646 g, 
58%).  Rf (1:4 ethyl acetate/petroleum ether) 0.65; max/cm
-1 (NaCl) 2960 (CH), 
1670 (CO), 1474, 1367, 1095, 908, 734; H (400 MHz, CDCl3) 0.92 (9H, s, C(CH3)3), 
2.08 (2H, d, J 8.0 Hz, 3-H2), 2.85–2.96 (4H, m, 7-H2 and 8-H2), 6.08 (1H, d, J 15.6 
Hz, 5-H), 6.84 (1H, dt, J 15.6, 8.0 Hz, 4-H), 7.17–7.31 (5H, m, 5 × ArH); C (100 MHz, 
CDCl3) 29.4 (3 × CH3), 30.2 (CH2), 31.5 (C), 41.7 (CH2), 47.0 (CH2), 126.1 (CH), 128.4 
(2 × CH), 128.5 (2 × CH), 132.3 (CH), 141.3 (C), 145.2 (CH), 199.4 (C); m/z (EI) 
230.1674 (M+. C16H22O requires 230.1671), 215 (11%), 174 (6), 159 (100), 133 (5), 
105 (18), 91 (46), 84 (42), 57 (56), 47 (6). 
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(4E)-1-Cyano-8-phenyloct-4-en-6-one 
O
CN
1
2
35
4
7
8
143  
The reaction was set up according to general procedure 1 using 5-phenylpent-1-en-
3-one 136 (0.972 g, 6.07 mmol), 5-hexenenitrile (1.20 mL, 10.6 mmol) and Grubbs 
2nd generation catalyst K (0.206 g, 0.24 mmol) in dichloromethane (25 mL).  The 
reaction mixture was stirred under reflux for 22 h before further Grubbs 2nd 
generation catalyst K (0.103 g, 0.12 mmol) was added and the reaction stirred 
under reflux again for 50 h.  Grubbs 2nd generation catalyst K (0.103 g, 0.12 mmol) 
was then added and the reaction mixture was stirred under reflux for a further 72 h 
before a final addition of Grubbs 2nd generation catalyst K (0.052 g, 0.06 mmol) and 
stirring under reflux for 24 h.  Purification by silica column chromatography, eluting 
with 1:3 ethyl acetate/petroleum ether gave (4E)-1-cyano-8-phenyloct-4-en-6-one 
143 as a pale brown oil (0.73 g, 53%).  Rf (1:4 ethyl acetate/petroleum ether) 0.15; 
max/cm
-1 (NaCl) 3028 (CH), 2934 (CH), 2246 (CN), 1669 (CO), 1453, 978, 701; H 
(400 MHz, CDCl3) 1.78–1.87 (2H, m, 1-H2), 2.32–2.42 (4H, m, 2-H2 and 3-H2), 2.84–
2.98 (4H, m, 7-H2 and 8-H2), 6.13 (1H, d, J 15.8 Hz, 5-H), 6.73 (1H, dt, J 15.8, 6.8 
Hz, 4-H), 7.16–7.33 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 16.7 (CH2), 23.8 (CH2), 
30.0 (CH2), 31.0 (CH2), 42.2 (CH2), 119.0 (C), 126.2 (CH), 128.4 (2 × CH), 128.5 (2 × 
CH), 131.6 (CH), 141.1 (C), 143.9 (CH), 199.1 (C); m/z (EI) 227.1308 (M+. C15H17NO 
requires 227.1310), 159 (20%), 122 (9), 105 (16), 91 (16), 77 (18), 44 (100). 
 
 
(4S)-4-(Methoxymethoxy)-1-pentene 
O O
1
2
3
4
5
145  
A stirred solution of (4S)-(+)-1-penten-4-ol 144 (0.12 mL, 1.17 mmol) in 
dichloromethane (10 mL) was cooled to 0 °C before diisopropylethylamine (0.30 mL, 
1.72 mmol) was added, followed by bromomethyl methyl ether (0.11 mL, 1.35 
mmol).  The reaction mixture was stirred at 0 °C for 0.5 h and then heated to 45 °C 
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and stirred under reflux for 45 h.  The reaction mixture was then allowed to cool to 
room temperature before further diisopropylethylamine (0.15 mL, 0.86 mmol) and 
bromomethyl methyl ether (0.06 mL, 0.74 mmol) were added.  The reaction 
mixture was again heated to 45 °C and stirred under reflux for 20 h before being 
cooled to room temperature, quenched by the addition of 2 M hydrochloric acid (10 
mL) and diluted with dichloromethane (20 mL).  The organic phase was dried 
(MgSO4), filtered, and concentrated in vacuo to give the desired crude product 145 
as a yellow oil (0.134 g, 89% crude yield), which decomposed upon attempted 
purification by silica column chromatography.  H (400 MHz, CDCl3) 1.18 (3H, d, J 
6.2 Hz, 5-H3), 2.17–2.26 (1H, m, 3-HH), 2.29–2.37 (1H, m, 3-HH), 3.37 (3H, s, 
OCH2OCH3), 3.76 (1H, sex, J 6.2 Hz, 4-H), 4.64 (1H, d, J 6.8 Hz, OCHHOCH3), 4.69 
(1H, d, J 6.8 Hz, OCHHOCH3), 5.04–5.12 (2H, m, 1-H2), 5.75–5.87 (1H, m, 2-H). 
 
 
(4S)-4-[(tert-butyldimethylsilyl)oxy]-1-pentene82 
 
 
 
 
A stirred solution of (4S)-(+)-1-penten-4-ol 144 (0.623 g, 7.23 mmol), triethylamine 
(2.00 mL, 14.5 mmol) and 4-dimethylaminopyridine (0.088 g, 0.72 mmol) in 
dichloromethane (30 mL) was cooled to 0 °C before tert-butyldimethylsilyl chloride 
(1.42 g, 9.40 mmol) was added slowly.  The reaction mixture was stirred at 0 °C for 
0.2 h, and then at room temperature for 21 h before water (50 mL) and 
dichloromethane (20 mL) were added.  The layers were separated, and the organic 
layers were further extracted using dichloromethane (30 mL).  The combined 
organic phases were then washed with a saturated aqueous solution of copper 
sulfate (2 × 40 mL) and then water (40 mL) before being dried (MgSO4), filtered, 
and concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 1:19 diethyl ether/petroleum ether gave (4S)-4-
[(tert-butyldimethylsilyl)oxy]-1-pentene 146 as a colourless oil (0.754 g, 52%).  Rf 
(1:4 ethyl acetate/petroleum ether) 0.62; max/cm
-1 (NaCl) 2959 (CH), 2092 (CH), 
1643 (C=C), 1472, 1376, 1255, 1093, 1004, 774; []D
24 +18.1 (c 1.0, CHCl3); H (400 
O
Si
1
2
3
4
5
146
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MHz, CDCl3) 0.05 (6H, s, 2 × SiCH3), 0.89 (9H, s, SiC(CH3)3), 1.13 (3H, d, J 6.0 Hz, 5-
H3), 2.11–2.25 (2H, m, 3-H2), 3.84 (1H, q, J 6.0 Hz, 4-H), 4.99–5.06 (2H, m, 1-H2), 
5.75–5.86 (1H, m, 2-H); C (100 MHz, CDCl3) -5.7 (CH3), -5.6 (CH3), 17.2 (C), 22.4 
(CH3), 24.9 (3 × CH3), 43.3 (CH2), 67.4 (CH), 115.5 (CH2), 134.6 (CH); m/z (CI) 201 
(MH+, 4%), 193 (9), 167 (8), 151 (7), 113 (29), 95 (22), 69 (100). 
 
 
(4E,7S)-7-[(tert-Butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-one 
O O
Si
8
7
6
5
42
1
147
 
The experiment was set up according to general procedure 1 using 5-phenylpent-1-
en-3-one 136 (0.800 g, 5.02 mmol), (4S)-4-[(tert-butyldimethylsilyl)oxy]-1-pentene 
K (1.08 g, 5.39 mmol) and Grubbs 2nd generation catalyst K (0.170 g, 0.20 mmol) in 
dichloromethane (35 mL).  The reaction mixture was stirred under reflux for 19 h 
before further Grubbs 2nd generation catalyst K (0.043 g, 0.05 mmol) was added and 
the reaction mixture was stirred under reflux again for 23 h.  Purification by silica 
column chromatography, and elution with 1:19 diethyl ether/petroleum ether gave 
(4E,7S)-7-[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-one 147 as a colourless 
oil (1.48 g, 89%).  Rf (1:4 ethyl acetate/petroleum ether) 0.59; max/cm
-1 (NaCl) 
2929 (CH), 1674 (CO), 1632 (C=C), 1454, 1375, 1256, 1128, 1003, 836; []D
22 +14.2 
(c 1.0, CHCl3); H (400 MHz, CDCl3) 0.03 (3H, s, SiCH3), 0.04 (3H, s, SiCH3), 0.87 (9H, 
s, SiC(CH3)3), 1.14 (3H, d, J 6.5 Hz, 1-H3), 2.32 (2H, t, J 6.5 Hz, 3-H2), 2.84–2.96 (4H, 
m, 7-H2 and 8-H2), 3.92 (1H, sex, J 6.5 Hz, 2-H), 6.10 (1H, d, J 16.0 Hz, 5-H), 6.83 
(1H, dt, J 16.0, 6.5 Hz, 4-H), 7.18–7.30 (5H, m, 5 × ArH); C (100 MHz, CDCl3) -4.7 
(CH3), -4.4 (CH3), 18.1 (C), 23.9 (CH3), 25.9 (3 × CH3), 30.1 (CH2), 41.5 (CH2), 42.8 
(CH2), 67.7 (CH), 126.1 (CH), 128.4 (2 × CH), 128.6 (2 × CH), 132.3 (CH), 141.3 (C), 
144.5 (CH), 199.4 (C); m/z (CI) 333.2253 (MH+. C20H33O2Si requires 333.2250), 275 
(11%), 237 (9), 201 (9), 181 (9), 159 (43), 137 (12), 97 (53), 71 (100). 
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(3R,4E)-1-Phenylnon-4-en-3-ol121 
OH
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The reaction was carried out according to general procedure 2, using (4E)-1-
phenylnon-4-en-3-one 140 (0.300 g, 1.39 mmol), (S)-(-)-2-methyl-CBS-
oxazaborolidine solution (1.0 M in toluene, 1.40 mL, 1.40 mmol), and borane 
tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 7.00 mL, 7.00 mmol) in 
tetrahydrofuran (10 mL).  Purification by silica column chromatography, and elution 
with 1:9 ethyl acetate/petroleum ether gave (3R,4E)-1-phenylnon-4-en-3-ol 148 as 
a colourless oil (0.299 g, 99%).  Chiral HPLC (Chiralcel IB column) analysis using 2% 
isopropanol in hexane indicated 84% ee; Rf (1:4 ethyl acetate/petroleum ether) 
0.39; []D
22 +17.5 (c 1.0, CHCl3) (lit.
121 []D +6.1 (c 0.952, CHCl3)); H (400 MHz, 
CDCl3) 0.90 (3H, t, J 7.2 Hz, 1-H3), 1.26–1.40 (4H, m, 2-H2 and 3-H2), 1.45 (1H, br s, 
OH), 1.75–1.93 (2H, m, 8-H2), 1.99–2.07 (2H, m, 4-H2), 2.62–2.79 (2H, m, 9-H2), 
4.03–4.12 (1H, m, 7-H), 5.49 (1H, ddt, J 15.2, 6.8, 1.2 Hz, 6-H), 5.66 (1H, dt, J 15.2, 
6.8 Hz, 5-H), 7.16–7.30 (5H, m, 5 × ArH); C (100 MHz,  CDCl3) 14.0 (CH3), 22.2 (CH2), 
31.4 (CH2), 31.8 (CH2), 31.9 (CH2), 38.9 (CH2), 72.5 (CH), 125.8 (CH), 128.4 (3 × CH), 
128.5 (2 × CH), 132.7 (CH), 142.0 (C); m/z (CI) 201.1646 (MH+. C15H23O-OH requires 
201.1643), 187 (11%), 133 (6), 117 (7), 91 (13), 69 (7). 
 
 
(4E)-1-Phenylnon-4-en-3-ol122 
OH
9
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A stirred solution of (4E)-1-phenylnon-4-en-3-one 140 (0.200 g, 0.93 mmol) in 
toluene (5 mL) was cooled to 0 °C before diisobutylaluminium hydride solution (1.0 
M in hexanes, 1.40 mL, 1.40 mmol) was added dropwise.  The reaction mixture was 
stirred at 0 °C for 3 h, and then at room temperature for 15 h before being cooled 
again to 0 °C and quenched by the slow addition of methanol (50 mL).  The 
resulting cloudy suspension was stirred at 0 °C for 1 h, then at room temperature 
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for 0.5 h before being filtered through a pad of Celite®.  The white gum was washed 
through with warm methanol (100 mL), and the combined filtrates were 
concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 1:9 ethyl acetate/petroleum ether gave (4E)-1-
phenylnon-4-en-3-ol rac-148 as a colourless oil (0.103 g, 51%).  For analytical data, 
see above compound 148. 
 
 
(3R,4E)-1,7-Diphenylhept-4-en-3-ol 
OH
75
4
3
2
1
6
149  
The reaction was carried out according to general procedure 2 using (4E)-1,7-
diphenylhept-4-en-3-one 141 (0.190 g, 0.72 mmol), (S)-(-)-2-methyl-CBS-
oxazaborolidine solution (1.0 M in toluene, 0.72 mL, 0.72 mmol) and borane 
tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 2.20 mL, 2.20 mmol) in 
tetrahydrofuran (10 mL).  Purification by silica column chromatography and elution 
with 3:7 ethyl acetate/petroleum ether gave (3R,4E)-1,7-diphenylhept-4-en-3-ol 
149 as a colourless oil (0.133 g, 69%).  Chiral HPLC (Chiralcel IB column) analysis 
using 4% isopropanol in hexane indicated 75% ee; Rf (1:4 ethyl acetate/petroleum 
ether) 0.32; max/cm
-1 (NaCl) 3356 (OH), 2925 (CH), 1602 (C=C), 1454, 970, 698; 
]D
22 +9.2 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.40 (1H, d, J 3.2 Hz, OH), 1.70–1.90 
(2H, m, 6-H2), 2.37 (2H, dt, J 7.6, 6.8 Hz, 2-H2), 2.57–2.73 (4H, m, 1-H2 and 7-H2), 
4.02–4.10 (1H, m, 5-H), 5.50 (1H, ddt, J 15.6, 7.0, 1.3 Hz, 4-H), 5.69 (1H, dtd, J 
15.6, 6.8, 0.7 Hz, 3-H), 7.15–7.30 (10H, m, 10 × ArH); C (100 MHz, CDCl3) 31.7 
(CH2), 33.9 (CH2), 35.6 (CH2), 38.7 (CH2), 72.3 (CH), 125.8 (CH), 125.9 (CH), 128.3 
(2 × CH), 128.4 (2 × CH), 128.5 (4 × CH), 131.4 (CH), 133.5 (CH), 141.6 (C), 142.0 
(C); m/z (EI) 266.1674 (M+. C19H22O requires 266.1671), 248 (10%), 161 (21), 144 (28), 
105 (42), 91 (100), 83 (18), 65 (11), 57 (11). 
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(4E)-1,7-Diphenylhept-4-en-3-ol 
OH
75
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The reaction was carried out according to general procedure 3 using (4E)-1,7-
diphenylhept-4-en-3-one 141 (0.040 g, 0.15 mmol) and diisobutylaluminium hydride 
solution (1.0 M in hexanes, 0.23 mL, 0.23 mmol) in toluene (5 mL).  Purification by 
silica column chromatography, eluting with 3:7 ethyl acetate/petroleum ether gave 
(4E)-1,7-diphenylhept-4-en-3-ol rac-149 as a colourless oil (0.024 g, 60%).  For 
analytical data, see above compound 149. 
 
 
(3R,4E)-7,7-Dimethyl-1-phenyloct-4-en-3-ol 
OH
64
3
2
1 5
150
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The reaction was carried out according to general procedure 2 using (4E)-7,7-
dimethyl-1-phenyloct-4-en-3-one 142 (0.200 g, 0.87 mmol), (S)-(-)-2-methyl-CBS-
oxazaborolidine solution (1.0 M in toluene, 0.90 mL, 0.90 mmol) and borane 
tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 2.60 mL, 2.60 mmol) in 
tetrahydrofuran (10 mL).  Purification by silica column chromatography, eluting 
with 1:9 ethyl acetate/petroleum ether gave (3R,4E)-7,7-dimethyl-1-phenyloct-4-
en-3-ol 150 as a colourless oil (0.156 g, 77%).  Chiral HPLC (Chiralcel IB column) 
analysis using 3% isopropanol in hexane indicated 69% ee; Rf (1:4 ethyl 
acetate/petroleum ether) 0.44; max/cm
-1 (NaCl) 3609 (OH), 3019 (CH), 1475, 1216, 
772; []D
22 +8.5 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.89 (9H, s, C(CH3)3), 1.45 (1H, d, 
J 3.6 Hz, OH), 1.76–1.98 (4H, m, 3-H2 and 7-H2), 2.63–2.76 (2H, m, 8-H2), 4.07–4.14 
(1H, m, 6-H), 5.49 (1H, dd, J 15.2, 7.2 Hz, 5-H), 5.69 (1H, dt, J 15.2, 7.6 Hz, 4-H), 
7.16–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 29.3 (3 × CH3), 30.9 (C), 31.8 (CH2), 
38.9 (CH2), 46.7 (CH2), 72.5 (CH), 125.8 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 129.5 
(CH), 135.1 (CH), 142.0 (C); m/z (EI) 232.1830 (M+. C16H24O requires 232.1827), 214 
(9%), 161 (26), 143 (24), 127 (46), 91 (100), 83 (51), 57 (98), 44 (15). 
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The reaction was carried out according to general procedure 3 using (4E)-7,7-
dimethyl-1-phenyloct-4-en-3-one 142 (0.050 g, 0.22 mmol) and diisobutylaluminium 
hydride solution (1.0 M in hexanes, 0.40 mL, 0.40 mmol) in toluene (5 mL).  
Purification by silica column chromatography, eluting with 1:9 ethyl 
acetate/petroleum ether gave (4E)-7,7-dimethyl-1-phenyloct-4-en-3-ol rac-150 as a 
colourless oil (0.057 g, 100%).  For analytical data, see above compound 150. 
 
 
(4E,6R)-1-Cyano-8-phenyloct-4-en-6-ol 
OH
CN
1
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The reaction was carried out according to general procedure 2 using (4E)-1-cyano-8-
phenyloct-4-en-6-one 143 (0.150 g, 0.65 mmol), (S)-(-)-2-methyl-CBS-
oxazaborolidine solution (1.0 M in toluene, 0.65 mL, 0.65 mmol) and borane 
tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 1.95 mL, 1.95 mmol) in 
tetrahydrofuran (3 mL).  Purification by silica column chromatography, and elution 
with 3:7 ethyl acetate/petroleum ether gave (4E,6R)-1-cyano-8-phenyloct-4-en-6-ol 
151 as a colourless oil (0.096 g, 63%).  Chiral HPLC (Chiralcel IB column) analysis 
using 6% isopropanol in hexane indicated 87% ee; Rf (1:4 ethyl acetate/petroleum 
ether) 0.09; max/cm
-1 (NaCl) 3448 (OH), 2932 (CH), 2251 (CN), 1454, 910, 731; 
[]D
23 +3.0 (c 0.5, CHCl3); H (400 MHz, CDCl3) 1.47–1.51 (1H, m, OH), 1.71–1.77 (2H, 
m, 2-H2), 1.78–1.93 (2H, m, 7-H2), 2.19-2.25 (2H, m, 3-H2), 2.35 (2H, t, J 7.2 Hz, 1-
H2), 2.62–2.77 (2H, m, 8-H2), 4.07–4.14 (1H, m, 6-H), 5.59–5.62 (2H, m, 4-H and 5-
H), 7.17–7.32 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 16.5 (CH2), 24.7 (CH2), 31.0 
(CH2), 31.8 (CH2), 38.8 (CH2), 72.1 (CH), 119.6 (C), 125.9 (2 × CH), 128.5 (2 × CH), 
129.0 (2 × CH), 135.1 (CH), 141.8 (C); m/z (CI) 230.1555 (MH+. C15H20NO requires 
230.1545), 212 (100%), 184 (8), 107 (27), 79 (30). 
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(4E)-1-cyano-8-phenyloct-4-en-6-ol 
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The reaction was carried out according to general procedure 3 using (4E)-1-cyano-8-
phenyloct-4-en-6-one 143 (0.050 g, 0.22 mmol) and diisobutylaluminium hydride 
solution (1.0 M in hexanes, 0.33 mL, 0.33 mmol) in toluene (5 mL).  Purification by 
silica column chromatography, eluting with 3:7 ethyl acetate/petroleum ether gave 
(4E)-1-cyano-8-phenyloct-4-en-6-ol rac-151 as a colourless oil (0.027 g, 54%).  For 
analytical data, see above compound 151. 
 
 
(3R,4E,7S)-7-[(tert-Butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-ol 
OH O
Si
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The reaction was carried out according to general procedure 2 using (4E,7S)-7-
[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-one 147 (0.500 g, 1.50 mmol), 
(S)-(-)-2-methyl-CBS-oxazaborolidine solution (1.0 M in toluene, 1.50 mL, 1.50 
mmol), and borane tetrahydrofuran complex solution (1.0 M in tetrahydrofuran, 
7.50 mL, 7.50 mmol) in tetrahydrofuran (15 mL).  Purification by silica column 
chromatography, and elution with 3:17 diethyl ether/petroleum ether gave 
(3R,4E,7S)-7-[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-ol 152 as a 
colourless oil (0.439 g, 87%).  Rf (1:4 ethyl acetate/petroleum ether) 0.43; max/cm
-
1 (NaCl) 3395 (OH), 2961 (CH), 1639 (C=C), 1455, 1254, 1084, 835, 774; []D
22 +17.1 
(c 1.0, CHCl3); H (400 MHz, CDCl3) 0.05 (6H, s, 2 × SiCH3), 0.88 (9H, s, SiC(CH3)3), 
1.12 (3H, d, J 6.0 Hz, 1-H3), 1.43 (1H, br s, OH), 1.76–1.93 (2H, m, 7-H2), 2.10–2.25 
(2H, m, 3-H2), 2.63–2.76 (2H, m, 8-H2), 3.83 (1H, sex, J 6.0 Hz, 2-H), 4.05–4.13 (1H, 
m, 6-H), 5.53 (1H, dd, J 15.4, 6.9 Hz, 5-H), 5.67 (1H, dt, J 15.4, 6.9 Hz, 4-H), 7.15–
7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) -4.7 (CH3), -4.5 (CH3), 18.2 (C), 23.5 
(CH3), 25.9 (3 × CH3), 31.8 (CH2), 38.8 (CH2), 42.6 (CH2), 68.5 (CH), 72.5 (CH), 125.8 
(CH), 128.4 (2 × CH), 128.5 (2 × CH), 129.0 (CH), 135.0 (CH), 142.0 (C); m/z 
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(FAB/NOBA/NaI) 357.2221 ([MNa]+. C20H34O2Si requires 357.2226), 333 (21%), 317 (6), 
268 (18), 228 (17), 208 (7), 186 (18), 160 (86), 148 (38), 117 (78), 105 (24), 75 (77). 
 
 
(4E,7S)-7-[(tert-Butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-ol 
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The reaction was carried out according to general procedure 3 using (4E,7S)-7-
[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-one 147 (0.060 g, 0.18 mmol) and 
diisobutylaluminium hydride solution (1.0 M in hexanes, 0.30 mL, 0.30 mmol) in 
toluene (5 mL).  Purification by silica column chromatography, eluting with 1:9 
ethyl acetate/petroleum ether gave (4E,7S)-7-[(tert-butyldimethylsilyl)oxy]-1-
phenyloct-4-en-3-ol 217 as a colourless oil (0.032 g, 53%).  For analytical data, see 
above compound 152.   
 
 
(3R)-5-Phenylpent-1-en-3-ol123 
OH
1
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The reaction was carried out according to general procedure 2, using 5-phenylpent-
1-en-3-one 136 (0.300 g, 1.87 mmol), (S)-(-)-2-methyl-CBS-oxazaborolidine solution 
(1.0 M in toluene, 1.87 mL, 1.87 mmol) and borane tetrahydrofuran complex 
solution (1.0 M in tetrahydrofuran, 5.62 mL, 5.62 mmol) in tetrahydrofuran (10 mL).  
Purification was carried out by silica column chromatography, and elution with 1:9 
ethyl acetate/petroleum ether gave (3S)-5-phenylpent-1-en-3-ol 153 as a colourless 
oil (0.225 g, 74%).  Chiral HPLC (Chiralcel IB column) analysis using 5% isopropanol 
in hexane indicated 68% ee; Rf (1:4 ethyl acetate/petroleum ether) 0.45; []D
25 +6.7 
(c 1.0, CHCl3), (lit.
123 []D
20 -5.8 (c 1.0, CHCl3)); H (400 MHz, CDCl3) 1.55 (1H, d, J 
3.9 Hz, OH), 1.79–1.93 (2H, m, 5-H2), 2.64–2.80 (2H, m, 4-H2), 4.09–4.17 (1H, m, 3-
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H), 5.14 (1H, d, J 10.4 Hz, 1-HH), 5.25 (1H, d, J 17.2 Hz, 1-HH), 5.91 (1H, ddd, J 
17.2, 10.4, 6.2 Hz, 2-H), 7.16–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 31.6 (CH2), 
38.5 (CH2), 72.5 (CH), 115.0 (CH2), 125.8 (CH), 128.4 (2 × CH), 128.5 (2 × CH), 141.0 
(CH), 141.8 (C); m/z (EI) 162.1041 (M+. C11H14O requires 162.1045), 144 (43%), 129 
(76), 105 (91), 91 (100), 5 (66), 51 (24), 44 (12). 
 
 
5-Phenylpent-1-en-3-ol124 
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The reaction was carried out according to general procedure 3, using 5-phenylpent-
1-en-3-one 136 (0.200 g, 1.25 mmol) and diisobutylaluminium hydride solution (1.0 
M in hexanes, 1.90 mL, 1.90 mmol) in toluene (5 mL).  Purification by silica column 
chromatography, eluting with 1:4 ethyl acetate/petroleum ether gave 5-
phenylpent-1-en-3-ol rac-153 as a colourless oil (0.085 g, 42%).  For analytical data, 
see above compound 153. 
 
 
(3E,5S)-1-Phenyl-5-(trichloromethylcarbonylamino)non-3-ene 
O
CCl3
NH
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The trichloroacetimidate formation reaction was carried out according to general 
procedure 4, using (3R,4E)-1-phenylnon-4-en-3-ol 148 (0.253 g, 1.16 mmol), 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.087 mL, 0.58 mmol), and trichloroacetonitrile 
(0.175 mL, 1.74 mmol) in dichloromethane (10 mL) to give the desired allylic 
trichloroacetimidate intermediate 154 (0.484 g).  H (400 MHz, CDCl3) 0.88 (3H, t, J 
7.0 Hz, 1-H3), 1.26–1.46 (4H, m, 2-H2 and 3-H2), 1.93–2.18 (4H, m, 4-H2 and 8-H2), 
2.65–2.81 (2H, m, 9-H2), 5.36 (1H, q, J 6.8 Hz, 7-H), 5.49 (1H, dd, J 15.4, 6.8 Hz, 6-
H), 5.81 (1H, dt, J 15.4, 6.7 Hz, 5-H), 7.16–7.31 (5H, m, 5 × ArH), 8.27 (1H, s, NH).  
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This intermediate was then subjected to an Overman rearrangement reaction, 
carried out according to general procedure 5 using potassium carbonate (0.060 g, 
0.43 mmol) in p-xylene (20 mL).  Purification by silica column chromatography, 
eluting with 1:19 diethyl ether/petroleum ether, gave (3E,5S)-1-phenyl-5-
(trichloromethylcarbonylamino)non-3-ene 155 as a colourless oil (0.283 g, 67% over 
2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.61; max/cm
-1 (NaCl) 3423 (NH), 
2933 (CH), 1712 (CO), 1509, 908, 741; []D
17 +16.0 (c 0.3, CHCl3); H (400 MHz, 
CDCl3) 0.89 (3H, t, J 7.0 Hz, 1-H3), 1.21–1.36 (4H, m, 2-H2 and 3-H2), 1.54–1.59 (2H, 
m, 4-H2), 2.37 (2H, q, J 7.4 Hz, 8-H2), 2.70 (2H, t, J 7.4 Hz, 9-H2), 4.29-4.36 (1H, m, 
5-H), 5.35 (1H, dd, J 15.6, 6.4 Hz, 6-H), 5.69 (1H, dt, J 15.6, 7.4 Hz, 7-H), 6.43 (1H, 
br d, J 7.6 Hz, NH), 7.13–7.30 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 13.9 (CH3), 22.4 
(CH2), 27.7 (CH2), 34.0 (CH2), 34.5 (CH2), 35.4 (CH2), 53.2 (CH), 92.9 (C), 125.9 (CH), 
128.3 (2 × CH), 128.5 (2 ×CH), 129.2 (CH), 132.2 (CH), 141.4 (C), 160.9 (C); m/z (CI) 
362.0842 (MH+. C17H23
35Cl3NO requires 362.0845), 329 (46%), 293 (80), 259 (35), 233 
(76), 219 (100), 201 (36), 145 (51), 101 (25), 81 (48), 71 (46). 
 
 
(3S,4E)-1,7-Diphenyl-3-(trichloromethylcarbonylamino)hept-4-ene 
O
CCl3
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The trichloroacetimidate formation reaction was carried out according to general 
procedure 4 using (3R,4E)-1,7-diphenylhept-4-en-3-ol 149 (0.098 g, 0.37 mmol), 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.03 mL, 0.18 mmol) and trichloroacetonitrile 
(0.06 mL, 0.55 mmol) in dichloromethane (5 mL) to give the desired allylic 
trichloroacetimidate intermediate (0.163 g).  H (400 MHz, CDCl3) 1.90–2.00 (1H, m, 
6-HH), 2.04–2.15 (1H, m, 6-HH), 2.38 (2H, q, J 6.8 Hz, 2-H2), 2.60–2.76 (4H, m, 1-H2 
and 7-H2), 5.34 (1H, q, J 6.6 Hz, 5-H), 5.50 (1H, ddt, J 15.4, 6.6, 1.3 Hz, 4-H), 5.84 
(1H, dt, J 15.4, 6.8 Hz, 3-H), 7.13–7.21 (5H, m, 5 × ArH), 7.23–7.31 (5H, m, 5 × ArH), 
8.26 (1H, s, NH).  This was then subjected to an Overman rearrangement reaction, 
carried out according to general procedure 5 using  potassium carbonate (0.015 g, 
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0.11 mmol) in p-xylene (5 mL).  Purification by silica column chromatography and 
elution with 1:9 ethyl acetate/petroleum ether gave (3S,4E)-1,7-diphenyl-3-
(trichloromethylcarbonylamino)hept-4-ene 156 as a colourless oil (0.111 g, 73% 
over 2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.53; max/cm
-1 (NaCl) 3422 
(NH), 3019 (CH), 1713 (CO), 1509, 1216, 756; []D
21 -12.7 (c 1.0, CHCl3); H (400 
MHz, CDCl3) 1.84–1.98 (2H, m, 2-H2), 2.39–2.47 (2H, m, 6-H2), 2.61 (2H, t, J 7.6 Hz, 
1-H2), 2.70 (2H, t, J 7.6 Hz, 7-H2), 4.33–4.41 (1H, m, 3-H), 5.39 (1H, dd, J 15.6, 6.4 
Hz, 4-H), 5.71 (1H, dt, J 15.6, 6.4 Hz, 5-H), 6.48 (1H, d, J 8.0 Hz, NH), 7.12–7.31 
(10H, m, 10 × ArH); C (100 MHz, CDCl3) 29.7 (CH2), 32.0 (CH2), 35.5 (CH2), 36.4 
(CH2), 53.1 (CH), 92.9 (C), 126.1 (CH), 126.3 (CH), 128.5 (4 × CH), 128.6 (2 × CH), 
128.7 (2 × CH), 128.8 (CH), 132.8 (CH), 141.0 (C), 141.4 (C), 161.1 (C); m/z (CI) 
410.0847 (MH+. C21H23
35Cl3NO requires 410.0845), 376 (18%), 343 (12), 307 (8), 249 
(11), 216 (5), 167 (7), 136 (12), 85 (66), 73 (100). 
 
 
(3E,5S)-7,7-Dimethyl-5-(trichloromethylcarbonylamino)-1-phenyloct-3-ene 
O
CCl3
NH
6
5
4
3
2
1
157
8
 
The acetimidate formation reaction was carried out according to general procedure 
4 using (3R,4E)-7,7-dimethyl-1-phenyloct-4-en-3-ol 150 (0.123 g, 0.53 mmol), 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.04 mL, 0.27 mmol) and trichloroacetonitrile 
(0.08 mL, 0.79 mmol) in dichloromethane (5 mL) to give the desired allylic 
trichloroacetimidate (0.284 g).  H (400 MHz, CDCl3) 0.87 (9H, s, C(CH3)3), 1.93 (2H, 
d, J 7.6 Hz, 3-H2), 1.95–2.05 (1H, m, 7-HH), 2.09–2.20 (1H, m, 7-HH), 2.66–2.83 (2H, 
m, 8-H2), 5.36 (1H, dt, J 6.8, 6.2 Hz, 6-H), 5.48 (1H, dd, J 15.3, 6.8 Hz, 5-H), 5.86 
(1H, dt, J 15.3, 7.6 Hz, 4-H), 7.16–7.31 (5H, m, 5 × ArH), 8.28 (1H, s, NH).  This was 
then subjected to an Overman rearrangement reaction, carried out according to 
general procedure 5 using potassium carbonate (0.018 g, 0.13 mmol) in p-xylene (6 
mL).  Purification by silica column chromatography, eluting with 1:19 ethyl 
acetate/petroleum ether gave (3E,5S)-7,7-dimethyl-5-
(trichloromethylcarbonylamino)-1-phenyloct-3-ene 157 as a white solid (0.206 g, 
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100% over 2 steps).  Mp 66–69 °C; Rf (1:4 ethyl acetate/petroleum ether) 0.59; 
max/cm
-1 (NaCl) 3338 (NH), 2955 (CH), 1689 (CO), 1518, 1245, 822; []D
22 -24.2 (c 
1.0, CHCl3); H (400 MHz, CDCl3) 0.95 (9H, s, C(CH3)3), 1.44 (1H, dd, J 14.4, 8.0 Hz, 
3-HH), 1.53 (1H, dd, J 14.4, 4.8 Hz, 3-HH), 2.35 (2H, dt, J 7.2, 7.0 Hz, 7-H2), 2.68 
(2H, t, J 7.2, 8-H2), 4.40–4.49 (1H, m, 4-H), 5.36 (1H, ddt, J 15.4, 6.8, 1.2 Hz, 5-H), 
5.68 (1H, dtd, J 15.4, 7.0, 1.2 Hz, 6-H), 6.41 (1H, d, J 8.0 Hz, NH), 7.14–7.29 (5H, 
m, 5 × ArH); C (100 MHz, CDCl3) 29.9 (3 × CH3), 30.5 (C), 34.0 (CH2), 35.4 (CH2), 
48.9 (CH2), 50.8 (CH), 92.9 (C), 125.9 (CH), 128.3 (2 × CH), 128.5 (2 × CH), 130.8 
(CH), 131.0 (CH), 141.5 (C), 160.2 (C); m/z (CI) 376.1005 (MH+. C18H25
35Cl3NO 
requires 376.1002), 342 (49%), 306 (100), 272 (43), 270 (15), 215 (10), 168 (36), 154 
(6), 107 (57), 71 (49). 
 
 
(4S,5E)-1-Cyano-4-(trichloromethylcarbonylamino)-8-phenyloct-5-ene 
 
O
CN
CCl3
NH
1
2
3
4
5
68
7
158
 
The trichloroacetimidate formation reaction was set up according to general 
procedure 4 using (4E,6R)-1-cyano-8-phenyloct-4-en-6-ol 151 (0.182 g, 0.79 mmol), 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.060 mL, 0.40 mmol) and trichloroacetonitrile 
(0.120 mL, 1.20 mmol) in dichloromethane (6 mL).  After stirring for 18 h, further 
1,8-diazabicyclo[5.4.0]undec-7-ene (0.030 mL, 0.20 mmol) and trichloroacetonitrile 
(0.060 mL, 0.60 mmol) were added and the reaction mixture was stirred again at 
room temperature for 6 h to give the desired allylic trichloroacetimidate 
intermediate (0.318 g).  H (400 MHz, CDCl3) 1.71–1.79 (2H, m, 2-H2), 1.94–2.04 (1H, 
m, 7-HH), 2.09–2.19 (1H, m, 7-HH), 2.23 (2H, q, J 6.9 Hz, 3-H2), 2.32 (2H, t, J 7.2 
Hz, 1-H2), 2.66–2.83 (2H, m, 8-H2), 5.31–5.38 (1H, m, 6-H), 5.59 (1H, dd, J 15.4, 6.5 
Hz, 5-H), 5.74 (1H, dtd, J 15.4, 6.9, 0.9 Hz, 4-H), 7.16–7.32 (5H, m, 5 × ArH), 8.29 
(1H, s, NH).  This was then subjected to an Overman rearrangement reaction, 
carried out according to general procedure 5 using potassium carbonate (0.020 g, 
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0.14 mmol) in p-xylene (7 mL).  Purification by silica column chromatography, and 
elution with 1:4 ethyl acetate/petroleum ether gave (4S,5E)-1-cyano-4-
(trichloromethylcarbonylamino)-8-phenyloct-5-ene 158 as a pale yellow oil (0.241 g, 
81% over 2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.24; max/cm
-1 (NaCl) 
3330 (NH), 2928 (CH), 2250 (CN), 1702 (CO), 1517, 822, 734; []D
23 -13.6 (c 1.0, 
CHCl3); H (400 MHz, CDCl3) 1.55–1.65 (2H, m, 2-H2), 1.68–1.77 (2H, m, 3-H2), 2.35–
2.43 (4H, m, 1-H2 and 7-H2), 2.71 (2H, t, J 7.4 Hz, 8-H2), 4.30–4.38 (1H, m, 4-H), 
5.33 (1H, ddt, J 15.4, 6.8, 1.3 Hz, 5-H), 5.73 (1H, dtd, J 15.4, 6.8, 1.0 Hz, 6-H), 
6.46 (1H, d, J 8.1 Hz, NH), 7.13–7.31 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 16.9 
(CH2), 21.7 (CH2), 33.7 (CH2), 33.9 (CH2), 35.2 (CH2), 52.5 (CH), 92.8 (C), 119.2 (C), 
126.1 (CH), 128.2 (CH), 128.4 (2 × CH), 128.5 (2 × CH), 133.7 (CH), 141.1 (C), 161.3 
(C); m/z (CI) 373.0640 (MH+. C17H20
35Cl3N2O requires 373.0641), 339 (30%), 305 (13), 
288 (12), 269 (8), 212 (11), 186 (17), 162 (23), 132 (13), 128 (8), 107 (37), 85 (23), 
79 (100), 69 (28). 
 
 
(2S,4S,5E)-2-[(tert-Butyldimethylsilyl)oxy]-4-(trichloromethylcarbonylamino)-8-
phenyloct-5-ene 
O O
Si
CCl3
NH
1
2
3
4
5
6
7
8
159  
The trichloroacetimidate formation reaction was carried out according to general 
procedure 4, using (3R,4E,7S)-7-[(tert-butyldimethylsilyl)oxy]-1-phenyloct-4-en-3-ol 
152 (0.100 g, 0.30 mmol), 1,8-diazabicyclo[5.4.0]undec-7-ene (0.022 mL, 0.15 
mmol) and trichloroacetonitrile (0.045 mL, 0.45 mmol) in dichloromethane (5 mL) 
to give the desired allylic trichloroacetimidate intermediate as a colourless oil 
(0.130 g).  H (400 MHz, CDCl3) 0.03 (6H, s, 2 × SiCH3), 0.87 (9H, s, SiC(CH3)3), 1.11 
(3H, d, J 6.1 Hz, 1-H3), 1.92–2.04 (1H, m, 3-HH), 2.07–2.28 (3H, m, 3-HH and 7-H2), 
2.64–2.82 (2H, m, 8-H2), 3.78–3.89 (1H, m, 2-H), 5.33–5.42 (1H, m, 6-H), 5.54 (1H, 
dd, J 15.3, 7.0 Hz, 5-H), 5.82 (1H, dt, J 15.3, 7.2 Hz, 4-H), 7.15–7.32 (5H, m, 5 × 
ArH), 8.27 (1H, s, NH).  This was then subjected to an Overman rearrangement 
reaction, carried out according to general procedure 5, using potassium carbonate 
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(0.015 g, 0.11 mmol) in p-xylene (5 mL).  Purification by silica column 
chromatography, eluting with 1:19 ethyl acetate/petroleum ether gave (2S,4S,5E)-
2-[(tert-butyldimethylsilyl)oxy]-4-(trichloromethylcarbonylamino)-8-phenyloct-5-
ene 159 as a colourless oil (0.124 g, 87% over 2 steps).  Rf (1:4 ethyl 
acetate/petroleum ether) 0.57; max/cm
-1 (NaCl) 3373 (NH), 2928 (CH), 1702 (CO), 
1514, 1254, 1079, 835; []D
19 -12.0 (c 0.3, CHCl3); H (400 MHz, CDCl3) 0.04 (3H, s, 
SiCH3), 0.05 (3H, s, SiCH3), 0.89 (9H, s, SiC(CH3)3), 1.18 (3H, d, J 6.0 Hz, 1-H3), 
1.60–1.68 (1H, m, 3-HH), 1.71–1.79 (1H, m, 3-HH), 2.37 (2H, q, J 7.0 Hz, 7-H2), 2.70 
(2H, t, J 7.0 Hz, 8-H2), 3.82 (1H, q, J 6.0 Hz, 2-H), 4.46 (1H, quin, J 6.8 Hz, 4-H), 
5.40 (1H, dd, J 15.4, 6.8 Hz, 5-H), 5.72 (1H, dt, J 15.4, 7.0 Hz, 6-H), 6.52 (1H, d, J 
8.0 Hz, NH), 7.14–7.30 (5H, m, 5 × ArH); C (100 MHz, CDCl3) -4.6 (CH3), -4.1 (CH3), 
18.1 (C), 24.0 (CH3), 25.9 (3 × CH3), 34.0 (CH2), 35.4 (CH2), 44.8 (CH2), 50.7 (CH), 
65.8 (CH), 92.9 (C), 126.0 (CH), 128.4 (2 × CH), 128.5 (2 × CH), 129.1 (CH), 132.4 
(CH), 141.4 (C), 160.7 (C); m/z (CI) 480.1490 (MH+. C22H35
35Cl2
37ClNO2Si requires 
480.1477), 478 (97%), 444 (75), 410 (19), 408 (15), 352 (14), 346 (8), 318 (5), 159 
(11), 133 (8), 81 (4). 
 
 
(2S)-2-(Trichloromethylcarbonylamino)hexanoic acid47 
HO
O
CCl3
NH
O
2
3
4
5
6
160  
(5S,6E)-9-Phenyl-5-(trichloromethylcarbonylamino)non-6-ene 155 (0.240 g, 0.66 
mmol) was dissolved in acetonitrile (9 mL) and carbon tetrachloride (9 mL) and to 
the stirred solution, sodium periodate (0.580 g, 2.71 mmol, dissolved in 12 mL of 
water) was added.  Ruthenium(III) chloride hydrate (0.007 g, 0.03 mmol) was then 
added, and the resulting reaction mixture was stirred at room temperature for 26 h 
before further sodium periodate (0.283 g, 1.32 mmol) and ruthenium(III) chloride 
hydrate (0.004 g, 0.02 mmol) were added.  The reaction mixture was stirred at 
room temperature for a further 22 h and the organic layers were extracted from 
the mixture using dichloromethane (100 mL), combined and then concentrated in 
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vacuo.  The residue was dissolved in ethyl acetate (100 mL) and washed with a 
saturated aqueous solution of sodium hydrogen carbonate (100 mL) and then a 
saturated aqueous solution of ammonium chloride (100 mL).  The aqueous phases, 
found to contain the desired product, were then combined and acidified using 2 M 
hydrochloric acid before being extracted using ethyl acetate (2 × 125 mL).  The 
organic phases were then combined, dried (MgSO4), filtered and concentrated in 
vacuo.  Purification was carried out using silica column chromatography, and 
elution with 1:1 ethyl acetate/petroleum ether gave (2S)-2-
(trichloromethylcarbonylamino)hexanoic acid 160 as a colourless oil (0.053 g, 29%).  
Rf (1:4 ethyl acetate/petroleum ether) 0.23; []D
22 +15.9 (c 0.85, CHCl3) (lit.
46 
[]D
29 +35.2) (c 0.27, CHCl3)); H (400 MHz, CDCl3) 0.92 (3H, t, J 7.0 Hz, 6-H3), 1.32–
1.42 (4H, m, 4-H2 and 5-H2), 1.79–1.91 (1H, m, 3-HH), 1.99–2.10 (1H, m, 3-HH), 4.63 
(1H, dt, J 7.3, 5.5 Hz, 2-H), 7.16 (1H, d, J 7.3 Hz, NH); C (100 MHz, CDCl3) 13.8 
(CH3), 22.2 (CH2), 27.0 (CH2), 31.5 (CH2), 53.8 (CH), 92.1 (C), 161.6 (C), 176.1 (C); 
m/z (CI) 275.9953 (MH+. C8H13
35Cl3NO3 requires 275.9961), 242 (71%), 230 (5), 208 
(13), 196 (9), 162 (24), 158 (11), 113 (11), 81 (23), 69 (24). 
 
 
Methyl (2S)-2-(trichloromethylcarbonylamino)hexanoate 
MeO
O
CCl3
NH
O
2
3
4
5
6
161  
The reaction was carried out according to general procedure 6, using (5S,6E)-9-
phenyl-5-(trichloromethylcarbonylamino)non-6-ene 155 (0.142 g, 0.39 mmol), 
sodium periodate (0.343 g, 1.61 mmol, dissolved in 9 mL of water), and 
ruthenium(III) chloride hydrate (0.010 g, 0.05 mmol) in acetonitrile (6 mL) and 
carbon tetrachloride (6 mL) to give a green/blue oil (0.122 g), which was reacted 
with thionyl chloride (0.20 mL, 2.74 mmol) in methanol (5 mL).  Purification by 
silica column chromatography, eluting with 1:9 diethyl ether/petroleum ether gave 
methyl (2S)-2-(trichloromethylcarbonylamino)hexanoate 161 as a colourless oil 
(0.039 g, 34% over 2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.58; []D
25 
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+19.0 (c 0.2, CHCl3); H (400 MHz, CDCl3) 0.87–0.93 (3H, m, 6-H3), 1.30–1.40 (4H, m, 
4-H2 and 5-H2), 1.72–1.83 (1H, m, 3-HH), 1.92–2.04 (1H, m, 3-HH), 3.81 (3H, s, 
OCH3), 4.58 (1H, q, J 6.2 Hz, 2-H), 7.14 (1H, d, J 6.2 Hz, NH); C (100 MHz, CDCl3) 
13.9 (CH3), 22.2 (CH2), 27.0 (CH2), 31.7 (CH2), 52.9 (CH3), 54.0 (CH), 92.2 (C), 161.4 
(C), 171.9 (C); m/z (CI) 290.0130 (MH+. C9H15
35Cl3NO3 requires 290.0118), 256 (100%), 
222 (20), 179 (10), 127 (5), 85 (40), 69 (55). 
 
 
Methyl (2S)-4-phenyl-2-(trichloromethylcarbonylamino)butanoate 
MeO
O
CCl3
NH
O
4
3
2
162
 
The reaction was carried out according to general procedure 6 using (3S,4E)-1,7-
diphenyl-3-(trichloromethylcarbonylamino)hept-4-ene 156 (0.100 g, 0.24 mmol), 
sodium periodate (0.213 g, 1.00 mmol, dissolved in 9 mL of water) and 
ruthenium(III) chloride hydrate (0.003 g, 0.01 mmol) in acetonitrile (6 mL) and 
carbon tetrachloride (6 mL) to give a blue/black oil (0.094 g), which was reacted 
with thionyl chloride (0.12 mL, 1.65 mmol) in methanol (5 mL).  Purification by 
silica column chromatography, eluting with 1:9 ethyl acetate/petroleum ether gave 
methyl (2S)-4-phenyl-2-(trichloromethylcarbonylamino)butanoate 162 as a 
colourless oil (0.035 g, 42%).  Rf (1:4 ethyl acetate/petroleum ether) 0.39; max/cm
-
1 (NaCl) 3344 (NH), 2925 (CH), 1742 (CO), 1713 (CO), 1513, 1455, 1215, 821; []D
21 
+29.9 (c 0.3, CHCl3); H (400 MHz, CDCl3) 2.05–2.14 (1H, m, 3-HH), 2.22–2.32 (1H, m, 
3-HH), 2.55–2.69 (2H, m, 4-H2), 3.71 (3H, s, OCH3), 4.56 (1H, q, J 5.2 Hz, 2-H), 
7.08–7.33 (6H, m, 5 × ArH and NH); C (100 MHz, CDCl3) 31.3 (CH2), 33.3 (CH2), 52.9 
(CH3), 53.7 (CH), 93.6 (C), 126.5 (CH), 128.4 (2 × CH), 128.7 (2 × CH), 140.0 (C), 
161.5 (C), 171.5 (C); m/z (CI) 338.0117 (MH+.C13H15
35Cl3NO3 requires 338.0118), 304 
(45%), 69 (12). 
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Methyl (2S)-4,4-dimethyl-2-(trichloromethylcarbonylamino)pentanoate 
MeO
O
CCl3
NH
O
2
3
163  
The reaction was carried out according to general procedure 6 using (4S,5E)-2,2-
dimethyl-4-(trichloromethylcarbonylamino)-8-phenyloct-5-ene 157 (0.150 g, 0.40 
mmol), sodium periodate (0.349 g, 1.63 mmol, dissolved in 9 mL of water) and 
ruthenium(III) chloride (0.008 g, 0.04 mmol) in acetonitrile (6 mL) and carbon 
tetrachloride (6 mL) to give a blue/black oil (0.160 g), which was then reacted with 
thionyl chloride (0.2 mL, 2.74 mmol) in methanol (5 mL).  Purification by silica 
column chromatography, eluting with 3:17 diethyl ether/petroleum ether gave 
methyl (2S)-4,4-dimethyl-2-(trichloromethylcarbonylamino)pentanoate 163 as a 
pale yellow solid (0.075 g, 62%).  Mp 76-79 °C; Rf (1:4 ethyl acetate/petroleum 
ether) 0.41; max/cm
-1 (NaCl) 3422 (NH), 2960 (CH), 1743 (CO), 1716 (CO), 1516, 
1371, 1215, 908; []D
22 -3.3 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.00 (9H, s, C(CH3)3), 
1.58–1.70 (1H, m, 3-HH), 1.88 (1H, dd, J 14.6, 3.1 Hz, 3-HH), 3.78 (3H, s, OCH3), 
4.62 (1H, td, J 8.6, 3.1 Hz, 2-H), 6.94 (1H, br m, NH); C (100 MHz, CDCl3) 29.5 (3 × 
CH3), 30.7 (C), 45.8 (CH2), 51.8 (CH3), 52.8 (CH), 106.9 (C), 161.4 (C), 172.3 (C); 
m/z (CI) 304.0264 (MH+. C10H17
35Cl3NO3 requires 304.0274), 270 (86%), 254 (10), 236 
(19), 113 (9), 81 (32), 69 (29). 
 
 
Methyl (2S)-5-cyano-2-(trichloromethylcarbonylamino)pentanoate 
MeO
O
CN
CCl3
NH
O
2
3
4
5
164  
The reaction was carried out according to general procedure 6, using (4S,5E)-1-
cyano-4-(trichloromethylcarbonylamino)-8-phenyloct-5-ene 158 (0.120 g, 0.32 
mmol), sodium periodate (0.282 g, 1.37 mmol, dissolved in 6 mL of water) and 
ruthenium(III) chloride hydrate (0.007 g, 0.03 mmol) in acetonitrile (4 mL) and 
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carbon tetrachloride (4 mL), stirring for 18 h to give a black oil (0.099 g), which was 
reacted with thionyl chloride (0.240 mL, 3.29 mmol) in methanol (7 mL).  
Purification by silica column chromatography, eluting with 3:7 ethyl 
acetate/petroleum ether gave methyl (2S)-5-cyano-2-
(trichloromethylcarbonylamino)pentanoate 164 as a colourless oil (0.056g, 58%).  Rf 
(1:4 ethyl acetate/petroleum ether) 0.09; max/cm
-1 (NaCl) 3339 (NH), 2918 (CH), 
2253 (CN), 1744 (CO), 1712 (CO), 1521, 1439, 1217, 912, 735; []D
21 +8.1 (c 0.5, 
CHCl3); H (400 MHz, CDCl3) 1.65–1.85 (2H, m, 4-H2), 1.88–1.98 (1H, m, 3-HH), 2.13–
2.23 (1H, m, 3-HH), 2.44 (2H, t, J 7.0 Hz, 5-H2), 3.85 (3H, s, OCH3), 4.61 (1H, td, J 
7.5, 6.0 Hz, 2-H), 7.33 (1H, d, J 6.0 Hz, NH); C (100 MHz, CDCl3) 16.8 (CH2), 21.4 
(CH2), 31.3 (CH2), 53.1 (CH3), 53.3 (CH), 92.0 (C), 118.8 (C), 161.9 (C), 171.1 (C); 
m/z (CI) 300.9900 (MH+. C9H12
35Cl3N2O3 requires 300.9914), 267 (76%), 251 (10), 233 
(48), 199 (9), 183 (9), 155 (12), 142 (8), 113 (25), 107 (85), 71 (100). 
 
 
(2S)-Dimethyl-2-(trichloromethylcarbonylamino)-hexadioate  
MeO
O
O
OMe
NH
CCl3
O
2
3
4
5
165  
The reaction was carried out according to general procedure 6, using (4S,5E)-1-
cyano-4-(trichloromethylcarbonylamino)-8-phenyloct-5-ene 158 (0.109 g, 0.29 
mmol), sodium periodate (0.256 g, 1.20 mmol, dissolved in 6 mL of water) and 
ruthenium(III) chloride hydrate (0.006 g, 0.03 mmol) in acetonitrile (4 mL) and 
carbon tetrachloride (4 mL).  After stirring for 18 h, further sodium periodate 
(0.064 g, 0.30 mmol) and ruthenium(III) chloride hydrate (0.002 g, 0.01 mmol) were 
added, and the reaction was stirred for a futher 6 h to give a blue/black oil (0.102 
g), which was reacted with thionyl chloride (0.30 mL, 4.11 mmol) in methanol (7 
mL).  Purification by silica column chromatography, and elution with 1:4 ethyl 
acetate/petroleum ether gave (2S)-dimethyl-2-(trichloromethylcarbonylamino)-
hexadioate 165 as a colourless oil (0.034 g, 35%).  max/cm
-1 (neat) 3300 (NH), 2955 
(CH), 1738 (CO), 1719 (CO), 1703 (CO), 1520, 1439, 1360, 1263, 1209, 1163, 1121, 
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821; []D
23 +19.5 (c 0.2, CHCl3); H (400 MHz, CDCl3) 1.59–1.78 (2H, m, 4-H2), 1.79–
1.90 (1H, m, 3-HH), 1.96–2.08 (1H, m, 3-HH), 2.37 (2H, t, J 7.2 Hz, 5-H2), 3.68 (3H, 
s, OCH3), 3.82 (3H, s, OCH3), 4.58 (1H, td, J 7.0, 5.2 Hz, 2-H), 7.34 (1H, d, J 7.0 Hz, 
NH); C (100 MHz, CDCl3) 20.3 (CH2), 31.2 (CH2), 33.1 (CH2), 51.7 (CH3), 53.0 (CH3), 
53.7 (CH), 92.1 (C), 161.6 (C), 171.4 (C), 173.3 (C); m/z (CI) 334.0002 (MH+. 
C10H15
35Cl3NO5 requires 334.0016), 300 (24%), 266 (10), 167 (8), 137 (21), 107 (51), 
73 (100).  Further elution with 1:3 ethyl acetate/petroleum ether also gave methyl 
(2S)-5-nitrile-2-(trichloromethylcarbonylamino)pentanoate 141 as a colourless oil 
(0.015 g, 17%).  (For full analytical data, see above compound 141). 
 
 
Methyl (2S,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-(trichloromethylcarbonyl-
amino)pentanoate 
MeO
O O
Si
CCl3
NH
O
2
3
4
5
166  
(2S,4S,5E)-2-[(tert-butyldimethylsilyl)oxy]-4-(trichloromethylcarbonylamino)-8-
phenyloct-5-ene 159 (0.107 g, 0.22 mmol) was dissolved in tert-butanol (2 mL) and 
to the stirred solution, potassium carbonate (0.093 g, 0.67 mmol, dissolved in 4 mL 
of water) was added, followed by sodium periodate (0.143 g, 0.67 mmol) and 
potassium permanganate (0.032 g, 0.20 mmol).  The reaction mixture was stirred at 
room temperature for 48 h before further potassium carbonate (0.047 g, 0.34 
mmol), sodium periodate (0.072 g, 0.34 mmol) and potassium permanganate (0.016 
g, 0.10 mmol) were added.  The reaction mixture was stirred at room temperature 
for a further 40 h before potassium carbonate (0.031 g, 0.22 mmol), sodium 
periodate (0.048 g, 0.22 mmol) and potassium permanganate (0.011 g, 0.07 mmol) 
were added.  The reaction was stirred again at room temperature for 18 h and then 
filtered through a pad of Celite® and washed with ethyl acetate (50 mL).  Water (50 
mL) was added to the filtrate, and the layers were separated.  The organic layers 
were further extracted using ethyl acetate (3 × 50 mL) and the combined organic 
phases were dried (MgSO4), filtered, and concentrated in vacuo to give a yellow oil 
(0.094 g).  This residue was then dissolved in toluene (5 mL) and methanol (5 mL), 
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and (trimethylsilyl)diazomethane solution (2.0 M in diethyl ether, 2.20 mL, 4.40 
mmol) was added dropwise.  The reaction mixture was stirred at room temperature 
for 1.75 h before being concentrated in vacuo.  Purification was carried out by 
silica column chromatography, and elution with 1:9 diethyl ether/petroleum ether 
gave methyl (2S,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-
(trichloromethylcarbonylamino)pentanoate 166 as a colourless oil (0.027 g, 30% 
over 2 steps).  Rf (1:4 ethyl acetate/petroleum ether) 0.46; max/cm
-1 (NaCl) 3420 
(NH), 2858 (CH), 1638 (CO), 1254, 1142, 822; []D
20 +25.6 (c 0.75, CHCl3); H (400 
MHz, CDCl3) 0.06 (3H, s, SiCH3), 0.07 (3H, s, SiCH3), 0.88 (9H, s, SiC(CH3)3), 1.20 (3H, 
d, J 6.0 Hz, 5-H3), 1.98–2.08 (1H, m, 3-HH), 2.09–2.18 (1H, m, 3-HH), 3.79 (3H, s, 
OCH3), 3.95–4.04 (1H, m, 4-H), 4.57 (1H, q, J 5.9 Hz, 2-H), 7.51 (1H, d, J 5.9 Hz, 
NH); C (100 MHz, CDCl3) -4.5 (CH3), -4.3 (CH3), 18.2 (C), 23.6 (CH3), 26.0 (3 × CH3), 
40.4 (CH2), 51.8 (CH3), 52.8 (CH), 65.7 (CH), 92.2 (C), 161.5 (C), 171.7 (C); m/z (CI) 
408.0746 (MH+. C14H27
35Cl2
37ClNO4Si requires 408.0748), 372 (39%), 338 (13), 314 (5), 
271 (9), 240 (11), 207 (6), 173 (9), 133 (7), 113 (40), 69 (100). 
 
 
(2S)-2-Aminohexanoic acid hydrochloride125 
HO
NH2
O
2
3
4
5
6
167
·HCl
 
The reaction was carried out according to general procedure 7, using methyl (2S)-2-
(trichloromethylcarbonylamino)hexanoate 161 (0.027 g, 0.09 mmol) in 6 M 
hydrochloric acid (5 mL), stirring under reflux for 18 h to give (2S)-2-aminohexanoic 
acid hydrochloride 167 as a pale yellow solid (0.012 g, 77%).  Mp 184–190 °C; []D
24 
+26.7 (c 1.0, 6 M HCl) (lit.125 []D
20 +10.3 (c 1.05, H2O); H (400 MHz, D2O) 0.87 (3H, 
t, J 6.7 Hz, 6-H3), 1.30–1.42 (4H, m, 4-H2 and 5-H2), 1.80–2.00 (2H, m, 3-H2), 4.00 
(1H, t, J 6.1 Hz, 2-H); C (100 MHz, D2O) 12.9 (CH3), 21.5 (CH2), 26.2 (CH2), 29.4 
(CH2), 53.2 (CH), 172.7 (C); m/z (CI) 132.1023 (MH
+. C6H14NO2 requires 132.1025), 
113 (13%), 97 (13), 81 (23), 71 (22). 
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(2S)-2-Amino-4-phenylbutanoic acid hydrochloride126 
·HCl
HO
NH2
O
2
3
4
168  
The reaction was carried out according to general procedure 7 using methyl (2S)-4-
phenyl-2-(trichloromethylcarbonylamino)butanoate 162 (0.018 g, 0.05 mmol) in 6 M 
hydrochloric acid, stirring under reflux for 20 h to give (2S)-2-amino-4-
phenylbutanoic acid hydrochloride 168 as a yellow solid (0.024 g, 100%).  Mp 244–
247 °C (lit.126 Mp 250–260 °C); []D
23 +4.7 (c 1.0, 1 M HCl) (lit.126 []D
20 +40.0 (c 0.6, 
3 M HCl); H (400 MHz, D2O) 2.15–2.36 (2H, m, 3-H2), 2.70–2.88 (2H, m, 4-H2), 4.07 
(1H, t, J 5.8 Hz, 2-H), 7.27–7.43 (5H, m, 5 × ArH); C (100 MHz, D2O) 30.5 (CH2), 
31.9 (CH2), 57.4 (CH), 126.6 (CH), 128.5 (2 × CH), 128.9 (2 × CH), 140.3 (C), 173.3 
(C); m/z (CI) 180 (MH+, 4%), 161 (22), 137 (56), 113 (31), 97 (33), 81 (73), 69 (100). 
 
 
(2S)-2-Amino-4,4-dimethylpentanoic acid hydrochloride127 
HO
NH2
O
2
3
169
·HCl
 
The reaction was carried out according to general procedure 7 using methyl (2S)-
4,4-dimethyl-2-(trichloromethylcarbonylamino)pentanoate 163 (0.047 g, 0.15 
mmol) in 6 M hydrochloric acid (5 mL), stirring under reflux for 24 h to give (2S)-2-
amino-4,4-dimethylpentanoic acid hydrochloride 169 as a pale yellow solid (0.040 g, 
100%).  Mp 198–202 °C; max/cm
-1 (neat) 3395 (NH), 2955 (CH), 1744 (CO), 1636, 
1404, 1211, 1072, 1026; []D
21 -50.0 (c 0.1, AcOH); H (400 MHz, D2O) 1.00 (9H, s, 
C(CH3)3), 1.70 (1H, dd, J 15.0, 5.6 Hz, 3-HH), 2.04 (1H, dd, J 15.0, 5.6 Hz, 3-HH), 
4.07 (1H, t, J 5.6 Hz, 2-H); C (100 MHz, D2O) 28.3 (3 × CH3), 29.6 (C), 43.8 (CH2), 
50.5 (CH), 173.2 (C); m/z (CI) 146.1188 (MH+. C7H16NO2 requires 146.1181), 135 (6%), 
113 (10), 97 (13), 81 (26), 69 (32). 
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(2S,4S)-4-Hydroxy-2-aminopentanoic acid128 
OHNH2
O
HO
2
3
4
5
170  
 
The reaction was carried out according to general procedure 7, using methyl 
(2S,4S)-4-[(tert-butyldimethylsilyl)oxy]-2-(trichloromethylcarbonylamino) 
pentanoate 166 (0.026 g, 0.06 mmol) in 6.0 M hydrochloric acid (4 mL), stirring 
under reflux for 16 h.  Purification was carried out using a DOWEX ion exchange 
column and elution with 0.5 M ammonium hydroxide solution gave (2S,4S)-4-
hydroxy-2-aminopentanoic acid 170 as a yellow solid (0.006 g, 71%).  Mp >250 °C 
(decomposition) (lit.128 Mp 228–230 °C); max/cm
-1 3350 (NH2, OH), 1601 (CO), 1406, 
1117, 1022, 721; []D
20 +18.6 (c 0.2, H2O) (lit.
128 []D
20 +21.0 (c 1.3, H2O)); H (400 
MHz, D2O) 1.27 (3H, d, J 6.6 Hz, 5-H3), 1.76–1.84 (1H, m, 3-HH), 2.09–2.15 (1H, m, 
3-HH), 3.82 (1H, dd, J 9.4, 4.4 Hz, 2-H), 4.08–4.12 (1H, m, 4-H); C (100 MHz, D2O) 
22.7 (CH3), 38.6 (CH2), 54.2 (CH), 66.7 (CH), 174.7 (C); m/z (CI) 134 (MH
+, 5%), 116 
(100), 97 (13), 71 (23). 
 
 
L-2-aminoadipic acid-6-amide hydrochloride 
HO
NH2
O
O
NH2
2
3
4
5
172
·HCl
 
A stirred solution of methyl (2S)-5-cyano-2-
(trichloromethylcarbonylamino)pentanoate 164 (0.025 g, 0.08 mmol) in tert-
butanol (0.6 mL) and water (0.3 mL) was cooled to 0 °C before lithium hydroxide 
hydrate (0.008 g, 0.18 mmol) was added.  The reaction mixture was stirred at 0 °C 
for 0.25 h, and then at room temperature for 3 h before being concentrated in 
vacuo to give a pale yellow residue (0.033 g), which was then dissolved in 6 M 
hydrochloric acid (5 mL).  The reaction mixture was allowed to stir under reflux for 
24 h before being allowed to cool to room temperature and concentrated in vacuo.  
The residue was partitioned between water (20 mL) and diethyl ether (20 mL), and 
  
158 
the aqueous phase was concentrated in vacuo to give L-2-aminoadipic acid-6-amide 
hydrochloride 172 as a white solid (0.023 g, 100%).  Mp 168–172 °C; max/cm
-1 
(NaCl) 3329 (NH2), 2949 (CH), 1697 (CO), 1526, 1437, 1342, 1209, 1026, 821, 779; 
[]D
23 +10.0 (c 2.0, 1 M HCl); H (400 MHz, D2O) 1.59–1.80 (2H, m, 4-H2), 1.84–2.02 
(2H, m, 3-H2), 2.46 (2H, t, J 7.2 Hz, 5-H2), 3.88 (1H, t, J 6.0 Hz, 2-H); C (100 MHz, 
D2O) 22.7 (CH2), 32.1 (CH2), 35.9 (CH2), 56.1 (CH), 175.5 (C), 180.7 (C); m/z (CI) 
151 (8%), 135 (23), 113 (62), 85 (72), 71 (90). 
 
 
L-2-aminoadipic acid hydrochloride129 
HO
O
OH
ONH2
2
3
4
5
173
·HCl
 
The reaction was carried out according to general procedure 7, using (2S)-dimethyl 
-2-(trichloromethylcarbonylamino)hexadioate 165 (0.027 g, 0.08 mmol) in 6 M 
hydrochloric acid (5 mL), stirring under reflux for 19 h to give L-2-aminoadipic acid 
hydrochloride 173 as a pale yellow solid (0.018 g, 100%).  Mp 173–175 °C (lit.129 Mp 
170–172 °C); max/cm
-1 3366 (NH2), 2936 (CH), 1670 (CO), 1643 (CO), 1587, 1497, 
1292, 1217, 1132, 1030, 764; []D
25 +27.8 (c 0.3, 6 M HCl) (lit.129 []D
25 +23.5 (c 1.0, 
5 M HCl)); H (400 MHz, D2O) 1.63–1.84 (2H, m, 4-H2), 1.89–2.09 (2H, m, 3-H2), 2.47 
(2H, t, J 7.2 Hz, 5-H2), 4.07 (1H, t, J 6.2 Hz, 2-H); C (100 MHz, D2O) 23.0 (CH2), 
32.4 (CH2), 36.2 (CH2), 56.1 (CH), 175.5 (C), 181.0 (C); m/z (CI) 144 (100%), 107 
(19), 85 (34), 69 (50). 
 
 
5-Methyl-1-phenyloct-4-en-3-one 
O
8
7
642
1
174  
To a stirred solution of 5-phenylpent-1-en-3-one 136 (0.10 g, 0.6 mmol) in toluene 
(5 mL), 2-methyl-1-pentene (0.230 mL, 1.86 mmol) was added, followed by 
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Hoveyda-Grubbs 2nd generation catalyst L (0.078 g, 0.12 mmol).  The reaction 
mixture was heated to 80 °C and stirred for 24 h before being allowed to cool to 
room temperature and concentrated in vacuo.  Purification was carried out by silica 
column chromatography, and elution with 1:39 diethyl ether/petroleum ether gave 
(4Z)-5-methyl-1-phenyloct-4-en-3-one Z-174 as a colourless oil (0.026 g, 19%), and 
(4E)-5-methyl-1-phenyloct-4-en-3-one E-174 as a colourless oil (0.030 g, 22%).  (NB: 
1H NMR spectroscopic analysis of the crude reaction product prior to purification 
indicated a 1:2 Z:E-product ratio). 
Z-isomer: 
Rf (1:4 ethyl acetate/petroleum ether) 0.64; max/cm
-1 (neat) 2960 (CH), 1686 (CO), 
1614 (C=C), 1454, 1363, 1115, 1031, 748; H (400 MHz, CDCl3) 0.88 (3H, t, J 7.4 Hz, 
1-H3), 1.35–1.45 (2H, m, 2-H2), 1.79 (3H, d, J 1.4 Hz, 4-CH3), 2.48–2.53 (2H, m, 3-
H2), 2.64–2.69 (2H, m, 7-H2), 2.82–2.87 (2H, m, 8-H2), 5.96–5.98 (1H, m, 5-H), 7.09–
7.23 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 14.2 (CH3), 21.5 (CH2), 25.5 (CH3), 30.1 
(CH2), 35.7 (CH2), 45.8 (CH2), 123.7 (CH), 125.9 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 
141.5 (C), 159.7 (C), 199.5 (C); m/z (EI) 216.1518 (M+. C15H20O requires 216.1514), 
183 (17%), 173 (100), 145 (5), 133 (16), 111 (94), 91 (73), 84 (72), 49 (55), 47 (10). 
E-isomer: 
Rf (1:4 ethyl acetate/petroleum ether) 0.57; max/cm
-1 (neat) 3003 (CH), 1710 (CO), 
1420, 1358, 1219, 1092, 903, 785; H (400 MHz, CDCl3) 0.83 (3H, t, J 7.3 Hz, 1-H3), 
1.37–1.48 (2H, m, 2-H2), 2.02 (2H, td, J 7.6, 1.2 Hz, 3-H2), 2.06 (3H, d, J 1.2 Hz, 4-
CH3), 2.63–2.71 (2H, m, 7-H2), 2.81–2.88 (2H, m, 8-H2), 5.97 (1H, sex, J 1.2 Hz, 5-H), 
7.07–7.24 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 14.2 (CH3), 21.5 (CH2), 25.5 (CH3), 
30.1 (CH2), 35.7 (CH2), 45.9 (CH2), 123.7 (CH), 125.9 (CH), 128.3 (2 × CH), 128.4 (2 
× CH), 141.5 (C), 159.7 (C), 199.5 (C); m/z (CI) 217.1588 (MH+. C15H21O requires 
217.1592), 215 (13%), 191 (13), 151 (49), 149 (16), 133 (15), 85 (22), 69 (26). 
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(3R,4E)-5-methyl-1-phenyloct-4-en-3-ol 
OH
8
7
64
3
2
1
175  
A stirred solution of (4E)-5-methyl-1-phenyloct-4-en-3-one E-174 (0.281 g, 1.30 
mmol) and (S)-(-)-2-methyl-CBS-oxazaborolidine solution (1.0 M in toluene, 1.30 mL, 
1.30 mmol) in tetrahydrofuran (8 mL) was cooled to -20 °C before borane 
dimethylsulfide complex solution (2.0 M in toluene, 0.98 mL, 1.96 mmol) was slowly 
added.  The reaction mixture was stirred at -20 °C for 7 h before being quenched 
by the addition of methanol (6 mL) and concentrated in vacuo.  Purification was 
carried out by silica column chromatography, and elution with 3:37 diethyl 
ether/petroleum ether gave (3R,4E)-5-methyl-1-phenyl-4-en-3-ol 175 as a 
colourless oil (0.289 g, 100%).  Chiral HPLC (Chiralcel IB column) analysis using 4% 
isopropanol in hexane indicated 46% ee; Rf (1:4 ethyl acetate/petroleum ether) 
0.54; max/cm
-1 (neat) 2959 (OH), 2924, 2295 (CH) 1460, 1379, 725; []D
21 +22.0 (c 
1.0, CHCl3); H (400 MHz, CDCl3) 0.89 (3H, t, J 7.3 Hz, 1-H3), 1.38 (1H, br s, OH), 
1.39–1.51 (2H, m, 2-H2), 1.63 (3H, d, J 1.2 Hz, 4-CH3), 1.70–1.81 (1H, m, 7-HH), 
1.87–1.96 (1H, m, 7-HH), 1.98 (2H, t, J 7.4 Hz, 3-H2), 2.59–2.74 (2H, m, 8-H2), 4.38 
(1H, dt, J 8.6, 6.6 Hz, 6-H), 5.21 (1H, dq, J 8.6, 1.2 Hz, 5-H), 7.14–7.31 (5H, m, 5 × 
ArH); C (100 MHz, CDCl3) 13.7 (CH3), 16.5 (CH3), 20.8 (CH2), 31.9 (CH2), 39.3 (CH2), 
41.7 (CH2), 68.1 (CH), 125.8 (CH), 127.7 (CH), 128.3 (2 × CH), 128.4 (2 × CH), 139.2 
(C), 142.1 (C); m/z (CI) 201.1642 (MH+. C15H23O-H2O requires 201.1643), 175 (6%), 
167 (10), 85 (31), 69 (22). 
 
 
(4E)-5-methyl-1-phenyloct-4-en-3-ol 
OH
8
7
64
3
2
1
rac-175
 
The reaction was carried out according to general procedure 3, using (4E)-5-methyl-
1-phenyloct-4-en-3-one E-174 (0.050 g, 0.23 mmol) and diisobutylaluminium 
hydride solution (1.0 M in hexanes, 0.35 mL, 0.35 mmol) in toluene (4 mL).  
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Purification by silica column chromatography, eluting with 1:19 ethyl 
acetate/petroleum ether gave (4E)-5-methyl-1-phenyloct-4-en-3-ol rac-175 as a 
colourless oil (0.027 g, 54%).  For analytical data, see above compound 175. 
 
 
(3E,5S)-5-methyl-1-phenyl-5-(trichloromethylcarbonylamino)oct-3-ene 
NH
CCl3
O
177 8
6
4
3
2
1
7

A stirred solution of (3R,4E)-5-methyl-1-phenyl-4-en-3-ol 175 (0.040 g, 0.18mmol) 
in dichloromethane (4 mL) was cooled to 0 °C before 1,8-diazabicyclo[5.4.0]undec-
7-ene (0.014 mL, 0.09 mmol) was added, followed by trichloroacetonitrile (0.028 
mL, 0.28 mmol).  The reaction mixture was heated to 45 °C and allowed to stir 
under reflux for 72 h before being cooled to room temperature and filtered through 
a plug of silica, which was washed through with diethyl ether (200 mL).  The filtrate 
was then concentrated in vacuo to give the allylic trichloroacetimidate 
intermediate 176 (0.066 g), which was dissolved in toluene (5 mL).  Potassium 
carbonate (0.015 g) was added, and the reaction mixture was degassed with argon 
for 5 min before being heated to 130 °C in a sealed Shlenck tube for 72 h.  The 
mixture was then cooled to room temperature and concentrated in vacuo.  
Purification by silica column chromatography gave (3E,5S)-5-methyl-1-phenyl-5-
(trichloromethylcarbonylamino)oct-3-ene 177 as a colourless oil (0.007 g, 11% over 
2 steps).  H (400 MHz, CDCl3)  0.92 (3H, t, J 7.5 Hz, 1-H3), 1.49 (2H, q, J 7.5 Hz, 2-
H2), 1.57 (3H, s, 4-CH3), 2.12–2.19 (2H, m, 3-H2), 2.37–2.48 (2H, m, 7-H2), 2.68–2.76 
(2H, m, 8-H2), 5.74 (1H, dt, J 15.8, 6.9 Hz, 6-H), 6.09 (1H, d, J 15.8 Hz, 5-H), 7.16–
7.32 (5H, m, 5 × ArH). 
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(2S)-2-(Benzyloxycarbonylamino)-6-hydroxyhexanoic acid93 
HO
OH
O
NH
O
O
2
3
4
5
6
181
 
A stirred suspension of N2-(carbobenxyloxy)-L-lysine 180 (5.00 g, 17.8 mmol) in 
water (35 mL) was heated to 60 °C and 4 M sodium hydroxide solution was added to 
adjust the solution to pH 10 before sodium nitroferricyanide(III) dihydrate (6.64 g, 
22.3 mmol) was added slowly.  The resulting dark brown solution was stirred at 
60 °C for 7 h, while maintaining the reaction mixture between pH 8–10 using 
regular additions of 4 M sodium hydroxide solution.  The mixture was then allowed 
to cool to room temperature and filtered through a pad of Celite® and the filtrate 
was acidified to pH 1 using 2 M hydrochloric acid.  The organic layers were 
extracted using ethyl acetate (3 × 150 mL), which were then combined, dried 
(MgSO4), filtered, and concentrated in vacuo to give (2S)-2-
(benzyloxycarbonylamino)-6-hydroxyhexanoic acid 181 as a green oil (5.29 g), 
which was used without further purification.  H (400 MHz, CDCl3) 1.40–1.90 (6H, m, 
3-H2, 4-H2 and 5-H2), 3.65 (2H, t, J 5.6 Hz, 6-H2), 4.38–4.44 (1H, m, 2-H), 5.11 (2H, 
s, OCH2C6H5), 5.44 (1H, d, J 8.0 Hz, NH), 7.30–7.37 (5H, m, 5 × ArH). 
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Methyl (2S)-2-(benzyloxycarbonylamino)-6-hydroxyhexanoate130 
HO
OMe
O
NH
O
O
2
3
4
5
6
182  
Concentrated hydrochloric acid (3.8 mL) was added slowly to a stirred solution of 
(2S)-2-(benzyloxycarbonylamino)-6-hydroxyhexanoic acid 181 (5.29 g, 18.8 mmol) 
in toluene (130 mL) and methanol (95 mL).  The reaction mixture was heated to 
90 °C and stirred for 18 h before being allowed to cool to room temperature.  The 
mixture was then neutralised by the addition of a saturated aqueous solution of 
sodium hydrogen carbonate and the organic solvent was removed in vacuo.  The 
organic layers were then extracted using ethyl acetate (3 × 150 mL) and the 
combined organic phases were dried (MgSO4), filtered, and concentrated in vacuo.  
Purification was carried out by silica column chromatography, and elution with 
ethyl acetate gave methyl (2S)-2-(benzyloxycarbonylamino)-6-hydroxyhexanoate 
182 as a yellow oil (2.80 g, 53% over 2 steps).  max/cm
-1 (NaCl) 3433 (NH/OH), 3019 
(CH), 2953 (CH), 1718 (CO), 1510, 1216, 1058, 755; []D
25 +12.5 (c 1.0, CHCl3); H 
(400 MHz, CDCl3) 1.38–1.88 (6H, m, 3-H2, 4-H2 and 5-H2), 3.63 (2H, t, J 6.4 Hz, 6-H2), 
3.74 (3H, s, OCH3), 4.36–4.42 (1H, m, 2-H), 5.11 (2H, s, OCH2C6H5), 5.33 (1H, d, J 
8.0 Hz, NH), 7.29–7.36 (5H, m, 5 × ArH); C (100 MHz, CDCl3) 21.5 (CH2), 32.0 (CH2), 
32.5 (CH2), 52.4 (CH3), 53.7 (CH), 62.4 (CH2), 67.0 (CH2), 128.1 (CH), 128.2 (2 × CH), 
128.6 (2 × CH), 136.2 (C), 156.0 (C), 173.0 (C); m/z (EI) 295.1420 (M+. C15H21NO5 
requires 295.1417), 263 (6%), 236 (66), 192 (89), 143 (19), 91 (100), 85 (32), 65 (17). 
 
 
 
 
 
 
 
  
164 
Methyl (2S)-2-(benzyloxycarbonylamino)-6-oxohexanoate 
O
H
O
O
NH
O
O
2
3
4
5
187  
 
A stirred solution of oxalyl chloride (0.055 mL, 0.65 mmol) in dichloromethane (2 
mL) was cooled to -78 °C, and dimethylsulfoxide (0.090 mL, 1.27 mmol) was added 
dropwise.  The mixture was stirred at -78 °C for 0.25 h and then a solution of (2S)-
2-(benzyloxycarbonylamino)-6-hydroxyhexanoate 182 (0.150 g, 0.51 mmol) in 
dichloromethane (3 mL) was added.  The mixture was stirred at -78 °C for a further 
0.25 h before triethylamine (0.355 mL, 2.55 mmol) was added.  The reaction 
mixture was stirred at -78 °C for 1 h, and then at room temperature for 4 h before 
being concentrated in vacuo.  The residue was then dissolved in dichloromethane 
(50 mL) and washed with 1 M hydrochloric acid (50 mL) and water (50 mL).  The 
organic layer was then dried (MgSO4), filtered, and concentrated in vacuo to give 
methyl (2S)-2-(benzyloxycarbonylamino)-6-oxohexanoate 187 as a yellow oil (0.129 
g), which was used immediately without further purification.  H (400 MHz, CDCl3) 
1.64–1.73 (3H, m, 3-HH and 4-H2), 1.79–1.92 (1H, m, 3-HH), 2.42–2.53 (2H, m, 5-H2), 
3.75 (3H, s, OCH3), 4.35–4.43 (1H, m, 2-H), 5.11 (2H, s, CH2C6H5), 5.33 (1H, d, J 8.5 
Hz, NH), 7.30–7.38 (5H, m, 5 × ArH), 9.75 (1H, s, CHO). 
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1-Methyl 8-ethyl (2S)-2-(benzyloxycarbonylamino)oct-6-enedioate 
OMe
O
NH
O
O
EtO
O
2
3
4
5
6
7
188  
A suspension of oven-dried lithium chloride (0.054 g, 1.27 mmol) in acetonitrile (5 
mL) was stirred for 0.2 h before triethyl phosphonoacetate (0.255 mL, 1.29 mmol) 
was added, followed by 1,8-diazabicyclo[5.4.0]undec-7-ene (0.190 mL, 1.27 mmol).   
The mixture was stirred at room temperature for 0.75 h before being added to 
methyl (2S)-2-(benzyloxycarbonylamino)-6-oxohexanoate 187 (0.129 g).  The 
reaction mixture was then stirred at room temperature for 20 h before being 
quenched by the addition of a saturated aqueous solution of ammonium chloride 
(20 mL).  The organic solvent was removed in vacuo and then water (50 mL) and 
ethyl acetate (100 mL) were added to the flask.  The layers were separated and the 
organic layers were further extracted with ethyl acetate (2 × 50 mL).  The 
combined organic phases were then dried (MgSO4), filtered, and concentrated in 
vacuo.  Purification was carried out by silica column chromatography, and elution 
with 1:4 ethyl acetate/petroleum ether gave 1-methyl 8-ethyl (2S)-2-
(benzyloxycarbonylamino)oct-6-ene-dioate 188 as a colourless oil (0.086 g, 47% 
over 2 steps).  max/cm
-1 (neat) 3329 (NH), 2953 (CH), 1713 (CO), 1524, 1456, 1206, 
1043, 739; []D
25 +14.5 (c 1.0, CHCl3); H (400 MHz, CDCl3) 1.22 (3H, t, J 7.1 Hz, 
OCH2CH3), 1.36–1.52 (2H, m, 4-H2), 1.54–1.66 (1H, m, 3-HH), 1.73–1.87 (1H, m, 3-
HH), 2.07–2.23 (2H, m, 5-H2), 3.68 (3H, s, OCH3), 4.12 (2H, q, J 7.1 Hz, OCH2CH3), 
4.27–4.37 (1H, m, 2-H), 5.04 (2H, s, CH2C6H5), 5.22 (1H, d, J 7.8 Hz, NH), 5.74 (1H, 
d, J 15.6 Hz, 7-H), 6.83 (1H, dt, J 15.6, 7.0 Hz, 6-H), 7.22–7.33 (5H, m, 5 × ArH); C 
(100 MHz, CDCl3) 14.3 (CH3), 23.7 (CH2), 31.5 (CH2), 32.3 (CH2), 52.5 (CH3), 53.6 
(CH), 60.3 (CH2), 67.1 (CH2), 122.0 (CH), 128.2 (CH), 128.3 (2 × CH), 128.6 (2 × CH), 
136.2 (C), 147.9 (CH), 155.9 (C), 166.6 (C), 172.8 (C); m/z (CI) 364.1758 (MH+. 
C19H26NO6 requires 364.1760), 363 (5%), 320 (16), 276 (5), 256 (12), 207 (56), 206 
(27), 191 (12), 151 (15), 83 (14). 
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Dimethyl (2S)-N-(tert-butoxycarbonyl)-2-aminobutane-1,4-dioate101 
OMe
O
MeO
O HN
O
O
192  
A stirred suspension of L-aspartic acid 191 (3.00 g, 22.5 mmol) in methanol (60 mL) 
was cooled to 0 °C before chlorotrimethylsilane (12.6 mL, 99.2 mmol) was added 
dropwise.  The reaction mixture was stirred at 0 °C for 0.1 h and then at room 
temperature for 24 h before being cooled again to 0 °C.  Triethylamine (20.0 mL, 
143 mmol) was added slowly, followed by di-tert-butyl dicarbonate (5.40 g, 24.8 
mmol).  The reaction mixture was stirred at room temperature for a further 2 h 
before being concentrated in vacuo.  The residue was suspended in diethyl ether 
(100 mL) and filtered, and the filtrate was concentrated in vacuo.  Purification was 
carried out by silica column chromatography, and elution with 1:3 ethyl 
acetate/petroleum ether gave dimethyl (2S)-N-(tert-butoxycarbonyl)-2-
aminobutane-1,4-dioate 192 as a white solid (4.85 g, 82%).  Mp 62–65 °C; max/cm
-1 
(neat) 2980 (CH), 1738 (CO), 1701 (CO), 1501, 1346, 1215, 1157, 1032, 997, 783; 
[]D
25 +39.5 (c 1.0, CHCl3) (lit.
101 []D
25 +35.8 (c 1.0, CHCl3)); H (400 MHz, CDCl3) 
1.45 (9H, s, C(CH3)3), 2.83 (1H, dd, J 16.9, 4.5 Hz, 3-HH), 3.01 (1H, dd, J 16.9, 4.1 
Hz, 3-HH), 3.70 (3H, s, OCH3), 3.76 (3H, s, OCH3), 4.53–4.64 (1H, m, 2-H), 5.49 (1H, 
br d, J 7.3 Hz, NH); C (100 MHz, CDCl3) 28.3 (3 × CH3), 36.7 (CH2), 49.9 (CH), 52.1 
(CH3), 52.8 (CH3), 80.2 (C), 155.4 (C), 171.5 (C), 171.6 (C); m/z (CI) 262.1293 (MH
+. 
C11H20NO6 requires 262.1291), 206 (100%), 162 (29), 113 (7), 97 (6), 85 (14), 69 (16). 
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N-Benzylidenebenzenesulfonamide131 
N
S
OO
202
 
Benzenesulfonamide 201 (15.0 g, 95.4 mmol) was added to a flask containing 
Amberlyst 15 ion-exchange resin (0.190 g), 5 Å molecular sieves, and toluene (75 
mL).  Benzaldehyde (9.90 mL, 97.5 mmol) was added, and the reaction mixture was 
stirred under Dean-Stark condensation conditions for 27 h.  The mixture was then 
allowed to cool to room temperature without stirring, and filtered.  The filtrate 
was concentrated in vacuo, and pentane (80 mL) was added to the orange residue.  
The flask was cooled in the refrigerator overnight, upon which a precipitate formed, 
which was then separated by filtration and washed with pentane (2 × 20 mL).  The 
solid was then dissolved in ethyl acetate (10 mL) with heating and then pentane (30 
mL) was added slowly, upon which the solid product began to precipitate.  The 
suspension was allowed to stand for 2 h before being filtered, and the solid was 
washed with pentane (30 mL) and air-dried to give N-
benzylidenebenzenesulfonamide 202 as a pale brown solid (12.1 g, 52%).  Mp 70–
73 °C (lit.131 Mp 76–80 °C); max/cm
-1 (neat) 3059 (CH), 1697, 1597, 1570, 1447, 
1312, 1155, 1088, 1001, 866, 748; H (400 MHz, CDCl3) 7.45–7.68 (6H, m, 6 × ArH), 
7.94 (2H, d, J 7.8 Hz, 2 × ArH), 8.02 (2H, d, J 7.3 Hz, 2 × ArH), 9.07 (1H, s, 
CHC6H5); C (100 MHz, CDCl3) 128.0 (2 × CH), 129.1 (2 × CH), 129.2 (2 × CH), 131.4 
(2 × CH), 132.3 (C), 133.6 (CH), 135.1 (CH), 138.2 (C), 170.6 (CH); m/z (EI) 
245.0510 (M+. C13H12NO2S requires 245.0511), 214 (8%), 181 (14), 141 (89), 104 (52), 
77 (100), 51 (32), 49 (26). 
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(±)-trans-2-(Phenylsulfonyl)-3-phenyloxaziridine131 
N
O
S
O O
H
193
 
N-Benzylidenebenzenesulfonamide 202 (9.84 g, 40.1 mmol) was dissolved in 
chloroform (30 mL), and a saturated aqueous solution of sodium hydrogen 
carbonate (40 mL) was added, followed by benzyl triethylammonium chloride (1.01 
g, 4.41 mmol).  The mixture was cooled to 0 °C, then a solution of m-
chloroperoxybenzoic acid (7.61 g, 44.1 mmol) in chloroform (80 mL) was added 
dropwise over 0.3 h and the reaction mixture was stirred at 0 °C for 1.5 h.  The 
mixture was allowed to warm to room temperature and then washed with water (70 
mL), 10% aqueous sodium sulfite solution (100 mL), water (2 × 70 mL) and a 
saturated aqueous solution of sodium chloride (30 mL) before being dried over 
anhydrous potassium carbonate for 1.5 h, filtered, and concentrated in vacuo 
(rotary evaporator water bath temperature maintained below 40 °C).  The white 
solid residue was then dissolved in minimal ethyl acetate (~80 mL), and the solution 
was filtered through fluted filter paper.  Pentane (40 mL) was added, and the 
solution was cooled in the refrigerator overnight, upon which a white precipitate 
formed.  The precipitate was collected by filtration, washed with pentane (20 mL) 
and air-dried for 1 h to give (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine 193 as 
a white solid (4.15 g).  The filtrate was then partially concentrated in vacuo and 
cooled in the refrigerator, upon which a yellow precipitate formed which was 
collected by filtration.  Diethyl ether (6 mL) was added to this solid, followed by 
pentane (8 mL), and the precipitate formed was collected by filtration and air-
dried to give a second batch of (±)-trans-2-(phenylsulfonyl)-3-phenyloxaziridine 193 
as a white solid (3.48 g, 73% total yield).  Mp 91–93 °C (lit.131 Mp 92–94 °C); 
max/cm
-1 (neat) 3354, 2513 (CH), 1906, 1447, 1348, 1233, 1167, 1086, 829, 760; H 
(400 MHz, CDCl3) 5.50 (1H, s, CHC6H5), 7.37–7.51 (5H, m, 5 × ArH), 7.64 (2H, t, J 7.9 
Hz, 2 × ArH), 7.76 (1H, t, J 7.2 Hz, ArH), 8.06 (2H, d, J 7.9 Hz, 2 × ArH); C (100 
MHz, CDCl3) 76.3 (CH), 128.3 (2 × CH), 128.8 (CH), 129.1 (CH), 129.4 (2 × CH), 129.5 
(CH), 129.8 (CH), 130.5 (C), 131.5 (CH), 134.7 (C), 135.1 (CH); m/z (CI) 262.0534 
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(MH+. C13H12NO3S requires 262.0538), 246 (100%), 183 (5), 158 (39), 143 (21), 106 
(66), 85 (12), 71 (15). 
 
 
Dimethyl (2S,3R)-N-(tert-butoxycarbonyl)-2-amino-3-hydroxybutane-1,4-
dioate132 
OMe
O
MeO
O HN
OH
O
O
2
3
anti-194  
A stirred solution of dimethyl (2S)-N-(tert-butoxycarbonyl)-2-aminobutane-1,4-
dioate 192 (0.460 g, 1.75 mmol) and (±)-trans-2-(phenylsulfonyl)-3-
phenyloxaziridine 193 (0.690 g, 2.64 mmol) in tetrahydrofuran (7 mL) was cooled to 
-78 °C before sodium bis(trimethylsilyl)amide solution (1.0 M in tetrahydrofuran, 
5.30 mL, 5.30 mmol) was added dropwise.  The reaction mixture was stirred at -
78 °C for 24 h before being quenched by the addition of a saturated aqueous 
solution of ammonium chloride (20 mL).  The organic layers were extracted using 
diethyl ether (2 × 50 mL) and then dried (MgSO4), filtered, and concentrated in 
vacuo.  Purification was carried out by silica column chromatography, and elution 
with 7:13 ethyl acetate/petroleum ether gave dimethyl (2S,3R)-N-(tert-
butoxycarbonyl)-2-amino-3-hydroxybutane-1,4-dioate anti-194 as a colourless oil 
(0.098 g, 20%).  max/cm
-1 (neat) 3370 (OH), 2957 (CH), 1708 (CO), 1508, 1364, 1221, 
1163, 1059, 1017, 723; []D
25 -33.9; H (400 MHz, CDCl3) 1.25 (1H, br s, OH), 1.43 
(9H, s, OC(CH3)3), 3.82 (3H, s, OCH3), 3.83 (3H, s, OCH3), 4.70 (1H, d, J 4.5 Hz, 3-H), 
4.79 (1H, d, J 8.8 Hz, 2-H), 5.28 (1H, br d, NH); C (100 MHz, CDCl3) 28.2 (3 × CH3), 
53.0 (CH3), 53.3 (CH3), 56.1 (CH), 71.0 (CH), 80.4 (C), 155.3 (C), 169.9 (C), 172.5 
(C); m/z (CI) 278 (MH+, 8%), 246 (6), 222 (100), 220 (8), 178 (34), 158 (21), 123 (6), 
106 (7), 85 (11), 71 (12). 
Also isolated from the column was dimethyl (2S,3S)-N-(tert-butoxycarbonyl)-2-
amino-3-hydroxybutane-1,4-dioate syn-194 as a colourless oil (0.094 g, 19%).  
max/cm
-1 (neat) 2957 (CH), 1748 (CO), 1420, 1360, 1221, 1165, 1092, 1019, 723; 
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[]D
25 +3.7 (c 0.9, CHCl3); H (400 MHz, CDCl3) 1.25 (1H, br s, OH), 1.46 (9H, s, 
OC(CH3)3), 3.75 (3H, s, OCH3), 3.84 (3H, s, OCH3), 4.54 (1H, br s, 3-H), 4.86 (1H, d, 
J 7.7 Hz, 2-H), 5.52 (1H, br d, NH); C (100 MHz, CDCl3) 28.3 (3 × CH3), 52.8 (CH3), 
53.0 (CH3), 57.1 (CH), 72.2 (CH), 80.7 (C), 155.6 (C), 169.1 (C), 172.0 (C); m/z (CI) 
278 (MH+, 4%), 262 (15), 222 (100), 204 (10), 178 (65), 158 (46), 122 (30), 71 (29). 
  
 
(R)-N-(tert-Butoxycarbonyl)-D-serine133 
HO OH
O
NH
O
O
2
3
211  
A stirred solution of D-serine 129 (4.77 g, 45.4 mmol) in 1,4-dioxane (40 mL) and 
1.0 M aqueous sodium hydroxide solution (90 mL, 90.0 mmol) was cooled to 0 °C 
before di-tert-butyl dicarbonate (11.9 g, 54.5 mmol) was added slowly.  The 
reaction mixture was stirred at 0 °C for 0.25 h and then at room temperature for 6 
h before the organic solvent was removed in vacuo (maintaining water bath 
temperature at 35 °C).  The remaining aqueous phase was acidified to pH 2 using 
2.5 M sulfuric acid, and the organic layers were extracted using ethyl acetate (3 × 
100 mL).  The combined organic phases were then dried (MgSO4), filtered, and 
concentrated in vacuo to give (R)-N-(tert-butoxycarbonyl)-D-serine 211 as a 
colourless oil (11.28 g), which was used without further purification.  max/cm
-1 
(neat) 3021 (NH), 1707 (CO), 1506, 1420, 1215, 1167, 742; []D
23 -0.6 (c 1.0, CHCl3); 
H (400 MHz, CDCl3) 1.46 (9H, s, C(CH3)3), 3.86 (1H, d, J 11.1 Hz, 3-HH), 3.96–4.14 
(1H, m, 3-HH), 4.29–4.44 (1H, m, 2-H), 5.71 (1H, d, J 6.6 Hz, NH); C (100 MHz, 
CDCl3) 28.3 (3 × CH3), 55.4 (CH), 63.0 (CH2), 80.9 (C), 156.4 (C), 173.8 (C); m/z (CI) 
206.1029 (MH+. C8H16NO5 requires 206.1028), 188 (9%), 150 (100), 132 (6), 106 (20), 
104 (6), 71 (8). 
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Methyl (2R)-2-tert-butoxycarbonylamino-3-hydroxypropionate134 
O OH
O
NH
O
O
2
3
203  
A stirred solution of crude (R)-N-(tert-butoxycarbonyl)-D-serine 211 (11.28 g) in 
N,N-dimethylformamide (70 mL) was cooled to 0 °C before potassium carbonate 
(6.91 g, 50.0 mmol) was added, followed by methyl iodide (5.70 mL, 91.6 mmol).  
The reaction mixture was stirred at 0 °C for 0.2 h, and then at room temperature 
for 20 h before being concentrated in vacuo.  The residue was partitioned between 
water (100 mL) and ethyl acetate (100 mL) and the layers were separated.  The 
organic layers were extracted further with ethyl acetate (2 × 100 mL) and the 
combined organic phases were dried (MgSO4), filtered, and concentrated in vacuo 
to give methyl (2R)-2-tert-butoxycarbonylamino-3-hydroxypropionate 203 as a 
yellow oil (10.73 g), which was used without further purification.  H (400 MHz, 
CDCl3) 1.46 (9H, s, C(CH3)3), 3.79 (3H, s, OCH3), 3.86–4.03 (2H, m, 3-H2), 4.34–4.44 
(1H, m, 2-H), 5.40–5.58 (1H, m, NH); C (100 MHz, CDCl3) 28.3 (3 × CH3), 52.7 (CH3), 
55.7 (CH), 63.7 (CH2), 80.4 (C), 155.8 (C), 171.2 (C); m/z (CI) 220.1187 (MH
+. 
C9H18NO5 requires 220.1185), 164 (100%), 146 (18), 120 (28), 107 (27), 85 (12), 73 
(18). 
 
 
Methyl (2R)-2-tert-butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] 
propionate135 
O
O O
Si
NH
O
O
2
3
212  
To a stirred solution of crude methyl (2R)-2-tert-butoxycarbonylamino-3-
hydroxypropionate 203 (10.73 g) in N,N-dimethylformamide (70 mL), imidazole 
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(4.33 g, 63.6 mmol) was added, followed by tert-butyldimethylsilyl chloride (8.30 g, 
55.1 mmol).  The reaction mixture was stirred at room temperature for 20 h before 
being concentrated in vacuo.  The residue was partitioned between water (100 mL) 
and ethyl acetate (150 mL), the layers were separated and the organic layers were 
further extracted with ethyl acetate (2 × 150 mL).  The combined organic phasess 
were then dried (MgSO4), filtered, and concentrated in vacuo.  Purification was 
carried out by silica column chromatography, and elution with 1:19 ethyl 
acetate/petroleum ether gave methyl (2R)-2-tert-butoxycarbonylamino-3-[(tert-
butyldimethylsilyl)oxy] propionate 212 as a colourless oil (11.29 g, 75% over 3 
steps).   []D
23 -16.1 (c 1.0, CHCl3) (lit.
135 []D
23 -19.2 (c 1.34, CHCl3)); H (400 MHz, 
CDCl3) 0.02 (3H, s, SiCH3), 0.04 (3H, s, SiCH3), 0.86 (9H, s, SiC(CH3)3), 1.46 (9H, s, 
OC(CH3)3), 3.74 (3H, s, OCH3), 3.82 (1H, dd, J 10.0, 2.8 Hz, 3-HH), 4.05 (1H, dd, J 
10.0, 2.8 Hz, 3-HH), 4.36 (1H, dt, J 8.8 Hz, 2.8 Hz, 2-H), 5.35 (1H, d, J 8.8 Hz, NH); 
C (100 MHz, CDCl3) -5.6 (CH3), -5.5 (CH3), 18.2 (C), 25.7 (3 × CH3), 28.4 (3 × CH3), 
52.3 (CH3), 55.6 (CH), 63.8 (CH2), 79.9 (C), 155.5 (C), 171.3 (C); m/z (CI) 334.2051 
(MH+. C15H32NO5Si requires 334.2050), 278 (100%), 220 (17), 85 (6), 69 (7). 
 
 
(2S)-2-tert-Butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] propan-1-ol 
HO O
Si
NH
O
O
1
2
3
204  
A stirred solution of methyl (2R)-2-tert-butoxycarbonylamino-3-[(tert-
butyldimethylsilyl)oxy] propionate 212 (1.45 g, 4.35 mmol) in diethyl ether (30 mL) 
was cooled to -78 °C before diisobutylaluminium hydride solution (1.0 M in hexanes, 
9.50 mL, 9.50 mmol) was added dropwise.  The reaction mixture was stirred at -
78 °C for 1 h and then at room temperature for 18 h before being quenched by the 
addition of a saturated aqueous solution of ammonium chloride (5 mL) at 0 °C.  The 
mixture was stirred at 0 °C for 0.5 h and then at room temperature for 0.5 h before 
being filtered through a pad of Celite® and washed with diethyl ether (200 mL).  
The filtrate was washed with water (3 × 50 mL) and then dried (MgSO4), filtered, 
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and concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 3:17 ethyl acetate/petroleum ether gave (2S)-2-
tert-butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy]-propan-1-ol 204 as a 
colourless oil (0.615 g, 46%).  max/cm
-1 (neat) 3449 (OH), 2930 (CH), 1692 (CO), 
1501, 1366, 1252, 1169, 1051, 833, 775; []D
23 -9.8 (c 1.0, CHCl3); H (400 MHz, 
CDCl3) 0.08 (6H, s, 2 × SiCH3), 0.90 (9H, s, SiC(CH3)3), 1.45 (9H, s, OC(CH3)3), 2.58–
2.80 (1H, br s, OH), 3.62–3.72 (2H, m, 2-H and 3-HH), 3.77–3.90 (3H, m, 3-HH and 
1-H2); C (100 MHz, CDCl3) -5.6 (2 × CH3), 18.2 (C), 25.8 (3 × CH3), 28.4 (3 × CH3), 
52.5 (CH), 64.2 (2 × CH2), 79.6 (C), 156.0 (C); m/z (CI) 306.2097 (MH
+. C14H32NO4Si 
requires 306.2101), 301 (11%), 250 (26), 232 (16), 196 (8), 195 (5), 169 (5), 155 (6), 
127 (8), 113 (31), 85 (63), 73 (100). 
 
 
(2S)-2-tert-Butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] propan-1-al 
O
H
O
Si
NH
O
O
2
3
213  
A stirred solution of oxalyl chloride (0.69 mL, 8.18 mmol) in dichloromethane (50 
mL) was cooled to -78 °C before dimethylsulfoxide (1.16 mL, 16.4 mmol) was added 
dropwise.  The reaction mixture was stirred at -78 °C for 0.25 h and then a solution 
of (2S)-2-tert-butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] propan-1-ol 204 
(2.08 g, 6.82 mmol) in dichloromethane (20 mL) was slowly added.  The reaction 
was stirred at -78 °C for 0.5 h and then triethylamine (4.75 mL, 34.1 mmol) was 
added.  The reaction mixture was stirred again at -78 °C for 0.5 h and then at room 
temperature for 6 h before being concentrated in vacuo to give crude (2S)-2-tert-
butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] propan-1-al 213 as a yellow 
residue, which was used without further purification. 
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Ethyl (2E,4S)-4-tert-butoxycarbonylamino-5-[(tert-butyldimethylsilyl)oxy] pent-
2-enoate136 
EtO O
Si
NH
O
O
O
2
3
4
5
205  
To a stirred suspension of oven-dried lithium chloride (0.723 g, 17.0 mmol) in 
acetonitrile (70 mL), 1,8-diazabicyclo[5.4.0]undec-7-ene (2.55 mL, 17.0 mmol) was 
added, followed by triethyl phosphonoacetate (3.40 mL, 17.0 mmol).  The mixture 
was stirred at room temperature for 1 h before being added to the crude aldehyde, 
(2S)-2-tert-butoxycarbonylamino-3-[(tert-butyldimethylsilyl)oxy] propan-1-al 213.  
The reaction mixture was then stirred at room temperature for 24 h before being 
quenched by the addition of a saturated aqueous solution of ammonium chloride 
(30 mL).  The organic solvent was removed in vacuo, and the organic layers were 
extracted using ethyl acetate (3 × 150 mL).  The combined organic phases were 
then dried (MgSO4), filtered, and concentrated in vacuo.  Purification was carried 
out by silica column chromatography, and elution with 1:19 ethyl 
acetate/petroleum ether gave ethyl (2E,4S)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy] pent-2-enoate 205 as a colourless oil (1.94 g, 76%).  []D
23 
+3.0 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.04 (3H, s, SiCH3), 0.05 (3H, s, SiCH3), 0.88 
(9H, s, SiC(CH3)3), 1.28 (3H, t, J 7.1 Hz, OCH2CH3), 1.45 (9H, s, OC(CH3)3), 3.66–3.76 
(2H, m, 5-H2), 4.19 (2H, q, J 7.1 Hz, OCH2CH3), 4.31–4.42 (1H, m, 4-H), 4.92 (1H, d, 
J 6.8 Hz, NH), 5.96 (1H, dd, J 15.7, 1.8 Hz, 2-H), 6.91 (1H, dd, J 15.7, 5.2 Hz, 3-H); 
C (100 MHz, CDCl3) -5.4 (2 × CH3), 14.2 (CH3), 18.3 (C), 25.8 (3 × CH3), 28.2 (C), 
28.4 (3 × CH3), 60.4 (CH2), 64.7 (CH2), 77.2 (CH), 122.0 (CH), 146.4 (CH), 155.2 (C), 
166.2 (C); m/z (CI) 374.2367 (MH+. C18H36NO5Si requires 374.2363), 319 (100%), 257 
(12), 118 (7), 85 (8), 69 (10). 
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(2E,4S)-4-tert-Butoxycarbonylamino-5-[(tert-butyldimethylsilyl)oxy] pent-2-en-
1-ol 
HO O
Si
NH
O
O
1
2
3
4
5
206
 
 
A stirred solution of ethyl (2E,4S)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy] pent-2-enoate 205 (3.19 g, 8.54 mmol) in dichloromethane 
(100 mL) was cooled to -78 °C before boron trifluoride diethyl etherate (2.00 mL, 
11.6 mmol) was added dropwise.  The mixture was stirred at -78 °C for 0.5 h before 
diisobutylaluminium hydride solution (1.0 M in hexanes, 25.5 mL, 25.5 mmol) was 
added dropwise.  The reaction mixture was then stirred at -78 °C for 3 h before 
being quenched by the addition of 5.0 M acetic acid solution in dichloromethane (30 
mL).  The mixture was poured into 10% aqueous tartaric acid solution (100 mL), and 
the organic layers were extracted using dichloromethane (2 × 200 mL).  The 
combined organic phases were washed with a saturated aqueous solution of sodium 
hydrogen carbonate (150 mL) before being dried (MgSO4), filtered, and 
concentrated in vacuo.  Purification was carried out by silica column 
chromatography, and elution with 1:3 ethyl acetate/petroleum ether gave (2E,4S)-
4-tert-butoxycarbonylamino-5-[(tert-butyldimethylsilyl)oxy] pent-2-en-1-ol 206 as a 
colourless oil (2.20 g, 78%).  max/cm
-1 (neat) 3451 (OH), 2930 (CH), 1701 (CO), 1499, 
1368, 1254, 1171, 1111, 909, 837, 733; []D
21 +2.8 (c 1.0, CHCl3); H (400 MHz, 
CDCl3) 0.04 (3H, s, SiCH3), 0.05 (3H, s, SiCH3), 0.89 (9H, s, SiC(CH3)3), 1.45 (9H, s, 
OC(CH3)3), 3.61 (1H, dd, J 10.0, 4.2 Hz, 5-HH), 3.69 (1H, dd, J 10.0, 4.4 Hz, 5-HH), 
4.16 (2H, dt, J 5.3, 1.3 Hz, 1-H2), 4.17–4.24 (1H, m, 4-H), 4.76–4.93 (1H, br, NH), 
5.71 (1H, ddt, J 15.6, 5.7, 1.3 Hz, 3-H), 5.84 (1H, dtd, J 15.6, 5.3, 1.3 Hz, 2-H); C 
(100 MHz, CDCl3) -5.4 (CH3), -5.4 (CH3), 18.3 (C), 25.9 (3 × CH3), 28.4 (3 × CH3), 
63.1 (CH2), 65.4 (CH2), 77.2 (CH), 79.4 (C), 130.0 (CH), 130.5 (CH), 155.4 (C); m/z 
(CI) 332.2253 (MH+. C16H34NO4Si requires 332.2257), 314 (6%), 277 (100), 259 (23), 
225 (16), 213 (24), 159 (7), 133 (10), 113 (21), 81 (52), 69 (77). 
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(3R,4S)-3-(trichloromethylcarbonylamino)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy] pent-1-ene and (3S,4S)-3-
(trichloromethylcarbonylamino)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy] pent-1-ene41 
O
NH
Si
O
O
NH
CCl3
O
1
2
3
4
5
O
NH
Si
O
O
NH
CCl3
O
1
2
3
4
5
+
syn-207 anti-207  
The trichloroacetimidate formation reaction was set up according to general 
procedure 4, using (2E,4S)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy]-pent-2-en-1-ol 206 (0.100 g, 0.30 mmol), 1,8-
diazabicyclo[5.4.0]undec-7-ene (0.023 mL, 0.15 mmol) and trichloroacetonitrile 
(0.045 mL, 0.45 mmol) in dichloromethane (4 mL), stirring at room temperature for 
5 h to give the desired allylic trichloroacetimidate intermediate 214 (0.138 g).  H 
(400 MHz, CDCl3) 0.04 (3H, s, SiCH3), 0.05 (3H, s, SiCH3), 0.88 (9H, s, SiC(CH3)3), 
1.45 (9H, s, OC(CH3)3), 3.61–3.73 (2H, m, 5-H2), 4.12–4.32 (1H, m, 4-H), 4.75–4.93 
(3H, m, 1-H2 and NH), 5.82–5.90 (2H, m, 2-H and 3-H), 8.30 (1H, s, NH).  This was 
then dissolved in dichloromethane (5 mL), and (S)-(+)-COP-Cl (0.013 g, 0.01 mmol) 
was added.  The reaction mixture was heated to 38 °C and stirred under reflux for 
46 h before further (S)-(+)-COP-Cl (0.013 g, 0.01 mmol) was added.  The reaction 
was stirred at 38 °C for 44 h before a final addition of (S)-(+)-COP-Cl (0.009 g, 0.006 
mmol) was added.  The reaction was stirred at 38 °C for a further 71 h before being 
filtered through a pad of Celite®, which was washed through with diethyl ether (50 
mL).  The filtrate was concentrated in vacuo, and purification was carried out by 
silica column chromatography.  Elution with 3:37 diethyl ether/petroleum ether 
gave (3R,4S)-3-(trichloromethylcarbonylamino)-4-tert-butoxycarbonylamino-5-
[(tert-butyldimethylsilyl)oxy]-pent-1-ene and (3S,4S)-3-
(trichloromethylcarbonylamino)-4-tert-butoxycarbonylamino-5-[(tert-
butyldimethylsilyl)oxy]-pent-1-ene 207 (0.109 g, 76% total yield over 2 steps).  1H 
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NMR spectroscopic analysis prior to purification indicated approximately 4.7:1 
(3S,4S):(3R,4S) ratio of product diastereoisomers. 
(3S,4S)-diastereoisomer (anti-207):41 
Mp 83–87 °C; max/cm
-1 (neat) 3347 (NH), 2930 (CH), 1697 (CO), 1684 (CO), 1514, 
1252, 1169, 1096, 1055, 833; []D
21 +4.0 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.11 (6H, 
s, 2 × SiCH3), 0.91 (9H, s, SiC(CH3)3), 1.45 (9H, s, OC(CH3)3), 3.74 (1H, dd, J 10.1, 
3.8 Hz, 5-HH), 3.82–3.94 (2H, m, 4-H and 5-HH), 4.65–4.74 (1H, m, 3-H), 4.95 (1H, 
br d, J 7.4 Hz, NH), 5.26–5.35 (2H, m, 1-H2), 5.81 (1H, ddd, J 17.2, 10.5, 5.2 Hz, 2-
H), 8.24 (1H, br d, J 7.2 Hz, NH); C (100 MHz, CDCl3) -5.4 (CH3), -5.3 (CH3), 18.5 
(C), 26.0 (3 × CH3), 28.3 (3 × CH3), 53.0 (CH), 56.6 (CH), 63.4 (CH2), 80.4 (C), 92.9 
(C), 117.3 (CH2), 133.1 (CH), 156.0 (C), 161.8 (C); m/z (CI) 475.1346 (MH
+. 
C19H34
35Cl3N2O4Si requires 475.1353) 421 (100%), 419 (96), 385 (37), 375 (30), 341 
(15), 274 (13), 218 (32), 174 (12), 133 (8), 85 (15). 
(3R,4S)-diastereoisomer (syn-207): 
Mp 97–102 °C; max/cm
-1 (neat) 3325 (NH), 2930 (CH), 1688 (CO), 1530, 1366, 1250, 
1165, 1115, 1055, 831, 775; []D
25 +2.3 (c 1.0, CHCl3); H (400 MHz, CDCl3) 0.07 (3H, 
s, SiCH3), 0.08 (3H, s, SiCH3), 0.92 (9H, s, SiC(CH3)3), 1.44 (9H, s, OC(CH3)3), 3.66–
3.75 (2H, m, 4-H and 5-HH), 3.80 (1H, dd, J 9.9, 2.5 Hz, 5-HH), 4.45 (1H, dt, J 9.1, 
7.6 Hz, 3-H), 5.11 (1H, br d, J 7.6 Hz, NH), 5.32 (1H, d, J 10.2 Hz, 1-HH), 5.41 (1H, 
d, J 17.1 Hz, 1-HH), 5.69 (1H, ddd, J 17.1, 10.2, 7.5 Hz, 2-H), 7.95 (1H, br d, J 6.2 
Hz, NH); C (100 MHz, CDCl3) -5.3 (2 × CH3), 18.4 (C), 26.0 (3 × CH3), 28.6 (3 × CH3), 
54.2 (CH), 57.1 (CH), 62.2 (CH2), 80.7 (C), 92.7 (C), 119.8 (CH2), 133.5 (CH), 157.2 
(C), 162.0 (C); m/z (CI) 475.1370 (MH+. C18H34
35Cl3N2O4Si requires 475.1353), 419 
(100%), 421 (97), 377 (69), 375 (67), 341 (18), 274 (21), 218 (59), 174 (44), 133 (50), 
69 (23). 
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